{"text": "Finally , recent data demonstrate the novel role of rituximab as a signal - inducing antibody , and as a chemosensitizing agent , capable of negative regulation of major survival pathways [ 16 ] .", "label": "", "metadata": {}, "score": "25.238522"}
{"text": "In this field , studies in B - NHL cell lines revealed several mechanisms involved in rituximab - mediated chemo / immunosensitization .Rituximab was shown to inhibit the p38 mitogen - activated protein kinase , nuclear factor- \u03ba B ( NF- \u03ba B ) , extracellular signal - regulated kinase 1/2 ( ERK 1/2 ) , and Akt antiapoptotic survival pathways [ 17 ] .", "label": "", "metadata": {}, "score": "26.482662"}
{"text": "Briefly , the major mechanism of rituximab - induced B - cell depletion involves antibody - dependent cell - mediated cytotoxicity ( ADCC ) and complement dependent cytotoxicity ( CDC ) [ 15 ] .", "label": "", "metadata": {}, "score": "26.612507"}
{"text": "A recent report by Beers et al . showed that rituximab is able to induce CD20 internalization in a B - CLL mouse model [ 54 ] .", "label": "", "metadata": {}, "score": "27.867348"}
{"text": "These data suggest that rILYd4 may enhance the anticancer activity of ofatumumab and rituximab in B - cell malignancies that have relapsed after prior antibody - based therapies .", "label": "", "metadata": {}, "score": "28.439816"}
{"text": "Interestingly , recent studies also show that rituximab strongly affects BCR signaling [ 22 ] .Pretreatment of lymphoma cells or healthy B - cells with rituximab results in a time - dependent inhibition of the BCR - signaling cascade involving Lyn , Syk , PLC \u03b3 2 , Akt , ERK , and calcium flux .", "label": "", "metadata": {}, "score": "29.794058"}
{"text": "Finally , in association with impaired ubiquitination and attenuated breakdown of CD20 , JY / BTZ cells harbored a net 3-fold increase in CD20 cell surface expression , which was functionally implicated in conferring a significantly increased anti - CD20/rituximab - mediated CDC .", "label": "", "metadata": {}, "score": "30.385342"}
{"text": "Here , we further investigated whether rILYd4 can sensitize B - cell malignancies to ofatumumab - mediated CDC and whether either ofatumumab - mediated CDC or rILYd4-enhanced ofatumumab - mediated CDC correlates with CD20 or CD59 expression , known biomarkers involved in rituximab activity .", "label": "", "metadata": {}, "score": "30.576832"}
{"text": "These authors observed that many tumors , including lymphomas , upregulate the expression of CD46 , an inhibitory complement receptor .As a means to overcome this issue , they identify a recombinant adenovirus type 35 fiber knop protein ( Ad35 K + + ) which , when incubated with lymphoma cells , leads to CD46 downregulation and cooperates with rituximab in inducing CDC .", "label": "", "metadata": {}, "score": "31.613844"}
{"text": "Several studies are assessing the role of rituximab as part of high - dose regimens ( HDT ) pre - ASCT in DLBCL because of its effectiveness , limited toxicity , and its ability to deplete B cells .", "label": "", "metadata": {}, "score": "33.08226"}
{"text": "Figure 1 : Schematic representation of the putative mechanisms mediating rituximab 's anticancer activity in NHL cells .The anti - CD20 monoclonal antibody rituximab has several mechanisms of action , including antibody - dependent cellular cytotoxicity ( ADCC ) , which involves recruitment of effector cells , mediated by Fc \u03b3 receptors ; complement - dependent cytotoxicity ( CDC ) ; apoptosis induction .", "label": "", "metadata": {}, "score": "33.16676"}
{"text": "The p53 mutant R248 can activate the transcription of several genes associated with chemoresistance , namely c - Myc , CXCL1 , PCNA , ABCB1 ( MDR1 ) , and IGF1R [ 51 - 53 , 56 , 77 , 86 , 87 ] ( Figure 2 ) .", "label": "", "metadata": {}, "score": "34.516556"}
{"text": "These were shown to transactivate the CD20 gene through promoter hyperacetylation and Sp1 recruitment .In line with these premises , HDAC inhibitors potentiated the activity of rituximab both in vitro and in vivo in murine lymphoma models .", "label": "", "metadata": {}, "score": "36.150505"}
{"text": "However , they were able to identify a rituximab triple mutant ( H57DE / H102YK / L93NR ) with an extremely potent apoptosis - inducing activity .", "label": "", "metadata": {}, "score": "36.344307"}
{"text": "Based on the differential impact on CD20 expression in BTZ - sensitive and BTZ - resistant cells , one should take caution when considering combining rituximab and BTZ for B cell targeting ; efficacy may only be realized in BTZ - resistant cells .", "label": "", "metadata": {}, "score": "36.81177"}
{"text": "A fragment - based approach was also considered but a different , more conventional , binding mode was observed .Compound selectivity against GSK-3beta was improved using a rational design strategy , with crystallographic verification of the CDK2 binding mode .", "label": "", "metadata": {}, "score": "37.06534"}
{"text": "Since BCR signaling appears to be crucial for healthy and malignant B cell survival and expansion [ 23 - 25 ] , this mode of action of rituximab could actually have an important role in mediating its anticancer activity .", "label": "", "metadata": {}, "score": "37.118896"}
{"text": "Together , these results suggest that increased expression levels of CD20 in JY / BTZ cells may be exploited as an alternative therapy to combat BTZ resistance through rituximab - induced CDC .", "label": "", "metadata": {}, "score": "37.429882"}
{"text": "Collectively , the data show that NVP - AUY922 is a potent , novel inhibitor of HSP90 , acting via several processes ( cytostasis , apoptosis , invasion , and angiogenesis ) to inhibit tumor growth and metastasis .", "label": "", "metadata": {}, "score": "37.507088"}
{"text": "The efficacy of rituximab is associated with proficient CD20 expression on the surface of B cells , and indeed , acquisition of rituximab resistance appears to be correlated with down - regulation of CD20 [ 8 , 9 ] .", "label": "", "metadata": {}, "score": "37.643234"}
{"text": "Recently , it has been reported [ 46 ] that proteasome inhibition and ubiquitination of CD20 triggers its degradation and decreases its cell surface expression .", "label": "", "metadata": {}, "score": "38.05086"}
{"text": "This alteration does not significantly affect the overall conformation of the p53 protein but changes the DNA binding response element , thereby altering interactions with DNA [ 84 ] .", "label": "", "metadata": {}, "score": "38.127483"}
{"text": "It has been demonstrated that using a cycle of rituximab in association with stem cell transplantations and after it as maintenance therapy , yields better results than transplant alone .", "label": "", "metadata": {}, "score": "38.179825"}
{"text": "New anti - CD20 mAbs ( tositumomab - like ) may be able to induce considerably less CD20 down - modulation than rituximab , and thus possibly be more effective ( see below ) [ 54 ] .", "label": "", "metadata": {}, "score": "38.4822"}
{"text": "These results demonstrate that acquired resistance to BTZ in B cells can be overcome by next generation PIs and by anti - CD20/rituximab - induced CDC , thereby paving the way for salvage therapy in BTZ - resistant disease .", "label": "", "metadata": {}, "score": "38.60981"}
{"text": "Importantly , rituximab depletes both malignant and normal CD20 + B lymphocytes [ 4 , 12 , 13 ] .Rituximab 's Mode of Action in Lymphoma Cells .", "label": "", "metadata": {}, "score": "38.661854"}
{"text": "V158411 abrogated gemcitabine and camptothecin induced cell cycle checkpoints , resulting in the expected modulation of cell cycle proteins and increased cell death in cancer cells .", "label": "", "metadata": {}, "score": "39.304276"}
{"text": "Further experimentation with this administration method is warranted to assess its applicability in patients .( vii ) Rituximab Mutants with Proapoptotic Activity .In order to improve rituximab anticancer activity , Li and colleagues modulated the binding property of this mAb by introducing several point mutations in its complementarity - determining regions [ 91 ] .", "label": "", "metadata": {}, "score": "39.310177"}
{"text": "Since levels of immunoproteasome subunits were largely unaltered and no mutations were observed in the \u03b25i subunit in JY / BTZ cells , it may also explain the marginal levels of cross - resistance that were observed for the immunoproteasome - specific inhibitor ONX 0914 .", "label": "", "metadata": {}, "score": "39.427223"}
{"text": "Improving Rituximab Efficacy and Overcoming Resistance .Despite the expression of CD20 on their lymphoma cells , some patients exhibit primary resistance and do not respond well to this targeted antibody therapy .", "label": "", "metadata": {}, "score": "39.668343"}
{"text": "These authors demonstrate that CD47 overexpression correlates with worse prognosis .Blocking anti - CD47 antibodies promote phagocytosis of NHL cells and cooperate with rituximab both in vitro and in vivo in murine NHL xenotransplant models .", "label": "", "metadata": {}, "score": "39.880226"}
{"text": "Interestingly , the duration of response appears to exceed 3 years in about 25 % of patients [ 123 ] .The benefit of adding a radioisotope to the antibody was confirmed in a study enrolling patients with indolent NHL that were refractory to rituximab .", "label": "", "metadata": {}, "score": "39.930443"}
{"text": "Human CD59 , a key membrane complement regulator that inhibits CDC , is highly expressed in B - cell malignancies and its upregulation is an important determinant of the sensitivity of B - cell malignancies to rituximab treatment .", "label": "", "metadata": {}, "score": "39.98301"}
{"text": "Several mechanisms have been reported that have the potential to contribute to reductions in rituximab efficacy .The identification of such mechanisms has allowed for the proposal of strategies to overcome these issues , and thus achieve better in vivo activity .", "label": "", "metadata": {}, "score": "40.093277"}
{"text": "Finally , it would be of additional future interest to explore whether aberrations in protein ubiquitination provoked by prolonged exposure to either BTZ or other types of PIs , may be instrumental to upregulated expression of other B cell surface markers that could elicit antibody - mediated CDC .", "label": "", "metadata": {}, "score": "40.098457"}
{"text": "In addition , the benefit of adding rituximab to chemotherapy in B - CLL was shown by several other trials [ 40 , 74 - 77 ] .", "label": "", "metadata": {}, "score": "40.209465"}
{"text": "Second , . FLT3 neutralizing antibodies target the extracellular domain , which is less prone to mutations than the kinase domain , reducing the possibility for drug resistance .", "label": "", "metadata": {}, "score": "40.25442"}
{"text": "In the treatment of autoimmune diseases , rituximab also now has an accepted place [ 3 - 5 , 43 ] , but BTZ or other PIs still await clinical evaluation .", "label": "", "metadata": {}, "score": "40.624153"}
{"text": "To avoid dominant negative interferences , knockdown of WT p53 using siRNA - mediated gene silencing combined with overexpression of oncomorphic p53 could examine oncomorphic activity .", "label": "", "metadata": {}, "score": "40.827812"}
{"text": "In addition to mediating chemoresistance , interactions between R273H / C mutant p53 and other proteins may contribute to oncogenesis or tumor progression .The best characterized R273H p53 interaction is with its family member p63 .", "label": "", "metadata": {}, "score": "41.01848"}
{"text": "To address these issues , we provoked acquired resistance to BTZ in a human B cell line model and investigated its impact on rituximab sensitivity and next - generation PIs designed to overcome BTZ - resistance .", "label": "", "metadata": {}, "score": "41.183174"}
{"text": "We will discuss here the current therapeutic applications of rituximab in indolent NHL , diffuse large B cell non - Hodgkin lymphoma ( DLBCL ) , and in B - cell chronic lymphocytic leukemia ( B - CLL ) .", "label": "", "metadata": {}, "score": "41.57233"}
{"text": "Through its ability to modulate multiple pathways involved in oncogenesis , Hsp90 has generated considerable interest as a therapeutic target .NVP - BEP800 is a novel , fully synthetic , orally bioavailable inhibitor that binds to the NH(2)-terminal ATP - binding pocket of Hsp90 .", "label": "", "metadata": {}, "score": "41.79412"}
{"text": "Other mAbs for NHL .In addition to the above - mentioned strategies aiming to improve rituximab activity , numerous research efforts have led to new mAbs directed against different target antigens and to the development of radioimmunoconjugates .", "label": "", "metadata": {}, "score": "42.022114"}
{"text": "CD20 is associated with resistance to rituximab , although the mechanism whereby this CD20 splice variant impairs the benefit of rituximab remains to be determined .", "label": "", "metadata": {}, "score": "42.2433"}
{"text": "These findings suggest that complement plays a role in the development of DSS - induced colitis and that blockade of the complement system might be useful for the acute phase of IBD treatment . C1INH , however , leads to an amelioration of DSS - induced colitis via a mechanism that does not involve the inhibition of complement or contact system activation but does result in significant suppression of leukocyte infiltration .", "label": "", "metadata": {}, "score": "42.315758"}
{"text": "These modified versions of rituximab hold promise as new therapeutic agents for B - cell lymphomas , although their efficacy in patients still has to be assessed .", "label": "", "metadata": {}, "score": "42.33251"}
{"text": "Moreover , these authors were able to establishe a human tumor - bearing NOD / Shi - scid - IL-2R \u03b3 ( null ) mouse model , in which human complement functions as the CDC mediator .", "label": "", "metadata": {}, "score": "42.35486"}
{"text": "A competitive binding assay gave a lower IC50 of 21 \u00b1 4 nmol / L for VER-50589 compared with 47 \u00b1 9 nmol / L for VER-49009 .", "label": "", "metadata": {}, "score": "42.422222"}
{"text": "Importantly , stabilization of the mutant protein restores WT p53 conformation and thereby normal function .To date , the effect of this drug has not been explored in in vivo cell or mouse models of cancer .", "label": "", "metadata": {}, "score": "42.59419"}
{"text": "These results rule out any significant role for p38 MAPK signalling in BT mediated cytotoxicity .Activation of the PI-3 K / Akt pathway has been shown to induce resistance to apoptosis induced by a number of drugs and has been linked to cisplatin resistance in ovarian cancer cell lines [ 39 , 40 ] .", "label": "", "metadata": {}, "score": "42.638435"}
{"text": "Recent data suggest that sequential radioimmunotherapy after chemotherapy may have significant clinical value .Additionally , novel monoclonal antibodies are under development .If these will prove to be more effective than rituximab will have to be assessed by randomized comparative trials .", "label": "", "metadata": {}, "score": "42.8207"}
{"text": "Moreover , anti - miR-155 delivered systemically showed uptake in the BM CD19(+ ) cells of WM - engrafted mice , resulting in the up - regulation of several miR-155 target mRNAs in these cells , and decreased tumor growth significantly in vivo .", "label": "", "metadata": {}, "score": "42.82559"}
{"text": "Acquisition of bortezomib resistance and cross - resistance to other proteasome inhibitors .The human JY B cell line was used as a model to examine the cellular effects of long - term exposure of B cells to BTZ , including the acquisition of BTZ resistance .", "label": "", "metadata": {}, "score": "42.90281"}
{"text": "Additionally , as compared to rituximab , Zevalin produces higher response rates among patients with follicular or low - grade lymphoma who have not previously received antibody - based treatments ( ORR 80 % versus 56 % , .", "label": "", "metadata": {}, "score": "43.012886"}
{"text": "10.1385/IR:31:2:119 PubMed View Article .Bil J , Winiarska M , Nowis D , Bojarczuk K , Basak GW , Sulek K , Jakobisiak M , Golab J , browska - Iwanicka A : Bortezomib modulates surface CD20 in B - cell malignancies and affects rituximab - mediated complement - dependent cytotoxicity .", "label": "", "metadata": {}, "score": "43.03361"}
{"text": "( iv ) Enhancing CDC .Studies showed that also complement can be depleted upon rituximab infusion in B - CLL patients [ 79 ] .", "label": "", "metadata": {}, "score": "43.05013"}
{"text": "Several anti - FLT3 antibodies , including EB10 , NC7 and D4 - 3 , inhibit both ligand - dependent ( wild - type receptor ) as well as ligand - independent ( mutant receptor ) activation of FLT3 ( see Piloto , Cancer Res . , supra . )", "label": "", "metadata": {}, "score": "43.138496"}
{"text": "This mechanism causes osmotic lysis of neoplastic B cells [ 13 , 14 ] .ADCC is triggered by the interaction between rituximab and the Fc receptor of natural killer ( NK ) cells [ 13 , 14 ] .", "label": "", "metadata": {}, "score": "43.16457"}
{"text": "The loss of p63 activity , due to a dominant negative effect of R273H p53 , can also increase invasive and metastatic properties through enhanced recycling of integrins and EGFR to the plasma membrane [ 82 ] .", "label": "", "metadata": {}, "score": "43.275906"}
{"text": "Phospho - Bcl-2 was detected using an antibody that detects Bcl-2 only when phosphorylated at threonine56 .Expression of pro - survival marker XIAP , a direct inhibitor of executioner caspases , such as caspase-3 , was down - regulated within 24 hrs following the BT treatment ( 100 \u03bcM ) in all the cell lines ( Figure 7 C ) .", "label": "", "metadata": {}, "score": "43.301933"}
{"text": "( A ) Relative mRNA levels of constitutive and immunoproteasome subunits in JY / WT and BTZ - resistant variants JY/35BTZ and JY/100BTZ .mRNA levels were normalized relative to \u03b2 - glucuronidase as house keeping gene .", "label": "", "metadata": {}, "score": "43.319157"}
{"text": "Whether the observed reduction in CD20 levels actually reflects shaving , or rather antigen masking by rituximab , remains unclear [ 79 , 80 ] .", "label": "", "metadata": {}, "score": "43.50009"}
{"text": "Studies analyzing sensitivity to drugs in hepatocellular carcinoma cells found that the mutant R248Q confers chemoresistance to doxorubicin and paclitaxel .This effect is mediated by the upregulation of multidrug resistance gene 1 ( MDR1 , also ABCB1 or P -glycoprotein ) [ 37 ] .", "label": "", "metadata": {}, "score": "43.627678"}
{"text": "The synergy of cisplatin pretreatment and CD95 triggering in inducing cell death was also shown in p53mu tumor cells derived from ascitic fluid of advanced - stage EOC patients .", "label": "", "metadata": {}, "score": "43.638462"}
{"text": "Second , C1INH bound to host CD36 and Chondroitin Sulfate - A molecules , interfering with cytoadhesion of infected RBCs by competitive binding to these receptors in vitro , and reducing sequestration in specific tissues and protecting against ECM in vivo .", "label": "", "metadata": {}, "score": "43.857117"}
{"text": "Novel protein interactions have been described between the p53 R273 mutant proteins and the transcription factors NF - Y , SP1 , SREBP-2 , MRE11 , and p63 .", "label": "", "metadata": {}, "score": "43.862457"}
{"text": "Similar to the R273 and R248 p53 oncomorphs , the R175H mutated protein can interact with proteins NF - Y , p63 , p73 , and SP-1 to increase cell cycle progression , survival , metastasis , and chemoresistance [ 57 , 61 , 79 , 81 , 82 ] .", "label": "", "metadata": {}, "score": "44.100494"}
{"text": "This interaction of R248 with p73 only occurs in the background of a codon 72 single nucleotide polymorphism ( SNP ) that encodes an arginine or a proline ( P72 or R72 ) .", "label": "", "metadata": {}, "score": "44.204956"}
{"text": "These data are consistent with a previous study by our group in which inhibition of EGFR only synergized with chemotherapy in the absence of R175H p53 [ 91 ] .", "label": "", "metadata": {}, "score": "44.306133"}
{"text": "The underlying mechanism of this effect has been assumed to result primarily from inhibition of complement system activation .We recently demonstrated that C1INH plays a direct role in suppression of leukocyte transmigration in the mouse intestinal ischemia and reperfusion model .", "label": "", "metadata": {}, "score": "44.31671"}
{"text": "We determined which catalytic subunits of phosphoinositide 3-kinase ( PI3 K ) were in active complex with the p85 regulatory subunit and showed enrichment for the \u03b1 subunit in three CLLs carrying PIK3CA amplification .", "label": "", "metadata": {}, "score": "44.376644"}
{"text": "( C ) Relative protein expression of constitutive and immunoproteasome subunits in JY / WT and BTZ - resistant variants JY/35BTZ and JY/100BTZ .( D ) Total constitutive and immunoproteasome subunit expression in JY / WT and BTZ - resistant variants JY/35BTZ and JY/100BTZ .", "label": "", "metadata": {}, "score": "44.440544"}
{"text": "Other approaches such as targeting cellular proteins responsible for stabilizing mutant p53 are another route that may bring success .A recent development involves inhibiting the heat - shock protein HSP90 , which chaperones many mutant p53 proteins [ 106 , 107 ] and prevents their degradation by the E3 ubiquitin ligase MDM2 [ 108 , 109 ] .", "label": "", "metadata": {}, "score": "44.518467"}
{"text": "This displacement was achieved with a nitrile group , presenting an example of efficient gain in binding affinity with minimal increase in molecular weight .Some compounds in this chemical series inhibit the proliferation of human cancer cell lines in vitro and cause depletion of oncogenic Hsp90 client proteins and concomitant elevation of the co - chaperone Hsp70 .", "label": "", "metadata": {}, "score": "44.528645"}
{"text": "Consistent with HSP90 inhibition , VER-50589 and VER-49009 caused induction of HSP72 and HSP27 alongside depletion of client proteins , including C - RAF , B - RAF , and survivin , and the protein arginine methyltransferase PRMT5 .", "label": "", "metadata": {}, "score": "44.665306"}
{"text": "Targeting CD20 Transcript Variants Associated with Resistance .Henry and coworkers have recently identified an alternative CD20 transcript variant ( .CD20 ) associated with resistance to rituximab [ 82 ] .", "label": "", "metadata": {}, "score": "44.75696"}
{"text": "In order to assess the role of pP38 signalling in BT induced cytotoxicity , a cell viability assay was performed in the presence of a p38 inhibitor , SB203580 .", "label": "", "metadata": {}, "score": "44.78679"}
{"text": "Consistent with these data , protein levels of constitutive proteasome subunits were increased in BTZ - resistant JY cells ( up to 2-fold ) , whereas the expression levels of immunoproteasome subunits remained largely unaltered ( Figure 2B -D ) .", "label": "", "metadata": {}, "score": "45.089043"}
{"text": "Abstract .Background .In clinical and experimental settings , antibody - based anti - CD20/rituximab and small molecule proteasome inhibitor ( PI ) bortezomib ( BTZ ) treatment proved effective modalities for B cell depletion in lymphoproliferative disorders as well as autoimmune diseases .", "label": "", "metadata": {}, "score": "45.1352"}
{"text": "In the present study , Compound K induced the activation of JNK and p38 MAPK in a time - dependent manner ( Figure 5A ) .", "label": "", "metadata": {}, "score": "45.205097"}
{"text": "BDP5290 demonstrated marked selectivity for MRCK\u03b2 over ROCK1 or ROCK2 for inhibition of myosin II light chain ( MLC ) phosphorylation in cells .While BDP5290 was able to block MLC phosphorylation at both cytoplasmic actin stress fibres and peripheral cortical actin bundles , the ROCK selective inhibitor Y27632 primarily reduced MLC phosphorylation on stress fibres .", "label": "", "metadata": {}, "score": "45.251007"}
{"text": "After treatment with MAPK inhibitors or / and Compound K , cell viability was assessed by MTT assay .( C )After transfection of siRNA against MAPK , and/or Compound K , cell viability was assessed by MTT assay .", "label": "", "metadata": {}, "score": "45.280334"}
{"text": "After treatment with MAPK inhibitors or / and Compound K , cell viability was assessed by MTT assay .( C )After transfection of siRNA against MAPK , and/or Compound K , cell viability was assessed by MTT assay .", "label": "", "metadata": {}, "score": "45.280334"}
{"text": "Therefore , several randomized trials have been conducted in order to analyze the benefit of rituximab maintenance treatment in NHL [ 66 - 68 ] .", "label": "", "metadata": {}, "score": "45.354897"}
{"text": "Our results demonstrate a significant restoration of cell viability in the presence of 1 mM ascorbic acid in all cell lines tested .Interestingly , cisplatin - resistant variants of IGROV-1 and A2780 demonstrated greater responses to ascorbic acid pre - treatment than their cisplatin - sensitive counterparts .", "label": "", "metadata": {}, "score": "45.487083"}
{"text": "It is yet unclear whether reduced CD19 levels in JY / BTZ cells would result in a B cell differentiation arrest ; this should be subject for further studies using panels of B cell differentiation - restricted cell surface markers .", "label": "", "metadata": {}, "score": "45.525173"}
{"text": "Here , we describe the detailed biological properties of VER-49009 and the corresponding isoxazole VER-50589 .X - ray crystallography showed a virtually identical HSP90 binding mode .", "label": "", "metadata": {}, "score": "45.57006"}
{"text": "iC1INH had a similar protective effect .Conclusions : These results suggested that C1INH prevented MIR injury in mice and that this cardioprotective effect may not solely result from complement inhibition , but might be also contributed by inhibiting leukocyte recruitment into ischemic tissue , an effect that is not mediated via protease inhibition .", "label": "", "metadata": {}, "score": "45.874386"}
{"text": "However , a cell viability assay using SB203580 pre - treatment ( an inhibitor of p38 ) did not restore cell viability ( Figure 7 B ) .", "label": "", "metadata": {}, "score": "45.89274"}
{"text": "Despite the fact that rituximab used in combination with chemotherapy has been shown to prolong the survival of patients with NHL , residual lymphoma cells ( which then become responsible for disease relapses ) frequently remain [ 65 ] .", "label": "", "metadata": {}, "score": "45.91287"}
{"text": "Activation of NF - \u03baB occurs via phosphorylation of I\u03baB\u03b1 at Ser32 and Ser36 .This is followed by proteasome - mediated degradation resulting in release and nuclear translocation of active NF - \u03baB , where it regulates expression of several pro - survival or pro - apoptotic proteins , e.g. , pIkB\u03b1 , pbcl-2 , bcl - xL , xIAP .", "label": "", "metadata": {}, "score": "45.960327"}
{"text": "Because BT also decreased pAkt expression , BT appears to indirectly reduce the DNA binding activity of NF - \u03baB and affect the expression of NF - \u03baB regulated anti - apoptotic proteins such as pIkB\u03b1 , pbcl-2 , bcl - xL , xIAP .", "label": "", "metadata": {}, "score": "45.98702"}
{"text": "The Met45Ile mutation in the constitutive \u03b25 subunit has apparently lesser consequences for ONX 0914 activity [ 20 ] .Together , constitutive and immunoproteasome targeted epoxyketone - based PIs like carfilzomib , currently evaluated in phase I - III clinical trials [ 54 ] , as well as ONX 0914 may readily overcome BTZ - resistance .", "label": "", "metadata": {}, "score": "45.99217"}
{"text": "4 , pp .2916 - 2924 , 2008 .View at Google Scholar . A. D. Kennedy , P. V. Beum , M. D. Solga et al . , \" Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia , \" Journal of Immunology , vol .", "label": "", "metadata": {}, "score": "45.99666"}
{"text": "Interestingly , down - regulation of several genes regulated by NF - \u03baB ( pIkB\u03b1 , XIAP , pbcl-2 , bcl - xL ) was observed in all cell lines ( Figure 7 C ) .", "label": "", "metadata": {}, "score": "46.08123"}
{"text": "Interestingly , down - regulation of several genes regulated by NF - \u03baB ( pIkB\u03b1 , XIAP , pbcl-2 , bcl - xL ) was observed in all cell lines ( Figure 7 C ) .", "label": "", "metadata": {}, "score": "46.08123"}
{"text": "However , studies show that the addition of rituximab to fludarabine plus cyclophosphamide ( FC ) does improve clinical outcomes in B - CLL patients .", "label": "", "metadata": {}, "score": "46.113373"}
{"text": "In addition , Tob1 inhibited proliferation , migration and invasion , which were reversed in MKN1 and AGS cells transfected with Tob1 siRNA .Overexpression of Tob1 in MKN28 and AGS cells induced the expression of Smad4 , leading to the increased expression and the promoter activity of p15 , which was diminished by silencing of Tob1 using specific siRNA .", "label": "", "metadata": {}, "score": "46.131516"}
{"text": "Liu J , Yoshida Y , Yamashita U : DNA - binding activity of NF - kappaB and phosphorylation of p65 are induced by N - acetylcysteine through phosphatidylinositol ( PI ) 3-kinase .", "label": "", "metadata": {}, "score": "46.163986"}
{"text": "Some reports have shown that ROS acted as upstream regulators , resulting in the activation of p38 MAPK and JNK [ 52 , 53 ] .", "label": "", "metadata": {}, "score": "46.267612"}
{"text": "Another novel protein interaction was recently identified between R273H and the nuclease MRE11 [ 73 ] .MRE11 is essential for repairing double - strand DNA breaks and is recruited to damaged DNA as part of the larger MRN DNA damage complex , consisting of Mre11 , Rad50 , and Nbs1 .", "label": "", "metadata": {}, "score": "46.317455"}
{"text": "Indeed , many tumors with this particular mutation have a significant correlation between p53 expression and AKT phosphorylation [ 82 ] .The oncomorph R273H / C association with SREBP transcription factors results in a novel p53-mediated regulation of mevalonate genes , which are involved in statin and sterol biosynthesis [ 60 ] .", "label": "", "metadata": {}, "score": "46.355415"}
{"text": "Finally , the efficacy of rituximab monotherapy in patients with relapsed or refractory CD20-positive low - grade or follicular lymphoma was examined in noncomparative multicentre trials [ 33 - 35 , 47 - 55 ] .", "label": "", "metadata": {}, "score": "46.39605"}
{"text": "Remarkably , IL-2 treatment can restore NK cell - mediated ADCC .In line with this concept , Berdeja and coworkers found that systemic interleukin-2 and adoptive transfer of lymphokine - activated killer cells improves antibody - dependent cellular cytotoxicity in patients with relapsed B - cell lymphoma treated with rituximab [ 86 ] .", "label": "", "metadata": {}, "score": "46.429703"}
{"text": "The sensitivity to CDC effects mediated by ofatumumab positively correlated with the ratio of CD20/CD59 and negatively correlated with CD59 levels on CLL cells .", "label": "", "metadata": {}, "score": "46.432472"}
{"text": "NF - kB inhibition in cancer cells has been shown to enhance chemotherapeutic response [ 44 , 45 ] .BT has also been reported to inhibit NF - kB signalling via inhibition of IkB\u03b1 phosphorylation in vitro [ 14 ] .", "label": "", "metadata": {}, "score": "46.516808"}
{"text": "Finally , Sato and colleagues have recently reported the identification of a novel CDC - enhancing variant of rituximab ( 113F ) [ 88 ] .", "label": "", "metadata": {}, "score": "46.530582"}
{"text": "Additionally , NF - kB regulated genes involved in cell survival , e.g. , IkB\u03b1 , xIAP , bcl-2 , bcl - xl and were analyzed by western blotting .", "label": "", "metadata": {}, "score": "46.719147"}
{"text": "Interestingly , WT p53 also interacts with several of these transcription factors ( i.e. , NF - Y and SP-1 ) , although the interaction has the opposite effect compared to oncomorphic p53 [ 58 , 69 , 83 ] .", "label": "", "metadata": {}, "score": "46.761658"}
{"text": "Interestingly , CD20 's ability to induce cytosolic Ca 2 + flux appears to be BCR dependent .Rituximab ( Rituxan , Mabthera ) , is the first anti - CD20 monoclonal antibody approved by the Food and Drug Administration ( FDA ) ( on November 26 , 1994 ) for the treatment of relapsed or refractory , CD20 + follicular lymphoma ( FL ) .", "label": "", "metadata": {}, "score": "46.790016"}
{"text": "Remarkably , while peripheral CD27- na\u00efve B cells were present , Bedognetti et al .found a profound depletion in CD27+B memory cells , which may well explain the defective induction of antiflu immunity .", "label": "", "metadata": {}, "score": "46.990158"}
{"text": "The anti - CD20 mAb rituximab is one of the best examples of this new class of therapeutics , since it has rapidly become a key part of the pharmacological schemes used to treat Non - Hodgkin 's lymphomas ( NHLs ) .", "label": "", "metadata": {}, "score": "47.04658"}
{"text": "In a human colon cancer xenograft model , 40f inhibits tumor growth by approximately 50 % .[ Show abstract ] [ Hide abstract ] ABSTRACT : Virtual screening against a pCDK2/cyclin A crystal structure led to the identification of a potent and novel CDK2 inhibitor , which exhibited an unusual mode of interaction with the kinase binding motif .", "label": "", "metadata": {}, "score": "47.06568"}
{"text": "It is also endowed with anti - inflammatory properties that are independent of protease inhibition .The goal of these studies was to investigate the role and mechanism of C1INH in alleviating IR - induced intestinal injury .", "label": "", "metadata": {}, "score": "47.07299"}
{"text": "Beyond immunotherapy approaches , small molecule targeting of B - cells has been achieved with proteasome inhibitors ( PIs ) such as bortezomib ( BTZ ) [ 10 ] .", "label": "", "metadata": {}, "score": "47.100727"}
{"text": "Potent direct CIR - mediated killing and in vitro tumor growth inhibition mediated by transduced PBMC were observed against targets expressing different levels of HER2 .", "label": "", "metadata": {}, "score": "47.124527"}
{"text": "( C ) Expression of cyclin - dependent kinase inhibitors such as p27 Kip1 and p21 Cip1 in BT treated cell lines , as analyzed by western blotting of cellular lysates using appropriate primary and secondary antibodies .", "label": "", "metadata": {}, "score": "47.21103"}
{"text": "These results indicate that JNK and p38 MAPK may play a role in Compound K - induced cytotoxicity in HT-29 cells .Experimental Section .Chemicals .", "label": "", "metadata": {}, "score": "47.256577"}
{"text": "[ Google Scholar ] .Gualberto , A. ; Aldape , K. ; Kozakiewicz , K. ; Tlsty , T.D. An oncogenic form of p53 confers a dominant , gain - of - function phenotype that disrupts spindle checkpoint control .", "label": "", "metadata": {}, "score": "47.279816"}
{"text": "Results represent the mean \u00b1 SD of 6 separate experiments .( B ) Resistance factor for BTZ and cross- resistance factors to ONX 0914 ( immunoproteasome inhibitor ) , MG-132 , and carfilzomib .", "label": "", "metadata": {}, "score": "47.30665"}
{"text": "For example , it is not certain if pharmacological activation of p53 will restore all of its multifaceted biological responses , assuming that the targeted cell is not killed following p53 activation .", "label": "", "metadata": {}, "score": "47.348618"}
{"text": "Results depicted are means \u00b1 SD of 5 - 8 separate experiments .Discussion .The current study describes two ways to overcome acquired resistance to BTZ in JY human B cells : ( a ) anti - CD20/rituximab - mediated CDC , and ( b ) next generation epoxyketone - based irreversible PIs .", "label": "", "metadata": {}, "score": "47.376442"}
{"text": "This study demonstrated that Compound K - mediated generation of ROS led to apoptosis through the modulation of a mitochondria - dependent apoptotic pathway and MAPK pathway .", "label": "", "metadata": {}, "score": "47.382706"}
{"text": "View at Google Scholar .P. McLaughlin , A. J. Grillo - L\u00f3pez , B. K. Link et al . , \" Rituximab chimeric anti - CD20 monoclonal antibody therapy for relapsed indolent lymphoma : half of patients respond to a four - dose treatment program , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "47.392483"}
{"text": "In vitro cytotoxicity and inhibition assays were carried out using normal and tumor cell lines expressing different levels of HER2 .Bulk populations of CIR - transduced PBMC could express high levels of the construct and subcloning ensured stable expression .", "label": "", "metadata": {}, "score": "47.58474"}
{"text": "This value increased to 60%-70 % after neutralization of CD46 and CD59 without an appreciable change of ADCC .These results suggest that C is the major contributor to the killing of EOC cells induced by the mixture of cMOV18 and cMOV19 .", "label": "", "metadata": {}, "score": "47.72417"}
{"text": "Binding of adenosine - derived inhibitors to Grp78 was characterized by surface plasmon resonance and isothermal titration calorimetry .X - ray crystal structures of Grp78 bound to ATP , ADPnP , and adenosine derivative 10 revealed differences in the binding site between Grp78 and homologous proteins .", "label": "", "metadata": {}, "score": "47.740448"}
{"text": "Altogether these data support the independent contribution of c - FLIP(L ) in refining the prognostic information obtained from standard clinical - pathological indicators , confirming its pivotal role in promoting cell survival .", "label": "", "metadata": {}, "score": "47.75087"}
{"text": "This study demonstrated that Compound K - mediated generation of ROS led to apoptosis through activation of p38 MAPK and JNK , which modulate the expression of Bcl-2 and Bax , and then trigger loss of mitochondrial membrane potential , cytochrome c release , and caspase activation .", "label": "", "metadata": {}, "score": "47.787148"}
{"text": "Finally , FLT3-specific antibodies can be active against both wild - type ( especially in the case of a neutralizing antibody ) and mutated FLT3 ( due to immune effector mechanisms ) , broadening the target patient population .", "label": "", "metadata": {}, "score": "47.871857"}
{"text": "The discovery of this compound will enable further investigations into the biological activities of MRCK proteins and their contributions to cancer progression .[ Show abstract ] [ Hide abstract ] ABSTRACT : Fragment - Based Drug Discovery ( FBDD ) is here to stay .", "label": "", "metadata": {}, "score": "47.877934"}
{"text": "In this context , it has been reported that rituximab - resistant B cells retain sensitivity for BTZ , but the reverse has not been demonstrated .", "label": "", "metadata": {}, "score": "47.966545"}
{"text": "Phorbol-12-myristate 13-acetate ( PMA ) and ionomycin were from Sigma ( St. Louis , MO , USA ) .Rituximab , a chimeric immunoglobulin G1 , was purchased from Roche ( Roche Netherlands B.V. , Woerden , The Netherlands ) .", "label": "", "metadata": {}, "score": "47.97998"}
{"text": "Medicinal chemistry combined with in vitro enzyme profiling led to the discovery of 4-chloro-1-(4-piperidyl)-N-[5-(2-pyridyl)-1H - pyrazol-4-yl]pyrazole-3-carboxamide ( BDP00005290 ; abbreviated as BDP5290 ) as a potent MRCK inhibitor .", "label": "", "metadata": {}, "score": "48.047413"}
{"text": "[ Google Scholar ] .Chen , KC ; Chang , LS .Arachidonic acid - induced apoptosis of human neuroblastoma SK - N - SH cells is mediated through mitochondrial alteration elicited by ROS and Ca(2+)-evoked activation of p38alpha MAPK and JNK1 .", "label": "", "metadata": {}, "score": "48.074154"}
{"text": "VER-155008 potentiated the apoptotic potential of a small molecule Hsp90 inhibitor in HCT116 but not HT29 or MDA - MB-468 cells .In vivo , VER-155008 demonstrated rapid metabolism and clearance , along with tumor levels below the predicted pharmacologically active level .", "label": "", "metadata": {}, "score": "48.078094"}
{"text": "In A375 melanoma and BT-474 breast cancer cell lines , NVP - BEP800 induced client protein degradation ( including ErbB2 , B - Raf(V600E ) , Raf-1 , and Akt ) and Hsp70 induction .", "label": "", "metadata": {}, "score": "48.080727"}
{"text": "The present invention seeks to provide human anti - FLT3 antibodies which induce rapid and efficient internalization and down - modulation of cell surface FLT3 compared with those inhibitors known in the art .", "label": "", "metadata": {}, "score": "48.102955"}
{"text": "Cell .Biol 2011 , 31 , 4464 - 4481 .[ Google Scholar ] .Gaiddon , C. ; Lokshin , M. ; Ahn , J. ; Zhang , T. ; Prives , C. A subset of tumor - derived mutant forms of p53 down - regulate p63 and p73 through a direct interaction with the p53 core domain .", "label": "", "metadata": {}, "score": "48.319454"}
{"text": "It is widely reported that cisplatin - resistant cell lines maintain high levels of Akt and NF - kB as compared to cisplatin - sensitive cell lines [ 38 ] .", "label": "", "metadata": {}, "score": "48.320316"}
{"text": "Finally , the ability of human SCC12 squamous cell carcinoma cells to invade a three - dimensional collagen matrix was strongly inhibited by 2 \u03bcM BDP5290 but not the identical concentration of Y27632 , despite equivalent inhibition of MLC phosphorylation .", "label": "", "metadata": {}, "score": "48.499924"}
{"text": "Survival of C1INH-/- mice was significantly increased with two doses of C1INH , one given immediately following CLP , and the second at 6 h post - CLP . C1INH may be important in protection from sepsis through enhancement of bacterial uptake by , and/or bactericidal capacity of , phagocytes .", "label": "", "metadata": {}, "score": "48.70758"}
{"text": "In this context , it may be anticipated that replacement of the non - polar , spatially flexible Met45 for another slightly more non - polar , bulkier , and more rigid amino acid as Ile , would affect optimal BTZ binding , thereby resulting in the conferring of drug resistance .", "label": "", "metadata": {}, "score": "48.736217"}
{"text": "For example , the restoration of a tumor suppressor protein , TP53 , is well reported for the discovery of novel cancer chemotherapeutics[56].Relatively less attention has been given to understanding the mechanisms of function of tumor suppressor proteins as targets for new anticancer therapies as compared to the extensive research regarding those of oncogenes .", "label": "", "metadata": {}, "score": "48.803123"}
{"text": "362 - 371 , 2006 .View at Google Scholar \u00b7 View at Scopus . A. R. Jazirehi and B. Bonavida , \" Cellular and molecular signal transduction pathways modulated by rituximab ( rituxan , anti - CD20 mAb ) in non - Hodgkin 's lymphoma : implications in chemosensitization and therapeutic intervention , \" Oncogene , vol .", "label": "", "metadata": {}, "score": "48.83535"}
{"text": "Background .Since the initial approval of rituximab , a monoclonal antibody against CD20 , in 1997 , it has become the cornerstone in the treatment of B cell lymphoproliferative diseases [ 1 ] .", "label": "", "metadata": {}, "score": "49.014294"}
{"text": "Inhibition of FLT3 signaling leads to apoptosis in dendritic cells and inhibition of immune responses .Small - molecule inhibitors are not completely FLT3-specific and drug resistance can develop .", "label": "", "metadata": {}, "score": "49.06009"}
{"text": "These mutations introduced amino acid alterations that clustered in critical positions ( Thr21 , Met45 , Ala49 and Cys52 ) in the BTZ binding pocket within the \u03b25 subunit [ 41 ] .", "label": "", "metadata": {}, "score": "49.14117"}
{"text": "Namely , CLL and mantle cell lymphoma showed greater downmodulation of CD20 in response to rituximab than FL and DLBCL did , and were less responsive to treatment .", "label": "", "metadata": {}, "score": "49.198174"}
{"text": "Moreover , TOB1 interacts with an oncogenic signaling mediator , \u03b2 - catenin , and inhibits \u03b2 - catenin - regulated gene transcription .TOB1 antagonizes the v - akt murine thymoma viral oncogene ( AKT ) signaling and induces cancer cell apoptosis by activating BCL2-associated X ( BAX ) protein and inhibiting the BCL-2 and BCL - XL expressions .", "label": "", "metadata": {}, "score": "49.26355"}
{"text": "However , clinical application of the strategy has been hampered by the potential side effects associated with immunogenicity and by low transduction efficiency .A fully human CIR was constructed that triggers immune activation through the zeta chain of CD3 and contains a human single - chain antibody fragment specific for an extracellular epitope of HER2 .", "label": "", "metadata": {}, "score": "49.33324"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The design and synthesis of novel adenosine - derived inhibitors of HSP70 , guided by modeling and X - ray crystallographic structures of these compounds in complex with HSC70/BAG-1 , is described .", "label": "", "metadata": {}, "score": "49.333706"}
{"text": "BT was reported to reduce melanoma cell migration in a dose - dependent fashion when assayed using in vitro cell migration and invasion systems [ 13 ] .", "label": "", "metadata": {}, "score": "49.41276"}
{"text": "Activity is independent of NQO1/DT - diaphorase , maintained in drug - resistant cells and under hypoxic conditions .The molecular signature of HSP90 inhibition , comprising induced HSP72 and depleted client proteins , was readily demonstrable .", "label": "", "metadata": {}, "score": "49.458305"}
{"text": "In IGROV-1CDDP , 47 % cell viability was restored and A2780-CDDP showed 40 % restoration ( Figure 6 B ) .Effect of BT on pro - survival ( pAkt , NF - \u03baB ) and pro - apoptotic ( pP38 ) signalling molecules .", "label": "", "metadata": {}, "score": "49.470596"}
{"text": "One dose limiting toxicity of a rituximab infusion reaction was seen on cohort 2 , but the regimen was otherwise well tolerated without evidence of differential toxicity by cohort .", "label": "", "metadata": {}, "score": "49.554077"}
{"text": "In vitro , C1INH bound to bacteria cultured from blood or peritoneal fluid of mice with CLP - induced sepsis , but had no direct effect on bacterial growth .", "label": "", "metadata": {}, "score": "49.591904"}
{"text": "6 , pp .753 - 759 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .J. G. Berdeja , A. Hess , D. M. Lucas et al . , \" Systemic interleukin-2 and adoptive transfer of lymphokine - activated killer cells improves antibody - dependent cellular cytotoxicity in patients with relapsed B - cell lymphoma treated with rituximab , \" Clinical Cancer Research , vol .", "label": "", "metadata": {}, "score": "49.597313"}
{"text": "NVP - AUY922 also significantly inhibited tumor cell chemotaxis / invasion in vitro , WM266.4 melanoma lung metastases , and lymphatic metastases from orthotopically implanted PC3LN3 prostate carcinoma .", "label": "", "metadata": {}, "score": "49.645782"}
{"text": "Interestingly , Bedognetti and coworkers have recently evaluated the impact of rituximab on the effectiveness of an antiflu vaccine in patients who had previously been treated with this mAb [", "label": "", "metadata": {}, "score": "49.686565"}
{"text": "The cluster was an independent prognostic factor in both internal and external validation sets .Forced expression of chrXq27.3-cluster selected miRNAs in human EOC cellular models was associated to reduction of cell proliferation and increased sensitivity to cisplatin .", "label": "", "metadata": {}, "score": "49.70017"}
{"text": "The effect on HSP90-p23 complexes , client protein degradation , and heat shock response was investigated in cell culture and breast cancer xenografts by immunohistochemistry , Western blot analysis , and immunoprecipitation .", "label": "", "metadata": {}, "score": "49.705086"}
{"text": "PubMed View Article .Sengupta S , Kim KS , Berk MP , Oates R , Escobar P , Belinson J , Li W , Lindner DJ , Williams B , Xu Y : Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases , which are negatively involved in lysophosphatidic acid - induced cell invasion .", "label": "", "metadata": {}, "score": "49.74423"}
{"text": "found that fresh frozen plasma would then restore rituximab efficacy .More studies on this approach should be performed in order to confirm its viability .", "label": "", "metadata": {}, "score": "49.760017"}
{"text": "In either case , prolonged BTZ exposure may elicit potential anti - inflammatory effects even when anti - proliferative effects are compromised .Acquisition of BTZ resistance in JY cells was associated with opposite impacts on cell surface expression of two common B - cell surface markers : down regulation of CD19 and upregulation of CD20 .", "label": "", "metadata": {}, "score": "49.807987"}
{"text": "Hsp70 is known to be anti - apoptotic , and therefore the induction of Hsp70 may ultimately limit the efficacy of Hsp90 inhibitors under certain circumstances .", "label": "", "metadata": {}, "score": "49.90266"}
{"text": "Specifically , the mutated codon is not in direct contact with DNA but rather creates a binding pocket in the core domain of the protein [ 97 ] that is a druggable interface .", "label": "", "metadata": {}, "score": "50.020622"}
{"text": "Here , we tested whether this mechanism would also apply for BTZ - resistant JY cells .We first determined whether PSMB5 harbored any of the previously described mutations [ 38 - 41 ] .", "label": "", "metadata": {}, "score": "50.053123"}
{"text": "Namely , the anti - CD20/CD20 complex was found to remain at the cell surface long enough to ensure cell killing by specific mechanisms .", "label": "", "metadata": {}, "score": "50.13698"}
{"text": "Due to the fact that disease status might affect immune response , only NHL patients without evidence of disease , who had completed rituximab no less than 6 months before the accrual , were selected for this evaluation .", "label": "", "metadata": {}, "score": "50.206818"}
{"text": "Remarkably , however , JY/35 and JY/100 cells retained full sensitivity towards the next - generation irreversible PI , carfilzomib .Acquisition of bortezomib ( BTZ ) resistant JY cells and proteasome inhibitor cross - resistance profile .", "label": "", "metadata": {}, "score": "50.26719"}
{"text": "Therapeutic effects were concordant with changes in pharmacodynamic markers , including HSP90-p23 dissociation , decreases in ERBB2 and P - AKT , and increased HSP70 protein levels .", "label": "", "metadata": {}, "score": "50.29809"}
{"text": "J. Biol .Chem 2002 , 277 , 18817 - 18826 .[ Google Scholar ] .Di Como , C.J. ; Gaiddon , C. ; Prives , C. p73 function is inhibited by tumor - derived p53 mutants in mammalian cells .", "label": "", "metadata": {}, "score": "50.30387"}
{"text": "Analogues from this series have high affinity for Hsp90 , as measured in a fluorescence polarization ( FP ) competitive binding assay , and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72 .", "label": "", "metadata": {}, "score": "50.49121"}
{"text": "Although a standard scheme for rituximab maintenance therapy has not been established yet , it is currently under investigation and the ongoing studies will establish the most effective regimen .", "label": "", "metadata": {}, "score": "50.52841"}
{"text": "[ Google Scholar ] .Deng , YT ; Huang , HC ; Lin , JK .Rotenone induces apoptosis in MCF-7 human breast cancer cell - mediated ROS through JNK and p38 signaling .", "label": "", "metadata": {}, "score": "50.542442"}
{"text": "CD20 could become a therapeutic target , for instance for the development of antilymphoma vaccines .Whether this approach will prove effective remains to be assessed .", "label": "", "metadata": {}, "score": "50.64484"}
{"text": "Collectively , our study demonstrates that the overexpression of Tob1 inhibits gastric cancer progression by activating Smad4- and inhibiting \u03b2\u2011catenin - mediated signaling pathways .Moreover , some agents kill p53-deficient cancer cells based on their increased tendency to undergo polyploidization .", "label": "", "metadata": {}, "score": "50.66073"}
{"text": "Proteasome inhibitors Anti - CD20/rituximab therapy B cells Autoimmune disorders Resistance .Electronic supplementary material .The online version of this article ( doi : 10 .", "label": "", "metadata": {}, "score": "50.721024"}
{"text": "Down - regulation of c - FLIP(L ) with antisense oligonucleotides increased CD95-mediated apoptosis as in cells sensitized by CHX , demonstrating the direct involvement of c - FLIP(L ) in apoptosis resistance .", "label": "", "metadata": {}, "score": "50.769375"}
{"text": "Mean cellular antiproliferative GI50 values for VER-50589 and VER-49009 for a human cancer cell line panel were 78 \u00b1 15 and 685 \u00b1 119 nmol / L , respectively , showing a 9-fold potency gain for the isoxazole .", "label": "", "metadata": {}, "score": "50.782806"}
{"text": "Methods .Here we studied the molecular basis of acquired resistance to BTZ in JY human B lymphoblastic cells following prolonged exposure to this drug and examined possibilities to overcome resistance by next generation PIs and anti - CD20/rituximab - mediated complement - dependent cytotoxicity ( CDC ) .", "label": "", "metadata": {}, "score": "50.843044"}
{"text": "Restoration of cell viability was analyzed .An additional cell viability assay was performed in order to assess role of p38 activation in BT induced cytotoxicity , in presence of the p38 inhibitor SB203580 .", "label": "", "metadata": {}, "score": "50.854652"}
{"text": "[ Google Scholar ] .Lin , J. ; Teresky , A.K. ; Levine , A.J. Two critical hydrophobic amino acids in the N -terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants .", "label": "", "metadata": {}, "score": "50.8555"}
{"text": "( ii )Galiximab : a primatised anti - CD80 ( IgG1 \u03bb ) mAb with human constant regions and primate ( cynomologus macaque ) variable regions [ 101 ] .", "label": "", "metadata": {}, "score": "50.881897"}
{"text": "The present invention seeks to provide human anti - FLT3 antibodies which have improved ability to activate downstream immune effector functions including ADCC as compared with those inhibitors known in the art .", "label": "", "metadata": {}, "score": "51.01605"}
{"text": "Abstract .Monoclonal antibodies have been the most successful therapeutics ever brought to cancer treatment by immune technologies .The use of monoclonal antibodies in B - cell Non - Hodgkin 's lymphomas ( NHL ) represents the greatest example of these advances , as the introduction of the anti - CD20 antibody rituximab has had a dramatic impact on how we treat this group of diseases today .", "label": "", "metadata": {}, "score": "51.035316"}
{"text": "Recently , this type of approach has shown promising results in B - cell malignances [ 109 ] .Single agent therapy APOLIZUMAB in previously untreated B - CLL patients showed an ORR of 83 % [ 110 ] .", "label": "", "metadata": {}, "score": "51.03543"}
{"text": "Growth suppression was mediated by G1 blockade involving increased p21 expression and suppressed cyclin B1 , CDK1 , and CDC25C.In addition , the compound inhibited growth of multicellular spheroids and caused severe retardation of population kinetics in long - term treatments .", "label": "", "metadata": {}, "score": "51.111794"}
{"text": "The majority of anticancer ( cytotoxic ) drugs induce apoptosis via the intrinsic ( mitochondrial - cytochrome c / Apaf-1/caspase-9 pathway ) [ 21 , 22 ] .", "label": "", "metadata": {}, "score": "51.15043"}
{"text": "Mol .Biol 1997 , 43 , 935 - 949 .[ Google Scholar ] .Chicas , A. ; Molina , P. ; Bargonetti , J. Mutant p53 forms a complex with Sp1 on HIV - LTR DNA .", "label": "", "metadata": {}, "score": "51.154793"}
{"text": "In these tumor models , NVP - BEP800 modulated Hsp90 client proteins and downstream signaling pathways at doses causing antitumor activity .NVP - BEP800 showed in vivo activity in a variety of dosing regimens covering daily to weekly schedules , potentially providing a high degree of flexibility in dose and schedule within the clinical setting .", "label": "", "metadata": {}, "score": "51.2682"}
{"text": "Nat .Genet 2000 , 25 , 47 - 54 .[ Google Scholar ] .Bargonetti , J. ; Chicas , A. ; White , D. ; Prives , C. p53 represses Sp1 DNA binding and HIV - LTR directed transcription .", "label": "", "metadata": {}, "score": "51.29557"}
{"text": "Here , we will focus on the use of rituximab in the treatment of NHL , on the clinical issues associated with this therapeutic , and on the most recent advances in the field of lymphoma immunotherapy .", "label": "", "metadata": {}, "score": "51.3374"}
{"text": "( v ) Improving Phagocytosis Through CD47 Blockade .Chao and colleagues have recently shown that multiple B - cell NHL subtypes , including DLBCL , FL , and B - CLL , exhibit increased levels of CD47 , a transmembrane protein which activates SIRP1a in phagocytic cells [ 89 ] .", "label": "", "metadata": {}, "score": "51.375713"}
{"text": "Page CH , Lin J , Jin Y , Castle VP , Nunez G , Huang M , Lin J : Overexpression of Akt / AKT can modulate chemotherapy - induced apoptosis .", "label": "", "metadata": {}, "score": "51.38249"}
{"text": "We showed that BT enhanced ROS generation .ROS mediated inactivation of CDKs by via oxidation [ 33 ] and enhanced expression of p21 can cause cell cycle arrest in G1- and S - phases resulting in reduced cellular proliferation .", "label": "", "metadata": {}, "score": "51.38897"}
{"text": "Importantly , C3 depletion by cobra venum factor , or the related drug ( HC3 - 1496 ) , appears to effectively overcome this mechanism and improve the activity of rituximab in lymphoma - bearing mice .", "label": "", "metadata": {}, "score": "51.389275"}
{"text": "Another transcription factor that has been shown to cooperate with R273H / C p53 is SP-1 , which is necessary for full R273H / C p53 transactivation in the context of human immunodeficiency virus type 1 ( HIV-1 ) long terminal repeat ( LTR)-mediated transcription [ 80 ] .", "label": "", "metadata": {}, "score": "51.455307"}
{"text": "A major finding in the current study is that JY / BTZ cells harboring the Met45Ile mutation in the \u03b25 subunit retained full sensitivity to carfilzomib , an epoxyketone - based PI .", "label": "", "metadata": {}, "score": "51.534527"}
{"text": "The best administration schedules , as well as the optimal duration of rituximab treatment , have yet to be determined .A deeper knowledge of the mechanisms underlying resistance to rituximab is also necessary in order to improve the activity of this and of similar therapeutics .", "label": "", "metadata": {}, "score": "51.645103"}
{"text": "Combinations such as anti - CD20 plus anti - CD22 , anti - CD20 plus anti - HLA - DR , anti - CD20 plus anti - TRAIL - R1 , anti - CD20 plus anti - CD80 have been evaluated preclinically and/or clinically , showing enhanced antitumor activity both in vitro and in vivo [ 92 - 94 ] .", "label": "", "metadata": {}, "score": "51.721054"}
{"text": "In addition , tumors from R175H TP53 transgenic mice display increased genomic instability .In experiments in lung cancer cells devoid of p53 , overexpression of the oncomorph R175H p53 enhances resistance to both etoposide and cisplatin [ 40 ] .", "label": "", "metadata": {}, "score": "51.730385"}
{"text": "Thus , we examined the prognostic role of transporters of the MRP family ( i.e. , ABCC1/MRP1 , ABCC4/MRP4 ) to gain insights into their clinical impacts .", "label": "", "metadata": {}, "score": "51.767517"}
{"text": "In the mature and functional \u03b25-subunit protein , this mutation introduced a Met to Ile substitution at amino acid 45 .It is noteworthy that the mutation in PSMB5 in JY/35 and JY/100 cells is heterozygous , indicating that these cells would still harbor one unaffected allele .", "label": "", "metadata": {}, "score": "51.778534"}
{"text": "Recently the emergence of synthetic , small molecule inhibitors has been described and both NVP - AUY922 and BIIB021 have entered clinical development .The medicinal chemistry of these and other published small molecule Hsp90 inhibitors is described in this review .", "label": "", "metadata": {}, "score": "51.820408"}
{"text": "Other development strategies have included : U.S. Pat .No .5,777,084 hybridoma antibodies ; WO95/27062 agonist antibodies , WO94/28391 antibodies to the ligand ; WO2005/094823 small molecules .", "label": "", "metadata": {}, "score": "51.91799"}
{"text": "However , efficient targeting of miRs in tumor cells in vivo remains a significant challenge for the development of miR-155-based therapeutics for the treatment of B - cell malignancies .", "label": "", "metadata": {}, "score": "51.949978"}
{"text": "J. Biol .Chem 2010 , 285 , 14160 - 14169 .[ Google Scholar ] .Preuss , U. ; Kreutzfeld , R. ; Scheidtmann , K.H. Tumor - derived p53 mutant C174Y is a gain - of - function mutant which activates the fos promoter and enhances colony formation .", "label": "", "metadata": {}, "score": "51.989513"}
{"text": "Preclinical efficacy studies of these compounds are collated and discussed in this review .More recent disclosures of small - molecule Hsp90 inhibitors include purine and resorcinol analogs , and the first small - molecule Hsp90 compounds showing oral efficacy have been described .", "label": "", "metadata": {}, "score": "52.147182"}
{"text": "The recovery of both variables to their original levels in serum - restimulated ( or lysophosphatidic acid - restimulated ) EOC cells was strongly delayed , for at least 24 h , in the presence of the PC - PLC inhibitor tricyclodecan-9-yl - potassium xanthate ( D609 ) .", "label": "", "metadata": {}, "score": "52.167175"}
{"text": "Expression of Bcl-2 is important in protection from drug - induced apoptosis in ovarian cancer thereby contributing to chemo - resistance [ 51 , 52 ] .", "label": "", "metadata": {}, "score": "52.216675"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Background : The myotonic dystrophy kinase - related CDC42-binding kinases MRCK\u03b1 and MRCK\u03b2 regulate actin - myosin contractility and have been implicated in cancer metastasis .", "label": "", "metadata": {}, "score": "52.26027"}
{"text": "Interestingly , stromal cells from miR-155-knockout mice led to significant inhibition of WM tumor growth , indicating that miR-155 may also contribute to WM proliferation through BM microenvironmental cells .", "label": "", "metadata": {}, "score": "52.30415"}
{"text": "10.1016/j.bcp.2011.10.009 PubMed View Article .Groll M , Berkers CR , Ploegh HL , Ovaa H : Crystal structure of the boronic acid - based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome .", "label": "", "metadata": {}, "score": "52.349377"}
{"text": "Conversely , the mixture of cMOVs was more effective , although the percentage of cell killing did not exceed 25 % .Fluorescence - activated cell sorting analysis of EOC cells for surface expression of the membrane C regulatory proteins ( mCRP ) revealed high levels of CD46 , variable expression of CD59 , and absence of CD55 .", "label": "", "metadata": {}, "score": "52.38935"}
{"text": "For example , substitution of arginine at codon 175 for proline ( R175P ) is a rare missense mutation , and cells with this mutation are capable of inducing cell cycle arrest but fail to activate apoptosis [ 32 ] .", "label": "", "metadata": {}, "score": "52.403957"}
{"text": "A potential strategy for cancer therapy is to reduce metastasis by blocking MRCK activity , either alone or in combination with ROCK inhibition .However , to date no potent small molecule inhibitors have been developed with selectivity towards MRCK .", "label": "", "metadata": {}, "score": "52.45463"}
{"text": "Conclusions and Perspectives .Combining rituximab with chemotherapy has proven to be an effective treatment for both indolent and aggressive forms of NHL .The same type of treatment can be used in patients with B - CLL , although its efficacy in this disorder appears to be lower .", "label": "", "metadata": {}, "score": "52.471794"}
{"text": "The present invention seeks to provide human anti - FLT3 antibodies which inhibit FL - induced phosphorylation of wild - type FLT3 and downstream kinases of MPK , PI3 K , and STAT5 pathways in leukemia compared with those inhibitors known in the art .", "label": "", "metadata": {}, "score": "52.539974"}
{"text": "These findings warrant further investigations on the role of PC - PLC and on the effects of its inhibition on the pathways responsible for constitutive EOC cell stimulation and cell proliferation .", "label": "", "metadata": {}, "score": "52.56791"}
{"text": "Expression of markers involved in antigen presentation in JY / WT and BTZ - resistant sublines .( A ) HLA - ABC ( MHC - I ) expression , ( B ) HLA - DR ( MHC - II ) expression , ( C ) CD80 expression , ( D ) CD86 expression , and ( E ) CD40 expression in JY / WT cells and BTZ - resistant JY cells analyzed by FACS .", "label": "", "metadata": {}, "score": "52.570007"}
{"text": "Thus , restoration of tumor suppressor gene function is considered as a rational approach for therapeutic intervention of carcinogenesis .For instance , the pharmacological activation of a tumor suppressor protein , p53 , is being widely studied for the development of new cancer chemotherapeutics ( 22 ) .", "label": "", "metadata": {}, "score": "52.571922"}
{"text": "The antibodies are used for treating growth of cancer cells and can be used alone or in combination with an anti - neoplastic agent , including but not limited to methotrexate ( MXT ) , for treatment of leukemia .", "label": "", "metadata": {}, "score": "52.601833"}
{"text": "The concentrations of the HSP90 inhibitor NVP - AUY922 required to reduce cell numbers by 50 % ( GI50 values ) were established in a panel of breast cancer cell lines and patient - derived human breast tumors .", "label": "", "metadata": {}, "score": "52.691887"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential chemotherapeutic agents for cancer .", "label": "", "metadata": {}, "score": "52.75305"}
{"text": "PubMed View Article .Vermeulen L , De Wilde G , Notebaert S , Vanden Berghe W , Haegeman G : Regulation of the transcriptional activity of the nuclear factor - kappaB p65 subunit .", "label": "", "metadata": {}, "score": "52.770187"}
{"text": "Full - text \u00b7 Article \u00b7 Oct 2008 \u00b7 AJP Gastrointestinal and Liver Physiology .The effect was not solely the result of inhibition of complement and contact system activation because reactive center - cleaved , inactive C1INH ( iC1INH ) also was effective .", "label": "", "metadata": {}, "score": "52.778282"}
{"text": "Chem 2001 , 276 , 6874 - 6878 .[ Google Scholar ] .Peng , Y. ; Chen , L. ; Li , C. ; Lu , W. ; Chen , J. Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization .", "label": "", "metadata": {}, "score": "52.7827"}
{"text": "[ 2 ] .BTZ has been reported to induce disregulation of intracellular Ca 2 + , triggering caspase activation and initiating apoptosis [ 56 ] .", "label": "", "metadata": {}, "score": "52.80186"}
{"text": "Similarly , activation of caspase-7 , as indicated by the appearance of a 20 kDa band , was observed in all BT treated cell lines .", "label": "", "metadata": {}, "score": "52.85822"}
{"text": "FBDD has delivered clinical development candidates for a broad range of targets including some of the most challenging cases such as -secretase ( BACE1 ) and protein - protein interactions .", "label": "", "metadata": {}, "score": "52.876312"}
{"text": "Conversely , no accumulation of ubiquitinated proteins were observed in JY/35 and JY/100 cells exposed to 35 nM and 100 nM BTZ , respectively .These results suggest that aberrant protein ubiquitination and degradation could be a contributing factor towards elevated levels of CD20 in BTZ - resistant JY cells .", "label": "", "metadata": {}, "score": "52.905724"}
{"text": "6 , pp .2188 - 2195 , 1997 .View at Google Scholar .M. Feuring - Buske , M. Kneba , M. Unterhalt et al . , \" IDEC - C2B8 ( Rituximab ) anti - CD20 antibody treatment in relapsed advanced - stage follicular lymphomas : results of a phase - II study of the German low - grade lymphoma study group , \" Annals of Hematology , vol . 79 , no . 9 , pp .", "label": "", "metadata": {}, "score": "52.922653"}
{"text": "Once activated , p53 protects against cancer by functioning as a sequence - specific transcription factor or through protein : protein interactions , activating cell cycle arrest , apoptosis , and DNA damage repair .", "label": "", "metadata": {}, "score": "52.956345"}
{"text": "PubMed View Article .Braddock D : Autotaxin and lipid signaling pathways as anticancer targets .Curr Opin Investig Drugs 2010 , 11 : 629 - 637 .", "label": "", "metadata": {}, "score": "52.958008"}
{"text": "Chem 2001 , 276 , 40583 - 40590 .[ Google Scholar ] .Li , D. ; Marchenko , N.D. ; Moll , U.M. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis .", "label": "", "metadata": {}, "score": "52.99248"}
{"text": "Together , these results indicate that upon acquisition of BTZ resistance , JY cells are markedly suppressed in their capacity to secrete TNF - \u03b1 .", "label": "", "metadata": {}, "score": "53.071167"}
{"text": "Finally , the results of a recently completed study ( ClinicalTrials.gov number , NCT00006721 ) , comparing CHOP followed by 131I - labeled tositumomab to rituximab plus CHOP for the initial treatment of FL , is predicted to redefine standard therapy for this disorder .", "label": "", "metadata": {}, "score": "53.1352"}
{"text": "The present invention seeks to provide alternative anti - FLT3 antibodies which have improved ligand blocking and binding affinity for FLT3 compared with those inhibitors known in the art .", "label": "", "metadata": {}, "score": "53.24019"}
{"text": "592 - 600 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . F. Sato , A. Ito , T. Ishida et al . , \" A complement - dependent cytotoxicity - enhancing anti - CD20 antibody mediating potent antitumor activity in the humanized NOD / Shi - scid , IL- .", "label": "", "metadata": {}, "score": "53.27462"}
{"text": "Saunders LP , Ouellette A , Bandle R , Chang WC , Zhou H , Misra RN , De La Cruz EM , Braddock DT : Identification of small - molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion .", "label": "", "metadata": {}, "score": "53.330616"}
{"text": "AMPK is highly sensitive to oxidative stress because increased cellular ROS change the AMP level , which leads to rapid AMPK activation .The involvement of AMPK in the inhibition of carcinogenesis can modulate the regulation of COX-2 [ 55 ] .", "label": "", "metadata": {}, "score": "53.376137"}
{"text": "Tsai PC , Hernandez - Ilizaliturri FJ , Bangia N , Olejniczak SH , Czuczman MS : Regulation of CD20 in rituximab - resistant cell lines and B - cell non - Hodgkin lymphoma .", "label": "", "metadata": {}, "score": "53.42267"}
{"text": "Expression of ubiquitinated proteins was detected using a mouse monoclonal antibody ( 1:200 ) as described above .\u03b2 - actin ( 1:1000 diluted antibody ) was used as the control for equal loading .", "label": "", "metadata": {}, "score": "53.53164"}
{"text": "BT can affect the DNA binding activity of NF - kB directly via oxidation by ROS [ 46 ] and/or indirectly by inhibiting phosphorylation of NF - \u03baB [ 47 ] and IkB\u03b1 .", "label": "", "metadata": {}, "score": "53.641747"}
{"text": "For example , the same studies that observed resistance to platinum - based chemotherapy found that cells with R273H p53 retain sensitivity to the topoisomerase II poison etoposide [ 40 ] .", "label": "", "metadata": {}, "score": "53.676918"}
{"text": "In this respect , TNF - \u03b1 has received the most attention as one of the critical cytokines in the pathophysiology of arthritis , and is thus a major druggable target for biological agents and small molecules [ 20 - 22 , 48 ] .", "label": "", "metadata": {}, "score": "53.742165"}
{"text": "This review provides a description of various pharmacological approaches tested to activate p53 ( both wild - type and mutant ) and to assess the effects of activated p53 on neoplastic progression .", "label": "", "metadata": {}, "score": "53.775303"}
{"text": "Our data demonstrate that BT treatment resulted in G1-phase cycle arrest and up - regulation of the expression of p27 Kip1 and p21 Cip1 .", "label": "", "metadata": {}, "score": "53.786484"}
{"text": "793 - 798 , 1994 .View at Google Scholar .J. P. Leonard , J. W. Friedberg , A. Younes et al . , \" A phase I / II study of galiximab ( an anti - CD80 monoclonal antibody ) in combination with rituximab for relapsed or refractory , follicular lymphoma , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "53.838978"}
{"text": "Our results revealed that phospho p38 MAPK and phospho JNK were notably increased after Compound K treatment .In contrast , Compound K treatment reduced the level of phospho ERK expression ( data not shown ) .", "label": "", "metadata": {}, "score": "53.857544"}
{"text": "Cusack JC , Liu R , Baldwin AS : NF - \u03baB and chemoresistance : potentiation of cancer drugs via inhibition of NF - \u03baB. Drug Resist Updat 1999 , 2 : 271 - 273 .", "label": "", "metadata": {}, "score": "53.92472"}
{"text": "When lytic potential of the 2 CIRs was evaluated , their efficiency was comparable under conditions of high CIR and Ag expression , whereas low - affinity CIR was more efficient than high - affinity CIR in conditions of limiting Ag and CIR expression levels .", "label": "", "metadata": {}, "score": "53.94288"}
{"text": "Propidium iodide staining or alamarBlue assay were used to evaluate the CDC effect .The levels of CD20 and CD59 on the cell membrane were analyzed by flow cytometry . rILYd4", "label": "", "metadata": {}, "score": "54.032814"}
{"text": "Combining Rituximab with Other mAbs .Rituximab activity in NHL as a single agent is limited , especially when administered to pretreated patients .However , combining rituximab with chemotherapy does achieve significantly better outcomes than chemotherapy alone .", "label": "", "metadata": {}, "score": "54.03554"}
{"text": "Immunoblot analyses of whole cell lysate reveal decreased phospho - NF - \u03baB p65 expression with increasing treatment time .BT treatment also down - regulated the expression of pIkB\u03b1 .", "label": "", "metadata": {}, "score": "54.039455"}
{"text": "It is noteworthy that the mutation in PSMB5 in JY / BTZ cells is heterozygous , indicating that cells still retained an intact WT allele .", "label": "", "metadata": {}, "score": "54.110794"}
{"text": "17 , pp .3135 - 3143 , 2000 .View at Google Scholar .T. A. Davis , C. A. White , A. J. Grillo - L\u00f3pez et al . , \" Single - agent monoclonal antibody efficacy in bulky non - Hodgkin 's lymphoma : results of a phase II trial of rituximab , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "54.167656"}
{"text": "New treatments for this unmet medical need are highly desirable .An antibody approach may overcome some of the shortcomings associated with small molecule FLT3 inhibitors .", "label": "", "metadata": {}, "score": "54.18775"}
{"text": "Similar findings were observed in the IR animals treated with iC1INH .These studies emphasize the therapeutic benefit of C1INH in preventing intestinal injury caused by IR .", "label": "", "metadata": {}, "score": "54.18804"}
{"text": "105 - 112 , 2002 .View at Google Scholar \u00b7 View at Scopus .J. L. Teeling , W. J. M. Mackus , L. J. J. M. Wiegman et al . , \" The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20 , \" Journal of Immunology , vol .", "label": "", "metadata": {}, "score": "54.246246"}
{"text": "Our results clearly demonstrate significant inhibition of ATX in a concentration and time dependent fashion .ATX / LPA stimulate the PI3-K , Akt , and ERK pathways and cause the activation of Rho and Rac [ 59 ] .", "label": "", "metadata": {}, "score": "54.28351"}
{"text": "7117 - 7126 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus . S. Alas and B. Bonavida , \" Rituximab inactivates signal transducer and activation of transcription 3 ( STAT3 ) activity in B - non - Hodgkin 's lymphoma through inhibition of the interleukin 10 autocrine / paracrine loop and results in down - regulation of Bcl-2 and sensitization to cytotoxic drugs , \" Cancer Research , vol .", "label": "", "metadata": {}, "score": "54.284683"}
{"text": "Inhibition of the cell cycle is a known target for the treatment of cancer [ 25 - 28 ] .Anticancer agent may cause cell cycle arrest via altering the regulation of cell cycle machinery .", "label": "", "metadata": {}, "score": "54.307434"}
{"text": "However , further studies are required to confirm role of NF - kB in the anti - tumor effects of BT in ovarian cancer cell lines .", "label": "", "metadata": {}, "score": "54.365196"}
{"text": "Data was expressed as mean \u00b1 SD of triplicate experiments .( B ) Activation of Caspases 3 and 7 and degradation of PARP as shown by western blot analysis .", "label": "", "metadata": {}, "score": "54.478813"}
{"text": "Cell .Biol 2005 , 25 , 10097 - 10110 .[ Google Scholar ] .Di Agostino , S. ; Cortese , G. ; Monti , O. ; Dell'Orso , S. ; Sacchi , A. ; Eisenstein , M. ; Citro , G. ; Strano , S. ; Blandino , G. The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs .", "label": "", "metadata": {}, "score": "54.480644"}
{"text": "Natl .Acad .Sci .USA 1996 , 93 , 8318 - 8323 .[ Google Scholar ] .Ludes - Meyers , J.H. ; Subler , M.A. ; Shivakumar , C.V. ; Munoz , R.M. ; Jiang , P. ; Bigger , J.E. ; Brown , D.R. ; Deb , S.P. ; Deb , S. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53 .", "label": "", "metadata": {}, "score": "54.51585"}
{"text": "As mentioned earlier , p21 is known inhibitor of CDK activity .These observations suggest that cell cycle regulation is one of the mechanisms of action of BT in ovarian cancer cells .", "label": "", "metadata": {}, "score": "54.524147"}
{"text": "Specifically , oncomorphic p53 binds to and sequesters other transcriptional factors or co - activators necessary for a normal stress response [ 57 , 64 - 72 ] .", "label": "", "metadata": {}, "score": "54.53201"}
{"text": "PubMed View Article .Miller SC , Huang R , Sakamuru S , Shukla SJ , Attene - Ramos MS , Shinn P , Van Leer D , Leister W , Austin CP , Xia M : Identification of known drugs that act as inhibitors of NF - kappaB signaling and their mechanism of action .", "label": "", "metadata": {}, "score": "54.588547"}
{"text": "3115 - 3120 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .N. Lamanna , M. Kalaycio , P. Maslak et al . , \" Pentostatin , cyclophosphamide , and rituximab is an active , well - tolerated regimen for patients with previously treated chronic lymphocytic leukemia , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "54.58943"}
{"text": "Experiments were performed in triplicate .Data was expressed as mean \u00b1 SD of triplicate experiments .Caspase 3/7 assay ( apoptosis assessment ) .Caspase 3/7 activity was measured using Caspase - Glo 3/7 assay kit from Promega , following the manufacturer 's instructions .", "label": "", "metadata": {}, "score": "54.696106"}
{"text": "[ Google Scholar ] .Chen , YJ ; Liu , WH ; Kao , PH ; Wang , JJ ; Chang , LS .Involvement of p38 MAPK- and JNK - modulated expression of Bcl-2 and Bax in Naja nigricollis CMS-9-induced apoptosis of human leukemia K562 cells .", "label": "", "metadata": {}, "score": "54.70188"}
{"text": "PubMed View Article .Witham J , Valenti MR , De - Haven - Brandon AK , Vidot S , Eccles SA , Kaye SB , Richardson A : The Bcl-2/Bcl - XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin .", "label": "", "metadata": {}, "score": "54.730446"}
{"text": "Dose response curves to calculate IC 50 values were plotted using Graph Pad Prism Software .In order to ascertain role of ROS in BT induced cytotoxicity , we performed cell viability assays in the presence of an antioxidant , ascorbic acid .", "label": "", "metadata": {}, "score": "54.800232"}
{"text": "Hence , more selective senescence inducers are required .Here we report a machine learning - based in silico screen to identify potential senescence agonists .", "label": "", "metadata": {}, "score": "54.836655"}
{"text": "5517 , pp .495 - 497 , 1975 .View at Google Scholar \u00b7 View at Scopus . A. Demidem , T. Lam , S. Alas , K. Hariharan , N. Hanna , and B. Bonavida , \" Chimeric anti - CD20 ( idec - C2B8 ) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs , \" Cancer Biotherapy and Radiopharmaceuticals , vol .", "label": "", "metadata": {}, "score": "54.89474"}
{"text": "Together , these data not only support the validity of cross - comparison analysis of gene expression data because known and expected correlations were confirmed but also point to the promise of such analysis in identifying new L - R signaling loops in cancer .", "label": "", "metadata": {}, "score": "54.931725"}
{"text": "( i ) Epratuzumab : a humanized IgG1 anti - CD22 antibody .It induces ADCC and CDC in preclinical studies .Phase I / II studies demonstrated objective responses in relapsed / refractory FL ( 24 % )", "label": "", "metadata": {}, "score": "54.973007"}
{"text": "J Pharmacol Exp Ther 2012 , 341 ( 1):174 - 82 .10.1124/jpet.111.187542 PubMed View Article .Chauhan D , Singh AV , Aujay M , Kirk CJ , Bandi M , Ciccarelli B , Raje N , Richardson P , Anderson KC : A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma .", "label": "", "metadata": {}, "score": "54.981052"}
{"text": "( iii ) Alemtuzumab ( Campath ) : a humanized monoclonal antibody against CD52 ( an antigen expressed by normal and malignant B- and T - lymphocytes , monocytes , and NK cells ) .", "label": "", "metadata": {}, "score": "55.01785"}
{"text": "Extent and duration of pharmacodynamic changes in an orthotopic human ovarian carcinoma model confirmed the superiority of VER-50589 over VER-49009 .VER-50589 accumulated in HCT116 human colon cancer xenografts at levels above the cellular GI50 for 24 h , resulting in 30 % growth inhibition .", "label": "", "metadata": {}, "score": "55.04148"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT :Although the heat shock protein 90 ( HSP90 ) inhibitor 17-allylamino-17-demethoxygeldanamycin ( 17-AAG ) shows clinical promise , potential limitations encourage development of alternative chemotypes .", "label": "", "metadata": {}, "score": "55.17478"}
{"text": "Annu Rev Immunol 2000 , 18 : 621 - 663 .10.1146/annurev.immunol.18.1.621 PubMed View Article .van der Heijden JW , Oerlemans R , Lems WF , Scheper RJ , Dijkmans BA , Jansen G : The proteasome inhibitor bortezomib inhibits the release of NFkappaB - inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients .", "label": "", "metadata": {}, "score": "55.18924"}
{"text": "10.1016/j.pharmthera.2010.01.001 PubMed View Article .Vos K , Thurlings RM , Wijbrandts CA , van Schaardenburg D , Gerlag DM , Tak PP : Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis .", "label": "", "metadata": {}, "score": "55.192177"}
{"text": "In summary , the information gained from studying the mutant p53 transcriptome and interactome described in this review has solidified the foundation for the development of strategies that can one day be used to treat the large number of cancer patients that harbor TP53 mutations .", "label": "", "metadata": {}, "score": "55.366043"}
{"text": "BT was also reported to show an inhibitory effect on cervical cancer cell growth during in vitro screening [ 14 ] .These previous studies have proposed possible mechanisms of action of BT against cancer cells .", "label": "", "metadata": {}, "score": "55.440346"}
{"text": "Significant down - regulation of pAkt expression was observed at 24 hrs post BT treatment .It has been reported that Akt inactivation is essential for drug sensitivity [ 41 , 42 ] .", "label": "", "metadata": {}, "score": "55.729233"}
{"text": "4 , pp .769 - 773 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . S. J. Horning , A. Younes , V. Jain et al . , \" Efficacy and safety of tositumomab and iodine-131 tositumomab ( Bexxar ) in B - cell lymphoma , progressive after rituximab , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "55.755444"}
{"text": "Our study thus uncovers patterns of clonal evolution in CLL , providing insights into its stepwise transformation , and links the presence of subclones with adverse clinical outcomes .", "label": "", "metadata": {}, "score": "55.762493"}
{"text": "For instance , induction of c - Myc , CXCL1 , MAPK family genes , and cyclins A2 , B1 , and B2 by R175H oncomorph increases proliferation [ 51 - 54 , 57 , 93 ] .", "label": "", "metadata": {}, "score": "55.77065"}
{"text": "An in - depth analysis of mouse models of mutant p53 proteins has been reviewed elsewhere [ 47 , 48 ] that focuses on the role of individual mutations in the tumorigenesis .", "label": "", "metadata": {}, "score": "55.81092"}
{"text": "Molecular alterations in BTZ - resistant JY cells .We and others [ 38 - 41 ] have previously discovered a mechanism of BTZ resistance in various haematological cell lines .", "label": "", "metadata": {}, "score": "55.995033"}
{"text": "These results demonstrate the opportunity for combining V158411 with standard of care chemotherapeutic agents to potentiate the therapeutic efficacy of these agents without increasing their toxicity to normal cells .", "label": "", "metadata": {}, "score": "56.020714"}
{"text": "Further compelling evidence for the phenomenon of oncomorphisms in p53 was shown in vivo using transgenic mice expressing various oncomorphic mutations .Knock - in mice with the p53 R175H mutation also display a high incidence of lymphomas and sarcomas , but in addition have a significant number of carcinomas and an increased metastasis rate [ 42 , 45 ] .", "label": "", "metadata": {}, "score": "56.054802"}
{"text": "The availability of CaMBr1-glycoconjugate in the minimal and functional antigenic structure and the identification of an efficacious vaccine formulation opens the way to exploring the activity of this glycoconjugate in a clinical setting .", "label": "", "metadata": {}, "score": "56.103363"}
{"text": "Additionally , a cell viability assay using LY294002 pre - treatment ( an inhibitor of pAkt ) neither enhanced BT cytotoxicity nor restored cell viability at 48 hrs post BT treatment .", "label": "", "metadata": {}, "score": "56.105152"}
{"text": "Previously BT was shown to inhibit solid tumor growth in several preclinical cancer models by targeting ATX [ 12 , 13 ] .ATX plays a major role in modulation of the cellular process through its enzymatic production of lysophosphatidic acid ( LPA ) .", "label": "", "metadata": {}, "score": "56.121346"}
{"text": "The second mechanism is via indirect transcriptional activation of genes mediated by oncomorphic p53 binding to non - typical transcription factors or transcriptional cofactors [ 64 ] .", "label": "", "metadata": {}, "score": "56.13535"}
{"text": "Sherr CJ , Roberts JM : CDK inhibitors : positive and negative regulators of G 1 -phase progression .Genes Dev 1999 , 13 : 1501 - 1512 .", "label": "", "metadata": {}, "score": "56.15284"}
{"text": "[ Google Scholar ] .Liu , K. ; Ling , S. ; Lin , W.C. TopBP1 mediates mutant p53 gain of function through NF - Y and p63/p73 .", "label": "", "metadata": {}, "score": "56.2053"}
{"text": "Four distinct mechanisms have been proposed to explain p53 oncomorphic activity ( Figure 2 ) [ 49 , 50 ] .In the first mechanism , a particular missense mutation alters the sequence specificity required for p53 transactivation of target genes , resulting in transcription of novel targets [ 51 - 63 ] .", "label": "", "metadata": {}, "score": "56.207054"}
{"text": "The process is illustrated with examples from recent medicinal chemistry programmes to discover compounds against the oncology targets Hsp90 and PDK1 .In addition , we summarise our experience with using molecular docking calculations to predict fragment binding and anecdotes on the selectivity and binding modes for fragments seen against a range of targets .", "label": "", "metadata": {}, "score": "56.21393"}
{"text": "The antibodies of the present invention possess these aforementioned characteristics , thereby providing significant advantages .Until the present invention , the combination of FLT3 inhibitors with methotrexate ( MTX ) for the treatment of leukemia has been perceived to have no benefit .", "label": "", "metadata": {}, "score": "56.23383"}
{"text": "10.1056/NEJMct1114348 PubMed View Article .Thaunat O , Morelon E , Defrance T : Am\"B\"valent : anti - CD20 antibodies unravel the dual role of B cells in immunopathogenesis .", "label": "", "metadata": {}, "score": "56.30838"}
{"text": "Despite evidence of its anti - proliferative effects in colon cancer , the cytotoxic mechanism of this effect with respect to the involvement of ROS and mitochondrial involved apoptosis , has not been investigated .", "label": "", "metadata": {}, "score": "56.327267"}
{"text": "PubMed .Kisselev AF , Callard A , Goldberg AL : Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate .", "label": "", "metadata": {}, "score": "56.339462"}
{"text": "Title : Anti - flt3 antibodies .Abstract : The present invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity .", "label": "", "metadata": {}, "score": "56.355194"}
{"text": "XIAP is known to prevent apoptosis through up - regulation of PI3k / Akt cell survival signalling pathway [ 49 ] .Down - regulation of XIAP induces apoptosis and increases cisplatin sensitivity [ 49 ] .", "label": "", "metadata": {}, "score": "56.36709"}
{"text": "Subsequent cell viability assay with ascorbic acid pretreatment were performed ( see cell viability assay above ) .Western blot analysis .Western blotting was carried out to analyze expression of effector caspase 3 and caspase 7 , using specific antibodies .", "label": "", "metadata": {}, "score": "56.503277"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .T. Robak , A. Dmoszynska , P. Solal - C\u00e9ligny et al . , \" Rituximab plus fludarabine and cyclophosphamide prolongs progression - free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "56.56789"}
{"text": "The Met45Ile substitution identified in BTZ - resistant JY cells consistently resided in the highly - conserved substrate / inhibitor - binding domain of the \u03b25 subunit .", "label": "", "metadata": {}, "score": "56.68702"}
{"text": "Frazier , M.W. ; He , X. ; Wang , J. ; Gu , Z. ; Cleveland , J.L. ; Zambetti , G.P. Activation of c - myc gene expression by tumor - derived p53 mutants requires a discrete C -terminal domain .", "label": "", "metadata": {}, "score": "56.74002"}
{"text": "Finally , for recurrent DLBCL , the standard of care is salvage chemotherapy followed by high - dose chemotherapy with stem cell transplantation .Rituximab and Autologous Stem Cells Transplantation for Advanced Stage DLBCL .", "label": "", "metadata": {}, "score": "56.757072"}
{"text": "p53 activation may also lead to regression of existing early neoplastic lesions and therefore may be important in developing cancer chemoprevention protocols .A large number of small molecules capable of reactivating p53 have been developed and some are progressing through clinical trials for prospective human applications .", "label": "", "metadata": {}, "score": "56.780396"}
{"text": "The ability of BT to induce cell death via apoptosis makes this drug a good candidate for the treatment of ovarian cancer .This study also demonstrates that BT induces apoptosis in ovarian cancer cells via activation of proteolytic effector caspases such as Caspase 3 and 7 and subsequent cleavage / inactivation of PARP-1 ( involved in DNA repair ) .", "label": "", "metadata": {}, "score": "56.816704"}
{"text": "Among this family , caspase-9 and -3 are the most crucial for the initiation and execution of apoptosis in various cell types [ 13 , 14 ] .", "label": "", "metadata": {}, "score": "56.838764"}
{"text": "Loss of the \u0394\u03c8 m was followed by cytochrome c release from the mitochondria , resulting in the activation of caspase-9 , -3 , and concomitant poly ADP - ribosyl polymerase ( PARP ) cleavage , which are the indicators of caspase - dependent apoptosis .", "label": "", "metadata": {}, "score": "56.848602"}
{"text": "Table 1 : Principal clinical trials of chemotherapy plus Rituximab versus chemotherapy alone in NHL .Importantly , clinical data on the benefit of rituximab combined with chemotherapy has also become available in patients with relapsed or refractory indolent B - cell NHL .", "label": "", "metadata": {}, "score": "56.85462"}
{"text": "pNFkB was detected using a specific antibody that detects NF - \u03baB p65 only when phosphorylated at Ser536 .Similarly , expression of phosphoIkB\u03b1 was detected using a monoclonal antibody that detects endogenous levels of I\u03baB\u03b1 only when phosphorylated at Ser32 .", "label": "", "metadata": {}, "score": "56.855656"}
{"text": "Bottom panel , stabilization of p53 expression was demonstrated 10 h after irradiation .Figure 3 .Proposed strategies for uncovering oncomorphic p53 functions : ( a ) Example of an experimental outline used to understand the function of specific TP53 mutants .", "label": "", "metadata": {}, "score": "56.89927"}
{"text": "PubMed View Article .Harper JW , Elledge SJ , Keyomarsi K , Dynlacht B , Tsai LH , Zhang P , Dobrowolski S , Bai C , Connell CL , Swindell E , Fox MP , Wei N : Inhibition of cyclin - dependent kinases by p21 .", "label": "", "metadata": {}, "score": "56.930458"}
{"text": "An additional mechanism was inhibition of NF - kB signalling via inhibition of I\u03baB\u03b1 phosphorylation and caspase 3/7 induction [ 14 ] .Based on these significant observations , we seek a better understanding of the effect BT on ovarian cancer cell lines , and specifically on cisplatin - resistant cell lines .", "label": "", "metadata": {}, "score": "57.00817"}
{"text": "[ Google Scholar ] .Scian , M.J. ; Stagliano , K.E. ; Anderson , M.A. ; Hassan , S. ; Bowman , M. ; Miles , M.F. ; Deb , S.P. ; Deb , S. Tumor - derived p53 mutants induce NF - kappaB2 gene expression .", "label": "", "metadata": {}, "score": "57.02188"}
{"text": "FEBS Lett 2001 , 509 , 435 - 438 .[ Google Scholar ] .Petrosillo , G ; Ruggiero , FM ; Paradies , G. Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria .", "label": "", "metadata": {}, "score": "57.034477"}
{"text": "Methods .The cytotoxic effects of BT against a panel of ovarian cancer cell lines were determined by Presto Blue cell viability assay .Markers of apoptosis such as caspases 3/7 , cPARP induction , nuclear condensation and mitochondrial transmembrane depolarization were assessed using microscopic , FACS and immunoblotting methods .", "label": "", "metadata": {}, "score": "57.036934"}
{"text": "Induction of mitochondria - dependent and caspase - dependent apoptosis by Compound K treatment .( A ) Apoptotic sub - G 1 cells were detected by flow cytometry after PI staining .", "label": "", "metadata": {}, "score": "57.05675"}
{"text": "View Article .Piccart MJ , Bertelsen K , James K , Cassidy J , Mangioni C , Simonsen E , et al .: Randomized intergroup trial of cisplatin - paclitaxel versus cisplatin - cyclophosphamide in women with advanced epithelial EOC : three - year results .", "label": "", "metadata": {}, "score": "57.06777"}
{"text": "However , at 48 hrs post - treatment , LDH release was observed even at lower concentration ( 100 \u03bcMBT ) especially in OVACAR-3 and A2780 cell lines .", "label": "", "metadata": {}, "score": "57.078213"}
{"text": "Abbreviations .ROS : .Reactive oxygen species .NF - \u03baB : .Nuclear factor kappa B .MAPK : .Mitogen - activated protein kinase .", "label": "", "metadata": {}, "score": "57.085358"}
{"text": "Under the same experimental conditions , CIR - mediated activity against normal cells expressing low HER2 levels was marginal .The CIR - mediated recognition of target cells induced the release of soluble factors able to inhibit growth of both HER - positive and HER2-negative bystander tumor cells .", "label": "", "metadata": {}, "score": "57.086586"}
{"text": "Additionally , cisplatin - resistant variants of A2780 and IGROV-1 derived by in vitro selection with cisplatin were also tested for BT cytotoxicity .A2780 , A2780-CDDP and IGROV-1 , IGROV-1CDDP represents isogenic ovarian cancer cell line pairs consisting of a cisplatin - sensitive parental line and a stable cisplatin - resistant sub - line derived by in vitro selection with cisplatin .", "label": "", "metadata": {}, "score": "57.152596"}
{"text": "Hershko A , Ciechanover A : The ubiquitin system .Annu Rev Biochem 1998 , 67 : 425 - 479 .10.1146/annurev.biochem.67.1.425 PubMed View Article .", "label": "", "metadata": {}, "score": "57.21605"}
{"text": "CDC and ADCC appear to be important to target leukemia / lymphoma cells circulating in the bloodstream [ 26 ] .Conversely , an immunological mechanism of action seems to be less important in the presence of nodal and extranodal involvement .", "label": "", "metadata": {}, "score": "57.256516"}
{"text": "Thus , by targeting MPS1 , SP600125 triggers a polyploidization program that can not be sustained by TP53(-/- ) cells , resulting in the activation of mitotic catastrophe , an oncosuppressive mechanism for the eradication of mitosis - incompetent cells .", "label": "", "metadata": {}, "score": "57.306335"}
{"text": "11 , pp .1229 - 1230 , 2002 .View at Google Scholar .T. A. Davis , A. J. Grillo - Lopez , C. A. White et al . , \" Rituximab anti - CD20 monoclonal antibody therapy in non - Hodgkin 's lymphoma : safety and efficacy of re - treatment , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "57.328495"}
{"text": "10.4049/jimmunol.1001040 PubMed View Article .Del Nagro CJ , Otero DC , Anzelon AN , Omori SA , Kolla RV , Rickert RC : CD19 function in central and peripheral B - cell development .", "label": "", "metadata": {}, "score": "57.4065"}
{"text": "Here we describe a series of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors that were identified following structure - driven optimization of purine hits revealed by NMR based screening of a proprietary fragment library .", "label": "", "metadata": {}, "score": "57.425842"}
{"text": "In comparison , no effect of BTZ treatment was observed for HLA - DR expression ( Figure 5B ) .Unlike in JY / WT cells , treatment of JY/35 and JY/100 cells with BTZ ( 35 nM and 100 nM BTZ , respectively ) had no significant effect on CD20 expression ( Figure 5A ) .", "label": "", "metadata": {}, "score": "57.43756"}
{"text": "[ Google Scholar ] .Singer , S. ; Ehemann , V. ; Brauckhoff , A. ; Keith , M. ; Vreden , S. ; Schirmacher , P. ; Breuhahn , K. Protumorigenic overexpression of stathmin / Op18 by gain - of - function mutation in p53 in human hepatocarcinogenesis .", "label": "", "metadata": {}, "score": "57.548344"}
{"text": "After establishing the expression models , the next step is to examine WTp53 and oncomorphic p53 function .Several different aspects of the p53 pathway should be evaluated , namely , cell cycle arrest and apoptosis .", "label": "", "metadata": {}, "score": "57.58525"}
{"text": "It has been observed that cancers carrying a wild - type p53 may also have interrupted downstream p53 regulatory signaling leading to disruption in p53 functions .", "label": "", "metadata": {}, "score": "57.593857"}
{"text": "Proteasome constitutive - immuno subunit ELISA assay ( ProCISE ) .The ProCISE assay for quantification of individual constitutive ( \u03b25 , \u03b21 , \u03b22 ) and immunoproteasome ( \u03b25i , \u03b21i , \u03b22i ) subunits was performed as previously described [ 33 , 34 ] .", "label": "", "metadata": {}, "score": "57.59986"}
{"text": "35 , pp .5616 - 5623 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . K. Dunleavy , T. White , N. Grant , et al . , \" Phase 1 study of combination rituximab with apolizumab in relapsed / refractory B - cell lymphoma and chronic lymphocytic leukemia , \" vol .", "label": "", "metadata": {}, "score": "57.650627"}
{"text": "10 , pp .3554 - 3561 , 2002 .View at Publisher \u00b7 View at Google Scholar .J. Lundin , H. Hagberg , R. Repp et al . , \" Phase 2 study of alemtuzumab ( anti - CD52 monoclonal antibody ) in patients with advanced mycosis fungoides / S\u00e9zary syndrome , \" Blood , vol .", "label": "", "metadata": {}, "score": "57.66851"}
{"text": "The compounds 17-AAG ( Kosan Biosciences Inc / National Cancer Institute ) and 17-DMAG ( Kosan Biosciences Inc / National Cancer Institute ) are Hsp90 inhibitors that are derived from the prototypical ansamycin natural product Hsp90 inhibitor geldanamycin .", "label": "", "metadata": {}, "score": "57.692623"}
{"text": "PC - PLC activity was 3-fold higher in total cell lysates and 5-fold higher in membrane - enriched fractions of EOC compared with EONT cells .", "label": "", "metadata": {}, "score": "57.706795"}
{"text": "Effect of Compound K on the MAPK signaling pathway .( A ) Cell lysates were electrophoresed and were immunoblotted using anti - JNK , -phospho JNK , -p38 , and -phospho p38 antibodies .", "label": "", "metadata": {}, "score": "57.76124"}
{"text": "Effect of Compound K on the MAPK signaling pathway .( A ) Cell lysates were electrophoresed and were immunoblotted using anti - JNK , -phospho JNK , -p38 , and -phospho p38 antibodies .", "label": "", "metadata": {}, "score": "57.76124"}
{"text": "C .Effect of BT treatment on NF - kB regulated cell survival genes such as pIkB\u03b1 , xIAP , pbcl-2 , bcl - xL , as analyzed by western blotting of cellular lysates .", "label": "", "metadata": {}, "score": "57.80607"}
{"text": "The structures of the fragments(s ) binding to the protein can then be used to design new compounds with increased affinity , specificity and novelty .", "label": "", "metadata": {}, "score": "57.834747"}
{"text": "Although it had been previously shown that Compound K induced apoptosis via a Ca 2 + /calmodulinactivated protein kinase - IV / AMP - activated protein kinase pathway in HT-29 colon cancer cells [ 28 , 29 ] , Compound K - induced ROS - mediated apoptosis in colon cancer cells had not been investigated .", "label": "", "metadata": {}, "score": "57.888603"}
{"text": "Experiments were performed in triplicate .Data was expressed as mean \u00b1 SD of triplicate experiments .In addition to homogenous caspase 3/7 assessment , we also analyzed expression of effector caspases , e.g. , caspase-3 and caspase-7 via immunoblotting using specific antibodies against caspase 3 and 7 ( see Western Blot Analysis below ) .", "label": "", "metadata": {}, "score": "57.9104"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Chk1 kinase is a critical component of the DNA damage response checkpoint especially in cancer cells and targeting Chk1 is a potential therapeutic opportunity for potentiating the anti - tumor activity of DNA damaging chemotherapy drugs .", "label": "", "metadata": {}, "score": "57.91821"}
{"text": "Cytotoxic therapies mediate killing of cancer cells by activating the intrinsic mitochondrial apoptotic pathway , and p53 status is a key factor in determining the efficacy of apoptotic signaling .", "label": "", "metadata": {}, "score": "57.920914"}
{"text": "10.1016/j.chembiol.2012.01.003 PubMed Central PubMed View Article .Huber EM , Basler M , Schwab R , Heinemeyer W , Kirk CJ , Groettrup M , Groll M : Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity .", "label": "", "metadata": {}, "score": "57.925747"}
{"text": "Compound K produced intracellular ROS in a time dependent fashion ; however , N -acetylcysteine ( NAC ) pretreatment resulted in the inhibition of this effect and the recovery of cell viability .", "label": "", "metadata": {}, "score": "57.951088"}
{"text": "It is therefore essential to focus on type of cell death induced by therapeutic agents .Ability to induce apoptosis is a critical factor for effective treatment against cancer [ 20 ] .", "label": "", "metadata": {}, "score": "57.985527"}
{"text": "Notably , although clinically effective , this mAb induces a dramatic decrease in CD4 + and CD8 + T lymphocytes and thus strongly increases the risk of infections .", "label": "", "metadata": {}, "score": "57.99891"}
{"text": "In addition , treatment with rituximab inhibits the overexpressed transcription repressor Yin Yang 1 ( YY1 ) [ 20 ] .YY1 downregulates Fas and DR5 expression and its inhibition leads to sensitization to Fas ligand and tumor necrosis factor - related apoptosis - inducing ligand-", "label": "", "metadata": {}, "score": "58.07579"}
{"text": "To assess whether BT - induced growth inhibition of the cells is mediated via alterations in cell cycle regulation , we evaluated the effect of BT on cell cycle distribution .", "label": "", "metadata": {}, "score": "58.0942"}
{"text": "( D ) Percentage CD20-positive JY / WT cells and BTZ - resistant variants .( E ) Expression of CD20 in BTZ - resistant JY cells relative to JY / WT cells .", "label": "", "metadata": {}, "score": "58.175797"}
{"text": "Sherr CJ : G 1 phase progression : cycling on cue .Cell 1994 , 79 : 551 - 555 .PubMed View Article .Sherr CJ , Roberts JM : Inhibitors of mammalian G 1 cyclin - dependent kinases .", "label": "", "metadata": {}, "score": "58.185467"}
{"text": "PubMed View Article .Godwin P , Baird AM , Heavey S , Barr MP , O'Byrne KJ , Gately K : Targeting nuclear factor - kappa B to overcome resistance to chemotherapy .", "label": "", "metadata": {}, "score": "58.201088"}
{"text": "Further , Compound K - induced decreases in the Bcl-2 protein and corresponding increases in the Bax protein , results in the opening of mitochondrial membrane pores , facilitating the release of cytochrome c from mitochondria into cytosol .", "label": "", "metadata": {}, "score": "58.214832"}
{"text": "[ Google Scholar ] .Budihardjo , I ; Oliver , H ; Lutter , M ; Luo , X ; Wang , X. Biochemical pathways of caspase activation during apoptosis .", "label": "", "metadata": {}, "score": "58.23413"}
{"text": "10.1182/blood-2012 - 04 - 403733 PubMed Central PubMed View Article .Busse A , Kraus M , Na IK , Rietz A , Scheibenbogen C , Driessen C , Blau IW , Thiel E , Keilholz U : Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits .", "label": "", "metadata": {}, "score": "58.24037"}
{"text": "10.1002/cncr.23224 PubMed View Article .Jazirehi AR , Vega MI , Bonavida B : Development of rituximab - resistant lymphoma clones with altered cell signaling and cross - resistance to chemotherapy .", "label": "", "metadata": {}, "score": "58.34881"}
{"text": "This result suggests that the ROS generated by Compound K induces the cell death .Induction of Apoptosis by Compound K via a Mitochondria - Dependent Pathway .", "label": "", "metadata": {}, "score": "58.374504"}
{"text": "Figure 4 .Induction of mitochondria - dependent and caspase - dependent apoptosis by Compound K treatment .( A ) Apoptotic sub - G 1 cells were detected by flow cytometry after PI staining .", "label": "", "metadata": {}, "score": "58.45746"}
{"text": "The concept of restoring WT p53 activity is strongly supported by in vitro and in vivo studies as well as several clinical trials showing that restoration of WT p53 function causes rapid tumor regression in mice and prolonged survival in humans [ 101 - 105 ] .", "label": "", "metadata": {}, "score": "58.494217"}
{"text": "It is well known that kinase activities of CDK - cyclin complexes are essential for progression of cell cycle at many check points [ 29 - 31 ] .", "label": "", "metadata": {}, "score": "58.586235"}
{"text": "Target antigen level appeared to be a critical determinant of specificity and delivery of signals leading to redirected effector functions .Soluble factors , released by redirected effectors at the site of antigen - driven activation , mediate potent bystander killing .", "label": "", "metadata": {}, "score": "58.617493"}
{"text": "Natl .Acad .Sci .USA 1996 , 93 , 8379 - 8383 .[ Google Scholar ] .Peng , Y. ; Chen , L. ; Li , C. ; Lu , W. ; Agrawal , S. ; Chen , J. Stabilization of the MDM2 oncoprotein by mutant p53 .", "label": "", "metadata": {}, "score": "58.641945"}
{"text": "All the details of toxicology and pharmacokinetic properties for BT are available ( Toxnet , National library of medicine ) .BT was shown to be an effective anti - cancer agent in preclinical models and is safe in non - cancer patients [ 11 - 13 ] .", "label": "", "metadata": {}, "score": "58.658222"}
{"text": "16 , pp .3025 - 3030 , 2000 .View at Google Scholar .J. D. Hainsworth , S. Litchy , H. A. Burris et al . , \" Rituximab as first - line and maintenance therapy for patients with indolent non - Hodgkin 's lymphoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "58.78315"}
{"text": "10.1038/nm1763 PubMed View Article .Orlowski RZ , Kuhn DJ : Proteasome inhibitors in cancer therapy : lessons from the first decade .Clin Cancer Res 2008 , 14 : 1649 - 1657 .", "label": "", "metadata": {}, "score": "58.807014"}
{"text": "Wang CY , Cusack JC Jr , Liu R , Baldwin AS Jr : Control of inducible chemoresistance : enhanced anti - tumor therapy through increased apoptosis by inhibition of NF - \u03baB. Nat Med 1999 , 5 : 412 - 417 .", "label": "", "metadata": {}, "score": "58.827217"}
{"text": "Bioessays 2000 , 22 : 1007 - 1017 .PubMed View Article .Zamzami N , Marchetti P , Castedo M , Decaudin D , Macho A , Hirsch T , Susin SA , Petit PX , Mignotte B , Kroemer G : Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death .", "label": "", "metadata": {}, "score": "58.834396"}
{"text": "( vi ) Topical IFN- \u03b1Delivery .Finally , Xuan and colleagues have proposed an approach to target IFN- \u03b1 molecules to lymphoma sites by constructing a fusion protein consisting of IFN- \u03b1 and an anti - CD20 mAb [", "label": "", "metadata": {}, "score": "58.847725"}
{"text": "LY294002 neither enhanced BT cytotoxicity nor restored the cell viability at 48 hrs post BT treatment .These results show that the Akt pathway may not mediate BT cytotoxicity in ovarian cancer cell lines .", "label": "", "metadata": {}, "score": "58.868214"}
{"text": "Sagarra , R.A. ; Andrade , L.A. ; Martinez , E.Z. ; Pinto , G.A. ; Syrjanen , K.J. ; Derchain , S.F. p53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer .", "label": "", "metadata": {}, "score": "58.889397"}
{"text": "10 , pp .1575 - 1581 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .T. Robak , P. Smolewski , B. Cebula , O. Grzybowska - Izydorczyk , and J. Z. B\u0142o\u0144ski , \" Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia , \" European Journal of Haematology , vol . 79 , no . 2 , pp .", "label": "", "metadata": {}, "score": "58.900986"}
{"text": "These results led to FDA approval of rituximab in combination with CHOP chemotherapy for previously untreated patients with DLBCL .Whether or not all patients need rituximab has been questioned .", "label": "", "metadata": {}, "score": "58.971157"}
{"text": "Experiments were performed in triplicate .Data was expressed as mean \u00b1 SD of triplicate experiments .Follow up cell viability assays in the presence of antioxidant ascorbic acid , demonstrated at least a 20 - 30 % restoration of cell viability in the presence of 1 mM ascorbic acid in OVACAR-3 , SKOV-3 , IGROV-1 and A2780 cells .", "label": "", "metadata": {}, "score": "58.973053"}
{"text": "First , the indiscriminate classification of all TP53 mutations as the same may under - represent the impact of individual mutations .Second , a majority of studies rely solely on immunohistochemistry ( IHC ) to determine if TP53 is mutated .", "label": "", "metadata": {}, "score": "58.974953"}
{"text": "11 , pp .4267 - 4272 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .G. Enblad , H. Hagberg , M. Erlanson et al . , \" A pilot study of alemtuzumab ( anti - CD52 monoclonal antibody ) therapy for patients with relapsed or chemotherapy - refractory peripheral T - cell lymphomas , \" Blood , vol .", "label": "", "metadata": {}, "score": "58.98033"}
{"text": "On the basis of its mechanism of action , preclinical activity profile , tolerability , and pharmaceutical properties , the compound recently has entered clinical phase I breast cancer trials .", "label": "", "metadata": {}, "score": "58.990654"}
{"text": "Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors , which were designed by combining structural elements of distinct low affinity hits generated from fragment - based and in silico screening exercises in concert with structural information from X - ray protein crystallography .", "label": "", "metadata": {}, "score": "59.074924"}
{"text": "The inhibitory protein c - FLIP(L ) is involved in resistance to CD95-mediated apoptosis in ovarian carcinoma cells with wild - type p53 .", "label": "", "metadata": {}, "score": "59.182106"}
{"text": "Agents causing cell cycle mediated apoptosis ; NF - kB and ATX inhibition are already considered ideal candidates for the treatment of ovarian cancer .Because BT was shown to exhibit these desirable properties in in vitro , it is being further explored as an effective therapeutic agent in mice ovarian cancer xenograft model , either alone or in combination .", "label": "", "metadata": {}, "score": "59.265953"}
{"text": "CAN-06 - 2184 PubMed View Article .Dimopoulos MA , Chen C , Kastritis E , Gavriatopoulou M , Treon SP : Bortezomib as a treatment option in patients with Waldenstrom macroglobulinemia .", "label": "", "metadata": {}, "score": "59.301407"}
{"text": "Compound K was shown to increase Bax expression while decreasing that of Bcl-2 expression .Therefore , Compound K - induced loss of the \u0394\u03c8 m may have been a result of an up - regulation of Bcl-2 and a down - regulation of Bax .", "label": "", "metadata": {}, "score": "59.309006"}
{"text": "J. Microbiol .Biotechnol 2008 , 18 , 1109 - 1114 .[ Google Scholar ] .Choi , K ; Choi , C. Proapoptotic ginsenosides compound K and Rh enhance Fas - induced cell death of human astrocytoma cells through distinct apoptotic signaling pathways .", "label": "", "metadata": {}, "score": "59.36161"}
{"text": "R. Marcus , K. Imrie , P. Solal - Celigny et al . , \" Phase III study of R - CVP compared with cyclophosphamide , vincristine , and prednisone alone in patients with previously untreated advanced follicular lymphoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "59.369217"}
{"text": "Biophys .Res .Commun 2000 , 279 , 383 - 390 .[ Google Scholar ] .[ Google Scholar ] .Hwang , C.I. ; Choi , J. ; Zhou , Z. ; Flesken - Nikitin , A. ; Tarakhovsky , A. ; Nikitin , A.Y. MET - dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell - derived HGF .", "label": "", "metadata": {}, "score": "59.37916"}
{"text": "25 , no .15 , pp .1986 - 1992 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . D. G. Maloney , A. J. Grillo - L\u00f3pez , C. A. White et al . , \" IDEC - C2B8 ( rituximab ) anti - CD20 monoclonal antibody therapy in patients with relapsed low - grade non - Hodgkin 's lymphoma , \" Blood , vol .", "label": "", "metadata": {}, "score": "59.398148"}
{"text": "6841 - 6846 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . E. A. Rossi , D. M. Goldenberg , T. M. Cardillo , R. Stein , and C. H. Chang , \" Hexavalent bispecific antibodies represent a new class of anticancer therapeutics-1 .", "label": "", "metadata": {}, "score": "59.432587"}
{"text": "This deserves further exploration in order to improve the clinical outcome in patients with bortezomib - resistant diseases .Methods .Cell culture and development of BTZ - resistant cell lines .", "label": "", "metadata": {}, "score": "59.440838"}
{"text": "As an internal standard for equal loading , blots were probed with an anti - \u03b2 - actin antibody .Effect of BT on caspase 3/7 activity ( apoptosis assessment ) .", "label": "", "metadata": {}, "score": "59.444542"}
{"text": "-rituximab against non - Hodgkin 's lymphoma cells , \" British Journal of Cancer , vol .83 , no .10 , pp .1375 - 1379 , 2000 .", "label": "", "metadata": {}, "score": "59.530617"}
{"text": "Griffioen M , van Egmond EH , Kester MG , Willemze R , Falkenburg JH , Heemskerk MH : Retroviral transfer of human CD20 as a suicide gene for adoptive T - cell therapy .", "label": "", "metadata": {}, "score": "59.547897"}
{"text": "Caspases expression peaked at 24 hrs post treatment .The activation of proteolytic caspases following drug exposure resulted in the cleavage of 118 kDa PARP-1 protein into an 89 kDa fragment in all BT treated cell lines ( Figure 2 B ) .", "label": "", "metadata": {}, "score": "59.56298"}
{"text": "Berndtsson M , Hagg M , Panaretakis T , Havelka AM , Shoshan MC , Linder S : Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA .", "label": "", "metadata": {}, "score": "59.59439"}
{"text": "18 , pp .4070 - 4078 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .P. V. Beum , M. A. Lindorfer , and R. P. Taylor , \" Within peripheral blood mononuclear cells , antibody - dependent cellular cytotoxicity of rituximab - opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving , \" Journal of Immunology , vol .", "label": "", "metadata": {}, "score": "59.703606"}
{"text": "At the end of the treatment time , labelled nucleotides were added and detected with HRP - HRP substrate ( TACS - Sapphire ) system .", "label": "", "metadata": {}, "score": "59.713497"}
{"text": "134 - 140 , 1981 .View at Google Scholar .N. M. Almasri , R. E. Duque , J. Iturraspe , E. Everett , and R. C. Braylan , \" Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia , \" American Journal of Hematology , vol .", "label": "", "metadata": {}, "score": "59.721745"}
{"text": "JY cells stably growing in BTZ concentrations of 35nM ( JY/35 ) and 100nM ( JY/100 ) were used for further characterization .Figure 1A shows the growth inhibition profiles of JY / WT , JY/35 and JY/100 cells after 72 hrs treatment with BTZ , revealing a clear shift in drug concentrations causing 50 % cell growth inhibition ( IC 50 value ) in JY/35 and JY/100 cells .", "label": "", "metadata": {}, "score": "59.758408"}
{"text": "Using high - content videomicroscopy based on fluorescent TP53(+/+ ) and TP53(-/- ) human colon carcinoma cells , we discovered that SP600125 , a broad - spectrum serine / threonine kinase inhibitor , kills p53-deficient cells more efficiently than their p53-proficient counterparts , in vitro .", "label": "", "metadata": {}, "score": "59.80388"}
{"text": "10.1038/nrd2085 PubMed View Article .Lang VR , Mielenz D , Neubert K , Bohm C , Schett G , Jack HM , Voll RE , Meister S : The early marginal zone B cell - initiated T - independent type 2 response resists the proteasome inhibitor bortezomib .", "label": "", "metadata": {}, "score": "59.844566"}
{"text": "In order to use TP53 mutations as biomarkers to predict patient response to chemotherapy , there needs to be a clear understanding of the biologic consequence of each mutation .", "label": "", "metadata": {}, "score": "59.861565"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Background : Activation of the complement system has been demonstrated to be an important mechanism in the mediation of myocardial ischemia and reperfusion ( MIR ) injury .", "label": "", "metadata": {}, "score": "59.88079"}
{"text": "[ Google Scholar ] .Akao , T ; Kanaoka , M ; Kobashi , K. Appearance of compound K , a major metabolite of ginsenoside Rb1 by intestinal bacteria , in rat plasma after oral administration -- measurement of compound K by enzyme immunoassay .", "label": "", "metadata": {}, "score": "59.884346"}
{"text": "The present invention provides an antibody , or fragment thereof , which binds an epitope within domains D4 or D5 of human FLT3 .The present invention provides a method of treating a pre - cancerous condition or cancer in a mammal comprising administering MTX in combination with a FLT3 inhibitor to the mammal in an amount effective to treat the pre - cancerous condition or cancer .", "label": "", "metadata": {}, "score": "59.954285"}
{"text": "PubMed .Nam SW , Clair T , Campo CK , Lee HY , Liotta LA , Stracke ML : Autotaxin ( ATX ) , a potent tumor mitogen , augments invasive and metastatic potential of ras - transformed cells .", "label": "", "metadata": {}, "score": "60.029663"}
{"text": "The complement and contact systems may be involved in the pathophysiological process of inflammatory bowel disease ( IBD ) .C1 inhibitor ( C1INH ) is the most important inhibitor of both the complement and contact systems .", "label": "", "metadata": {}, "score": "60.06613"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .P. Hillmen , A. B. Skotnicki , T. Robak et al . , \" Alemtuzumab compared with chlorambucil as first - line therapy for chronic lymphocytic leukemia , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "60.094563"}
{"text": "Understanding the basic science of TP53 oncomorphic mutations can lead to identifying better therapies for patients with oncomorphic mutations in their tumors , and potentially avoid the high incidence of chemoresistance that is currently one of the barriers to improving survival for this deadly disease .", "label": "", "metadata": {}, "score": "60.105606"}
{"text": "( B ) Effect of p38 inhibitor SB203580 and pAkt inhibitor LY294002 on BT treated cells .To assess role of p38 and pAkt activation in BT induced cytotoxicity , cells were treated with 100 \u03bcM", "label": "", "metadata": {}, "score": "60.1695"}
{"text": "The studies described above will pave the way for appropriate comparisons of specific mutants , and possibly identify common signaling pathways that can be targeted for anti - cancer drugs .", "label": "", "metadata": {}, "score": "60.23652"}
{"text": "When oncomorphic mutations are acquired , cancer susceptibility is increased .Figure 1 .The spectrum of protection against cancer provided by WT p53 .As copies of WT p53 ( TP53 + /+ ) are lost , cancer protection decreases .", "label": "", "metadata": {}, "score": "60.31942"}
{"text": "Caspase activity was found to be dependent on time and concentration of BT .As shown in Figure 2 A ( column graph ) , at 6 hrs post treatment , caspase activity was observed only at 200 \u03bcM in all cell lines except A2780 which showed significant activity even at 50 \u03bcM BT .", "label": "", "metadata": {}, "score": "60.357273"}
{"text": "Of additional interest was the notion that alongside these short term effects , acquisition of BTZ resistance in JY cells provoked a dramatic reduction in the basal levels of TNF - \u03b1 production , being most pronounced in JY/100 cells .", "label": "", "metadata": {}, "score": "60.375874"}
{"text": "Results are depicted as relative Mean Fluorescence Index ( MFI ) and represent the mean \u00b1 SEM of 5 separate experiments .( C ) Representative figure of CD19 expression in JY / WT cells and BTZ - resistant variants .", "label": "", "metadata": {}, "score": "60.443363"}
{"text": "IR resulted in intestinal injury in C57BL/6 , C1INH(-/- ) , Bk2R(-/- ) , and C3(-/- ) mice with significantly increased neutrophil infiltration into intestinal tissue .", "label": "", "metadata": {}, "score": "60.449837"}
{"text": "Genet 1993 , 4 , 42 - 46 .[ Google Scholar ] .Blandino , G. ; Levine , A.J. ; Oren , M. Mutant p53 gain of function : Differential effects of different p53 mutants on resistance of cultured cells to chemotherapy .", "label": "", "metadata": {}, "score": "60.49749"}
{"text": "Smith - Sorensen , B. ; Kaern , J. ; Holm , R. ; Dorum , A. ; Trope , C. ; Borresen - Dale , A.L. Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status .", "label": "", "metadata": {}, "score": "60.545746"}
{"text": "A significant number of TP53 mutations have been reported in the literature , though only a small proportion has been characterized experimentally .Unfortunately , TP53 sequence alone can not provide definitive information regarding its function in the setting of the tumor , thereby limiting the predictive value of TP53 mutational status with regards to prognosis and response to therapy .", "label": "", "metadata": {}, "score": "60.572247"}
{"text": "Human C1-inhibitor ( C1INH ) is a multifunctional protease inhibitor that regulates coagulation , vascular permeability and inflammation with beneficial effects in inflammatory disease models including septic shock .", "label": "", "metadata": {}, "score": "60.645233"}
{"text": "Chem 2010 , 285 , 14229 - 14238 .[ Google Scholar ] .Chin , K.V. ; Ueda , K. ; Pastan , I. ; Gottesman , M.M. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53 .", "label": "", "metadata": {}, "score": "60.66781"}
{"text": "10.1016/j.str.2005.11.019 PubMed View Article .Kale AJ , McGlinchey RP , Lechner A , Moore BS : Bacterial self - resistance to the natural proteasome inhibitor salinosporamide A. ACS Chem Biol 2011 , 6 : 1257 - 1264 .", "label": "", "metadata": {}, "score": "60.724552"}
{"text": "In the autoimmune disease setting , clinical studies with PIs are far less advanced , although in pre - clinical studies , PI therapy demonstrated promising results as anti - arthritic treatment strategy , also by B cell depletion [ 18 - 22 ] .", "label": "", "metadata": {}, "score": "60.727398"}
{"text": "Western blot analysis of cell cycle regulatory proteins revealed up - regulation of both P27 ( kip1 ) and p21 upon BT treatment ( Figure 5 C ) .", "label": "", "metadata": {}, "score": "60.815315"}
{"text": "Additional file 1 : Figure S3 .Induction of allogeneic T - cell proliferation by JY / WT and BTZ - resistant JY cells .T cell stimulatory capacity of the short term treatment ( 24 hours ) of BTZ JY / WT ( \u00b1 10nM BTZ ) , JY/35 ( \u00b1 35nM BTZ ) and JY/100 ( \u00b1 100nM BTZ ) .", "label": "", "metadata": {}, "score": "60.844643"}
{"text": "PubMed View Article .Buolamwini JK : Cell cycle molecular targets in novel anticancer drug discovery .Curr Pharm Des 2000 , 6 : 379 - 392 .", "label": "", "metadata": {}, "score": "60.85813"}
{"text": "PubMed View Article .Nam SW , Clair T , Kim YS , et al . :Autotaxin ( NPP-2 ) , a metastasis - enhancing motogen , is an angiogenic factor .", "label": "", "metadata": {}, "score": "60.88861"}
{"text": "[ Google Scholar ] .Rohlke , P. ; Milde - Langosch , K. ; Weyland , C. ; Pichlmeier , U. ; Jonat , W. ; Loning , T. p53 is a persistent and predictive marker in advanced ovarian carcinomas : Multivariate analysis including comparison with Ki67 immunoreactivity .", "label": "", "metadata": {}, "score": "60.89727"}
{"text": "115 , no .12 , pp .2420 - 2429 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . L. Fischer , O. Penack , C. Gentilini et al . , \" The anti - lymphoma effect of antibody - mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer ( NK ) cells , \" Experimental Hematology , vol .", "label": "", "metadata": {}, "score": "61.063652"}
{"text": "As most of the other tumor suppressor proteins , TOB1 is inactivated in many human cancers .Homozygous deletion of TOB1 in mice is reported to be responsible for cancer development in the lung , liver , and lymph node , whereas the ectopic overexpression of TOB1 shows anti - proliferation , and a decrease in the migration and invasion abilities on cancer cells .", "label": "", "metadata": {}, "score": "61.129097"}
{"text": "Cytochrome C , Apaf1 ( apoptotic protease activating factor-1 ) and dATP then form an apoptosome to which procaspase-9 is recruited and activated .We observed a switch from apoptosis to necrosis with increasing BT concentrations .", "label": "", "metadata": {}, "score": "61.186157"}
{"text": "[ Google Scholar ] .Werner , H. ; Karnieli , E. ; Rauscher , F.J. ; LeRoith , D. Wild - type and mutant p53 differentially regulate transcription of the insulin - like growth factor I receptor gene .", "label": "", "metadata": {}, "score": "61.189003"}
{"text": "We term the resulting change an oncomorphism .In this review , we discuss particular TP53 mutations , including known oncomorphic properties of the resulting mutant p53 proteins .", "label": "", "metadata": {}, "score": "61.229435"}
{"text": "We investigated whether the cytotoxicity of Compound K was associated with the induction of apoptosis .Sub G 1 -hypodiploid cells , which are an indicator of apoptosis , increased in Compound K - treated cells as compared to control cells ( Figure 4A ) .", "label": "", "metadata": {}, "score": "61.231598"}
{"text": "The approach includes the design of a fragment library , identification of fragments that bind competitively to a target by ligand - based NMR techniques and protein crystal structures to characterize binding .", "label": "", "metadata": {}, "score": "61.27732"}
{"text": "View at Publisher \u00b7 View at Google Scholar .S. Maddipatla , F. J. Hernandez - Ilizaliturri , J. Knight , and M. S. Czuczman , \" Augmented antitumor activity against b - cell lymphoma by a combination of monoclonal antibodies targeting trail - r1 and cd20 , \" Clinical Cancer Research , vol .", "label": "", "metadata": {}, "score": "61.278725"}
{"text": "[ Google Scholar ] .Petitjean , A.M.E. ; Kato , S. ; Ishioka , C. ; Tavtigian , S.V. ; Hainaut , P. ; Olivier , M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype : Lessons from recent developments in the IARC TP53 database .", "label": "", "metadata": {}, "score": "61.278763"}
{"text": "The factors determining whether or not cells apoptose in response to Hsp90 inhibition or the combination of Hsp90 plus Hsc70/Hsp70 inhibition remain to be determined .", "label": "", "metadata": {}, "score": "61.311752"}
{"text": "The cell surface protein CD20 is a 33-kDa protein expressed by mature B cells and most malignant B cells , but not by pre - B cells or differentiated plasma cells [ 4 - 8 ] .", "label": "", "metadata": {}, "score": "61.356133"}
{"text": "Mol Cancer Ther ; 9(4 ) ; 906 - 19 .( c)2010 AACR .[ Show abstract ] [ Hide abstract ] ABSTRACT :The anti - apoptotic function of the 70 kDa family of heat shock proteins and their role in cancer is well documented .", "label": "", "metadata": {}, "score": "61.399395"}
{"text": "Ag - driven CIR activation resulted in the production of soluble factors mediating efficient bystander effect .By carefully defining CIR surface expression and increasing affinity for a specific target antigen , it may be possible to selectively exclude CIR - mediated activity against targets expressing low levels of antigen , as normal cells .", "label": "", "metadata": {}, "score": "61.428436"}
{"text": "17 , pp .3258 - 3267 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .J. P. Leonard , M. Coleman , J. C. Ketas et al . , \" Phase I / II trial of epratuzumab ( humanized anti - CD22 antibody ) in indolent non - Hodgkin 's lymphoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "61.4408"}
{"text": "Accordingly , a clinical effect of BTZ in B cell driven diseases has been found .BTZ is highly effective in inducing plasma cell death , thus , is now being implemented both in first line and relapsed and refractory multiple myeloma ( MM ) [ 14 ] .", "label": "", "metadata": {}, "score": "61.44761"}
{"text": "These proteasome entities are part of the immunoproteasome , which is mainly expressed in cells of hematological origin and can generate a distinct peptide repertoire for MHC - class I presentation [ 30 ] .", "label": "", "metadata": {}, "score": "61.55107"}
{"text": "Additional file 1 : Figure S1 .Analysis of PSMB5 gene mutations in BTZ - resistant JY cells .Sequencing of PSMB5 gene exon 2 in JY / WT cells and in the BTZ - resistant JY cells : JY/35BTZ and JY/100BTZ .", "label": "", "metadata": {}, "score": "61.586742"}
{"text": "Results and Discussion .ROS - Induced Cytotoxic Effect of Compound K on HT-29 Colon Cancer Cells .Compound K is an active metabolite of ginsenosides and exhibits anti - tumor effects against various types of cancer cells [ 16 , 17 , 19 - 23 , 28 - 36 ] .", "label": "", "metadata": {}, "score": "61.67415"}
{"text": "For both benign and neoplastic B cells , however , the long term effects of BTZ exposure are largely unexplored and deserve further investigation .In this study , we investigated the long - term effects of B - cell exposure to BTZ and onset of resistance to BTZ using EBV - transformed JY lymphoblast cells as a benign autoimmune disorder in vitro B - cell model .", "label": "", "metadata": {}, "score": "61.756165"}
{"text": "This work was supported by a research grant from Jeju National University Hospital .References .Suzuki , YJ ; Forman , HJ ; Sevanian , A. Oxidants as stimulators of signal transduction .", "label": "", "metadata": {}, "score": "61.802017"}
{"text": "Wong , K.B. ; deDecker , B.S. ; Freund , S.M. ; Proctor , M.R. ; Bycroft , M. ; Fersht , A.R. Hot - spot mutants of p53 core domain evince characteristic local structural changes .", "label": "", "metadata": {}, "score": "61.822342"}
{"text": "15 , pp .4556 - 4564 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . E. Tobin , G. L. DeNardo , N. Zhang , A. L. Epstein , C. Liu , and S. DeNardo , \" Combination immunotherapy with anti - CD20 and anti - HLA - DR monoclonal antibodies induces synergistic anti - lymphoma effects in human lymphoma cell lines , \" Leukemia and Lymphoma , vol .", "label": "", "metadata": {}, "score": "61.827553"}
{"text": "R175 p53 .The p53 oncomorph R175H is the third most common TP53 mutation in all cancers and is the best characterized mutation .Many different types of cancer cell lines that harbor this mutation as well as murine cancer models have been used to study the oncogenic properties of R175H , and these studies have suggested a role in chemoresistance [ 40 ] .", "label": "", "metadata": {}, "score": "61.88714"}
{"text": "R. O'Donnell , G. DeNardo , D. Kukis , et al . , \" 67copper-2-iminothiolane-6-[p-(bromoacetamido ) benzyl]-teta - lym-1 for radioimmunotherapy of non - hodgkin 's lymphoma , \" Clinical Cancer Research , vol .", "label": "", "metadata": {}, "score": "61.895157"}
{"text": "Compound K induced the release of cytochrome c from mitochondria into cytosol ( Figure 4D ) .The mitochondrial membrane disruption by Compound K activated caspase-9 ( 37 and 39 kDa ) and caspase-3 ( 19 and 17 kDa ) , a target of caspase-9 , which was further demonstrated by PARP cleavage ( 89 kDa ) ( Figure 4D ) .", "label": "", "metadata": {}, "score": "61.908424"}
{"text": "BT was shown to induce cell death via apoptosis .The mechanism(s ) of actions appears to be via cell cycle regulation , ROS generation , NF - kB inhibition and ATX inhibition .", "label": "", "metadata": {}, "score": "61.92576"}
{"text": "We have previously described the discovery and synthesis of novel adenosine - derived inhibitors of the 70 kDa family of heat shock proteins ; the first inhibitors described to target the ATPase binding domain .", "label": "", "metadata": {}, "score": "61.933434"}
{"text": "Carcinogenesis 2009 , 30 , 1744 - 1753 .[ Google Scholar ] .El - Najjar , N ; Chatila , M ; Moukadem , H ; Vuorela , H ; Ocker , M ; Gandesiri , M ; Schneider - Stock , R ; Gali - Muhtasib , H. Reactive oxygen species mediate thymoquinone - induced apoptosis and activate ERK and JNK signaling .", "label": "", "metadata": {}, "score": "61.968853"}
{"text": "Zehn D , Cohen CJ , Reiter Y , Walden P : Efficiency of peptide presentation by dendritic cells compared with other cell types : implications for cross - priming .", "label": "", "metadata": {}, "score": "62.0014"}
{"text": "Clin .Cancer Res . in press .[ Google Scholar ] .Figure 1 .The spectrum of protection against cancer provided by WT p53 .", "label": "", "metadata": {}, "score": "62.01967"}
{"text": "CR rates ranging between 3 and 17 % were recorded in these studies .Remarkably , studies show that , in FL , sequential administration of standard chemotherapy followed by rituximab induces molecular clearance ( as detected by PCR for the Bcl-2/IgH rearrangement ) in more than 70 % of the patients [ 42 , 43 , 56 ] .", "label": "", "metadata": {}, "score": "62.071804"}
{"text": "4 , pp .235 - 242 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .M. Pfreundschuh , L. Tr\u00fcmper , A. \u00d6sterborg et al . , \" CHOP - like chemotherapy plus rituximab versus CHOP - like chemotherapy alone in young patients with good - prognosis diffuse large - B - cell lymphoma : a randomised controlled trial by the MabThera International Trial ( MInT ) Group , \" Lancet Oncology , vol .", "label": "", "metadata": {}, "score": "62.128284"}
{"text": "BT may inhibit cell survival directly via inhibition of ATX or indirectly via inhibition of PI3-K , Akt or NF - kB pathways .", "label": "", "metadata": {}, "score": "62.14364"}
{"text": "16 , pp .3051 - 3059 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .J. P. Leonard , M. Coleman , J. C. Ketas et al . , \" Epratuzumab , a humanized anti - CD22 antibody , in aggressive non - Hodgkin 's lymphoma : phase I / II clinical trial results , \" Clinical Cancer Research , vol .", "label": "", "metadata": {}, "score": "62.145042"}
{"text": "20 , pp .8384 - 8392 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .P. Gupta , D. M. Goldenberg , E. A. Rossi , and C.-H. Chang , \" Multiple signaling pathways induced by hexavalent , monospecific , anti - CD20 and hexavalent , bispecific , anti - CD20/CD22 humanized antibodies correlate with enhanced toxicity to B - cell lymphomas and leukemias , \" Blood , vol .", "label": "", "metadata": {}, "score": "62.245644"}
{"text": "Mutations are primarily localized to the highly conserved DNA binding domain and inactivate wild type ( WT ) p53 function .The spectrum of mutations in TP53 is extremely diverse , and a few particular mutations can actively promote oncogenesis ( Figure 1 ) .", "label": "", "metadata": {}, "score": "62.263206"}
{"text": "Moreover this rearrangement may occasionally be found in healthy peripheral blood lymphocytes [ 58 ] .In fact , a recent study by van Oers and coworkers suggests that BCL-2/IgH polymerase chain reaction status at the end of induction treatment would not be predictive for progression - free survival in relapsed / resistant FL [ 59 ] .", "label": "", "metadata": {}, "score": "62.29563"}
{"text": "Chem 1996 , 271 , 15084 - 15090 .[ Google Scholar ] .Blagosklonny , M.V. ; Toretsky , J. ; Bohen , S. ; Neckers , L. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90 .", "label": "", "metadata": {}, "score": "62.328625"}
{"text": "CD95-mediated apoptosis was blocked in human ovarian cancer cells .In cell lines with wild - type p53 , treatment with the protein synthesis inhibitor cycloheximide ( CHX ) together with anti - CD95 overcame the resistance , suggesting the presence of a labile inhibiting protein .", "label": "", "metadata": {}, "score": "62.357224"}
{"text": "Chen , M ; Wang , J. Initiator caspases in apoptosis signaling pathways .Apoptosis 2002 , 7 , 313 - 319 .[ Google Scholar ] .", "label": "", "metadata": {}, "score": "62.3948"}
{"text": "Natl .Acad .Sci .USA 2009 , 106 , 17705 - 17710 .[ Google Scholar ] .Weisz , L. ; Zalcenstein , A. ; Stambolsky , P. ; Cohen , Y. ; Goldfinger , N. ; Oren , M. ; Rotter , V. Transactivation of the EGR1 gene contributes to mutant p53 gain of function .", "label": "", "metadata": {}, "score": "62.425873"}
{"text": "SF3B1 , which functions at the catalytic core of the spliceosome , was the second most frequently mutated gene ( with mutations occurring in 15 % of patients ) .", "label": "", "metadata": {}, "score": "62.494648"}
{"text": "Evidence of abnormal phosphatidylcholine metabolism might have implications in EOC biology and might provide an avenue to the development of noninvasive clinical tools for EOC diagnosis and treatment follow - up .", "label": "", "metadata": {}, "score": "62.561684"}
{"text": "[ 36 ] .The first one involved young , the latter elderly , DLBCL patients .In the multicenter study conducted by Coiffier and colleagues , therapy using rituximab combined with standard CHOP chemotherapy demonstrated a higher efficacy than CHOP alone , in terms of both event - free survival at 2 years ( 57 % versus 38 % , . )", "label": "", "metadata": {}, "score": "62.59662"}
{"text": "View at Google Scholar .G. L. DeNardo , S. J. DeNardo , D. S. Goldstein et al . , \" Maximum - tolerated dose , toxicity , and efficacy of I - Lym-1 antibody for fractionated radioimmunotherapy of non - Hodgkin 's lymphoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "62.603264"}
{"text": "[ Google Scholar ] .Holmila , R. ; Fouquet , C. ; Cadranel , J. ; Zalcman , G. ; Soussi , T. Splice mutations in the p53 gene : Case report and review of the literature .", "label": "", "metadata": {}, "score": "62.60747"}
{"text": "In the presence of 5 % baby rabbit serum [ 47 ] and over a broad range of rituximab concentrations , significantly increased CDC was noted for JY/100 cells as compared to JY / WT cells with a mean difference of 17 % lysis ( Figure 6 ) .", "label": "", "metadata": {}, "score": "62.65805"}
{"text": "J. Clin .Invest 2008 , 118 , 2516 - 2525 .[ Google Scholar ] .Choo , MK ; Sakurai , H ; Kim , DH ; Saiki , I. A ginseng saponin metabolite suppresses tumor necrosis factor - alpha - promoted metastasis by suppressing nuclear factor - kappaB signaling in murine colon cancer cells .", "label": "", "metadata": {}, "score": "62.704212"}
{"text": "This unique effect of BT on ROS generation in cisplatin - resistant cells implies that BT could have a role in the treatment of platinum - resistant ovarian cancer , either alone or in combination with other cytotoxic drugs .", "label": "", "metadata": {}, "score": "62.71346"}
{"text": "Other key cellular events that might be examined to establish oncomorphic activity include apoptosis , cell cycle progression , proliferation , migration , invasion , colony formation , cytotoxicity and chemoresistance .", "label": "", "metadata": {}, "score": "62.717194"}
{"text": "PubMed View Article .Englert RP , Shacter E : Distinct modes of cell death induced by different reactive oxygen species : amino acyl chloramines mediate hypochlorous acid - induced apoptosis .", "label": "", "metadata": {}, "score": "62.731304"}
{"text": "Following heat denaturation , Lammli sample buffer along with \u03b2 - mercaptoethanol was added to lysates and subjected to SDS - PAGE electrophoresis and immunoblotting .", "label": "", "metadata": {}, "score": "62.73791"}
{"text": "As each p53 oncomorph has unique properties , it is of importance to conduct studies in ovarian cancer models in order to understand how these alterations affect ovarian cancer biology and the developing chemoresistance .", "label": "", "metadata": {}, "score": "62.767105"}
{"text": "PubMed View Article .Rokudai S , Fujita N , Kitahara O , Nakamura Y , Tsuruo T : Involvement of FKHR - dependent TRADD expression in chemotherapeutic drug - induced apoptosis .", "label": "", "metadata": {}, "score": "62.79501"}
{"text": "Cell .Biol 2007 , 9 , 573 - 580 .[ Google Scholar ] .Haupt , S. ; di Agostino , S. ; Mizrahi , I. ; Alsheich - Bartok , O. ; Voorhoeve , M. ; Damalas , A. ; Blandino , G. ; Haupt , Y. Promyelocytic leukemia protein is required for gain of function by mutant p53 .", "label": "", "metadata": {}, "score": "62.833435"}
{"text": "Intracellular ROS , as signaling intermediates , are involved in cell death signal transduction pathways .Compound K induced ROS generation as compared to control in a time - dependent manner ( Figure 3A ) , and NAC , a distinct antioxidant and ROS scavenger , exerted a scavenging effect on the ROS generated by Compound K ( Figure 3B ) .", "label": "", "metadata": {}, "score": "62.844788"}
{"text": "Expression of B cell surface markers CD19 and CD20 on JY / WT cells and BTZ - resistant variants .( A ) Percentage CD19-positive JY / WT cells and BTZ - resistant variants .", "label": "", "metadata": {}, "score": "62.89835"}
{"text": "Our results demonstrate inhibitory effect of BT on NF - kB regulated proteins in ovarian cancer cell lines .BT treatment may promote apoptotic role for NF - \u03baB by repressing anti - apoptotic gene expression .", "label": "", "metadata": {}, "score": "63.02389"}
{"text": "Cell .Biol 1998 , 18 , 3735 - 3743 .[ Google Scholar ] .Yan , W. ; Chen , X. Identification of GRO1 as a critical determinant for mutant p53 gain of function .", "label": "", "metadata": {}, "score": "63.108917"}
{"text": "Finally Zevalin also appears to be effective against some diffuse large B - cell lymphomas , and mantle - cell lymphomas , when used in sequence with chemotherapy ( ORR of 53 % versus 19 % ; OS 22.4 , versus 4.6 , resp . )", "label": "", "metadata": {}, "score": "63.124123"}
{"text": "Upon activation with PMA and ionomycin , JY cells produced TNF - \u03b1 levels of 7000 \u00b1 3700 pg / ml , which was diminished by 20 % in the presence of 10 nM BTZ ( Figure 3 ) .", "label": "", "metadata": {}, "score": "63.175354"}
{"text": "Indeed , incubation of NK cells with rituximab - coated target cells leads to CD16 ( Fc \u03b3 RIIIa ) downregulation and to upregulation of CD107a , a marker for degranulation and exhaustion [ 84 , 85 ] .", "label": "", "metadata": {}, "score": "63.224777"}
{"text": "After treatment with NAC and/or Compound K , intracellular ROS were detected at 24 h by spectrofluorometer after DCF - DA treatment .( C )", "label": "", "metadata": {}, "score": "63.239616"}
{"text": "After treatment with NAC and/or Compound K , intracellular ROS were detected at 24 h by spectrofluorometer after DCF - DA treatment .( C )", "label": "", "metadata": {}, "score": "63.239616"}
{"text": "4 , pp .975 - 980 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .W. Wierda , S. O'Brien , S. Wen et al . , \" Chemoimmunotherapy with fludarabine , cyclophosphamide , and rituximab for relapsed and refractory chronic lymphocytic leukemia , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "63.240227"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Heat shock protein 90 ( HSP90 ) is a key component of a multichaperone complex involved in the post - translational folding of a large number of client proteins , many of which play essential roles in tumorigenesis .", "label": "", "metadata": {}, "score": "63.301514"}
{"text": "2825 - 2833 , 1998 .View at Google Scholar .B. Coiffier , E. Lepage , J. Bri\u00e8re et al . , \" Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large - B - cell lymphoma , \" New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "63.34356"}
{"text": "10.1038/nri2687 PubMed View Article .Borissenko L , Groll M : 20S proteasome and its inhibitors : crystallographic knowledge for drug development .Chem Rev 2007 , 107 : 687 - 717 .", "label": "", "metadata": {}, "score": "63.347694"}
{"text": "CCR-11- 1429 PubMed Central PubMed View Article .Moreau P , Richardson PG , Cavo M , Orlowski RZ , San Miguel JF , Palumbo A , Harousseau JL : Proteasome inhibitors in multiple myeloma : ten years later .", "label": "", "metadata": {}, "score": "63.38973"}
{"text": "We focused on Bithionol ( BT ) , a clinically approved anti - parasitic drug as an anti - ovarian cancer drug .BT has previously been shown to inhibit solid tumor growth in several preclinical cancer models .", "label": "", "metadata": {}, "score": "63.405094"}
{"text": "- 935 .PubMed View Article .Xu Y , Gaudette DC , Boynton JD , et al .: Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients .", "label": "", "metadata": {}, "score": "63.50978"}
{"text": "10.1136/ard.2008.097709 PubMed View Article .Neubert K , Meister S , Moser K , Weisel F , Maseda D , Amann K , Wiethe C , Winkler TH , Kalden JR , Manz RA , Voll RE : The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus - like disease from nephritis .", "label": "", "metadata": {}, "score": "63.52855"}
{"text": "The 3D Fragment Consortium is developing fragment - screening libraries with enhanced 3D characteristics and evaluating their effect on the quality of fragment - based hit identification ( FBHI ) projects .", "label": "", "metadata": {}, "score": "63.5804"}
{"text": "Cancer Cell 2010 , 17 , 273 - 285 .[ Google Scholar ] .Sankala , H. ; Vaughan , C. ; Wang , J. ; Deb , S. ; Graves , P.R. Upregulation of the mitochondrial transport protein , Tim50 , by mutant p53 contributes to cell growth and chemoresistance .", "label": "", "metadata": {}, "score": "63.657913"}
{"text": "Proposed strategies for uncovering oncomorphic p53 functions : ( a ) Example of an experimental outline used to understand the function of specific TP53 mutants .", "label": "", "metadata": {}, "score": "63.805855"}
{"text": "All antibodies were purchased from Cell Signaling Technologies , ( Danvers , MA ) .PrestoBlue \u2122 Cell Viability Reagent and ROS Dye - carboxy - H2DCFDA were purchased from Invitrogen ( Carlsbad , CA ) .", "label": "", "metadata": {}, "score": "63.81019"}
{"text": "Freed - Pastor , W.A. ; Prives , C. Mutant p53 : One name , many proteins .Genes Dev 2012 , 26 , 1268 - 1286 .", "label": "", "metadata": {}, "score": "63.834488"}
{"text": "These results are also confirmed by TUNEL assay which detects DNA fragmentation .As shown in Figure 3 ( line graph ) , increased DNA fragmentation was observed with increasing BT concentrations in all the cell lines tested .", "label": "", "metadata": {}, "score": "63.918476"}
{"text": "First , we studied the cytotoxic effect ( IC 50 determination ) against a panel of ovarian cancer cell lines exhibiting varying sensitivities to cisplatin .", "label": "", "metadata": {}, "score": "63.92552"}
{"text": "Yttrium-90 : labelled ibritumomab tiuxetan ( zevalin ) , ( 2 ) iodine-131 : labelled tositumomab ( bexxar ) .These therapeutics hold great promise for the treatment of NHL and their usefulness has recently been confirmed by several clinical trials [ 112 - 122 ] .", "label": "", "metadata": {}, "score": "63.962006"}
{"text": "It is transiently expressed on the surface of activated B cells , dendritic cells , and T cells of healthy individuals [ 102 ] .Additionally , a variety of lymphoid malignancies constitutively express CD80 , making this antigen a suitable target [ 103 ] .", "label": "", "metadata": {}, "score": "64.042725"}
{"text": "In addition to these markers of cell death , we looked at other apoptosis - specific nuclear changes such as chromatin condensation as well as changes in mitochondrial potential .", "label": "", "metadata": {}, "score": "64.045135"}
{"text": "Exposure of compound 12 to HCT116 cells caused significant reduction in cellular levels of Raf-1 and Her2 at concentrations similar to that which caused cell growth arrest .", "label": "", "metadata": {}, "score": "64.09273"}
{"text": "Induction of Apoptosis by Compound K via JNK and p38 MAPK Activation .Various studies have suggested a possible mechanism for the JNK and p38 MAPK pathway , as related to mitochondrial depolarization and apoptosis induction [ 48 ] .", "label": "", "metadata": {}, "score": "64.100006"}
{"text": "Cell proliferation , cell apoptosis and caspase 3/7 activity was determined for VER-155008 in the absence or presence of small molecule Hsp90 inhibitors .VER-155008 inhibited the proliferation of human breast and colon cancer cell lines with GI(50)s in the range 5.3 - 14.4 microM , and induced Hsp90 client protein degradation in both HCT116 and BT474 cells .", "label": "", "metadata": {}, "score": "64.154724"}
{"text": "10.1016/j.cell.2011.12.030 PubMed View Article .Groettrup M , Kirk CJ , Basler M : Proteasomes in immune cells : more than peptide producers ?", "label": "", "metadata": {}, "score": "64.16598"}
{"text": "The reaction product was measured by reading the absorbance at 410 nm .The percent of ATX inhibition of treated cells was calculated against untreated cells .", "label": "", "metadata": {}, "score": "64.16611"}
{"text": "Nat Genet 2001 ; 29:295 ) .Analysis revealed a Bonferroni - corrected significant correlation of 105 L - R pairs in at least one data set and , by systematic analysis , identified 39 more frequently correlated L - R pairs , 7 of which were already biologically confirmed .", "label": "", "metadata": {}, "score": "64.171875"}
{"text": "Natl .Acad .Sci .USA 2000 , 97 , 4174 - 4179 .[ Google Scholar ] .Lee , M.K. ; Sabapathy , K. The R246S hot - spot p53 mutant exerts dominant - negative effects in embryonic stem cells in vitro and in vivo .", "label": "", "metadata": {}, "score": "64.178276"}
{"text": "To further define key signalling responses of ovarian cancer cells to treatment with BT , we analyzed the expression and activation / phosphorylation of cellular markers involved in pro - apoptotic ( p38 ) or pro - survival ( pAkt , NF - kB ) signalling .", "label": "", "metadata": {}, "score": "64.19332"}
{"text": "They herald the advent of therapeutic strategies based on targeted agents that will likely be more effective and , at the same time , less toxic than traditional chemotherapy - based treatments .", "label": "", "metadata": {}, "score": "64.21846"}
{"text": "[ Google Scholar ] .Baekelandt , M. ; Kristensen , G.B. ; Nesland , J.M. ; Trope , C.G. ; Holm , R. Clinical significance of apoptosis - related factors p53 , Mdm2 , and Bcl-2 in advanced ovarian cancer .", "label": "", "metadata": {}, "score": "64.29802"}
{"text": "16 , pp .5327 - 5334 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . A. Younes , K. Hariharan , R. S. Allen , and B. R. Leigh , \" Initial trials of anti - CD80 monoclonal antibody ( galiximab ) therapy for patients with relapsed or refractory follicular lymphoma , \" Clinical Lymphoma , vol .", "label": "", "metadata": {}, "score": "64.33516"}
{"text": "We trained a neural network using 3517 compounds identified as active or inactive against these targets .One hundred and forty - seven virtual hits were acquired for validation in growth inhibition and senescence - associated \u03b2 - galactosidase assays .", "label": "", "metadata": {}, "score": "64.34638"}
{"text": "The fact that BT treatment reduced ATX activity would imply that treated cells are exposed to a higher oxidative stress , eventually leading to apoptosis or necrosis .", "label": "", "metadata": {}, "score": "64.360016"}
{"text": "Nat .Struct .Mol .Biol 2009 , 16 , 1086 - 1093 .[ Google Scholar ] .Scian , M.J. ; Stagliano , K.E. ; Deb , D. ; Ellis , M.A. ; Carchman , E.H. ; Das , A. ; Valerie , K. ; Deb , S.P. ; Deb , S. Tumor - derived p53 mutants induce oncogenesis by transactivating growth - promoting genes .", "label": "", "metadata": {}, "score": "64.3855"}
{"text": "[ Google Scholar ] .Ventura , A. ; Kirsch , D.G. ; McLaughlin , M.E. ; Tuveson , D.A. ; Grimm , J. ; Lintault , L. ; Newman , J. ; Reczek , E.E. ; Weissleder , R. ; Jacks , T. Restoration of p53 function leads to tumour regression in vivo .", "label": "", "metadata": {}, "score": "64.47761"}
{"text": "TOB1-overexpressing cancer cells have limited potential of growing as xenograft tumors in nude mice upon subcutaneous implantation .This review addresses the molecular basis of TOB1 tumor suppressor function with special emphasis on its regulation of intracellular signaling pathways .", "label": "", "metadata": {}, "score": "64.515144"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Heat shock protein ( Hsp)90 is a molecular chaperone that is responsible for the correct folding of a large number of proteins , which allows these proteins to achieve their functional conformation .", "label": "", "metadata": {}, "score": "64.54486"}
{"text": "[ Google Scholar ] .Dittmer , D. ; Pati , S. ; Zambetti , G. ; Chu , S. ; Teresky , A.K. ; Moore , M. ; Finlay , C. ; Levine , A.J. Gain of function mutations in p53 .", "label": "", "metadata": {}, "score": "64.60776"}
{"text": "Additionally , cells cultured from these tumors demonstrate an increased capacity to proliferate [ 35 ] .In studies of lung and bladder cancer cells , overexpression of R273H p53 on a TP53 null background results in resistance to cisplatin [ 40 , 41 ] .", "label": "", "metadata": {}, "score": "64.63994"}
{"text": "Goyeneche AA , Caron RW , Telleria CM : Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo .Clin Cancer Res 2007 , 13 ( 11):3370 - 3379 .", "label": "", "metadata": {}, "score": "64.642166"}
{"text": "Briefly , for PSMB5 , a Taqman gene expression assay was used according to the manufacturers ' instructions ( Hs00605652_m1 , Applied Biosystems ) .All other primers and probes were designed using Primer Express software ( Applied Biosystems ) and are indicated in Additional file 1 : Table S1 .", "label": "", "metadata": {}, "score": "64.66798"}
{"text": "To define the cellular response of ovarian cancer cell lines to treatment with BT , we analysed the expression and/or activation of cellular markers that are hallmarks of pro - survival ( pAkt , pNF - \u03baB p65 ) and pro - apoptotic signalling ( pP38 MAPK ) in all cell lines .", "label": "", "metadata": {}, "score": "64.7009"}
{"text": "We will discuss these issues and present an overview of the most significant clinical studies with monoclonal antibodies for NHL treatment carried out to date .", "label": "", "metadata": {}, "score": "64.72545"}
{"text": "60 - 66 , 2002 .View at Publisher \u00b7 View at Google Scholar .T. E. Witzig , L. I. Gordon , F. Cabanillas et al . , \" Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low - grade , follicular , or transformed B - cell non - Hodgkin 's lymphoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "64.73365"}
{"text": "All cell lines were cultured at 37 \u00b0 C in a humidified atmosphere at 5 % CO 2 .The cisplatin resistant variants A2780-CDDP and IGROV-1CDDP cells were treated with 3 \u03bcM cisplatin every 3rd passage to maintain cisplatin resistance .", "label": "", "metadata": {}, "score": "64.74731"}
{"text": "2392 - 2399 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . H. Wang , Y. Liu , Z. Y. Li , X. Fan , A. Hemminki , and A. Lieber , \" A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy , \" Blood , vol .", "label": "", "metadata": {}, "score": "64.81697"}
{"text": "T. Ahmadi and S. J. Schuster , \" Variations on the fludarabine , cyclophosphamide , and rituximab combination in chronic lymphocytic leukemia therapy : what have we learned ? \"", "label": "", "metadata": {}, "score": "64.84816"}
{"text": "The differential sensitivity to chemotherapeutics is most likely due to the distinct mechanisms of action of each agent .In addition , cells cultured from the tumors demonstrate an abrogation of the G2/M checkpoint following radiation , which leads to increased genomic instability as demonstrated by the 78 % rate of translocations in pre - tumor R248W thymocytes .", "label": "", "metadata": {}, "score": "64.913055"}
{"text": "Expression of these splice variants in ovarian cancer are associated with a worse prognosis and resistance to chemotherapy [ 31 ] .Missense mutations can also result in loss of WT p53 function , with a hyper - stabilized but non - functional p53 detectable by IHC .", "label": "", "metadata": {}, "score": "64.91421"}
{"text": "Figure 3 .Intracellular ROS generation induced by Compound K treatment .( A ) Intracellular ROS generated by Compound K were detected at indicated times by a spectrofluorometer after DCF - DA treatment .", "label": "", "metadata": {}, "score": "64.93985"}
{"text": "[ Google Scholar ] .Song , H. ; Hollstein , M. ; Xu , Y. p53 gain - of - function cancer mutants induce genetic instability by inactivating ATM .", "label": "", "metadata": {}, "score": "64.9601"}
{"text": "New molecular predictors are needed to identify patients with higher risk of relapse or death from disease .In a retrospective study , we investigated the prognostic impact of activated leukocyte cell adhesion molecule ( ALCAM ) expression in epithelial ovarian cancer .", "label": "", "metadata": {}, "score": "65.06222"}
{"text": "J. Cancer 2000 , 88 , 162 - 171 .[ Google Scholar ] .Deb , S. ; Jackson , C.T. ; Subler , M.A. ; Martin , D.W. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells .", "label": "", "metadata": {}, "score": "65.10825"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Intratumoral heterogeneity plays a critical role in tumor evolution .To define the contribution of DNA methylation to heterogeneity within tumors , we performed genome - scale bisulfite sequencing of 104 primary chronic lymphocytic leukemias ( CLLs ) .", "label": "", "metadata": {}, "score": "65.20349"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .M. J. Keating , I. Flinn , V. Jain et al . , \" Therapeutic role of alemtuzumab ( Campath-1H ) in patients who have failed fludarabine : results of a large international study , \" Blood , vol .", "label": "", "metadata": {}, "score": "65.219696"}
{"text": "Here , we studied the association between c - FLIP(L ) and p53 expressions and their prognostic impact in EOC patients .Tumor tissue from 207 patients diagnosed with primary EOC was analyzed by immunohistochemistry ( IHC ) for c - FLIP(L ) and p53 expressions , and multiple correspondence analysis ( MCA ) was used to evaluate the multivariable pattern of association among patients ' clinical - pathological characteristics and biological determinants .", "label": "", "metadata": {}, "score": "65.2831"}
{"text": "This method has the potential to produce a high frequency of both false negatives and false positives .Consistent with this notion , a recent meta - analysis investigated the relationship between the presence of a TP53 mutation and clinical outcome in ovarian cancer patients following chemotherapy [ 24 ] .", "label": "", "metadata": {}, "score": "65.29555"}
{"text": "10.1517/14728214.2011.523418 PubMed View Article .Am J Hematol 2010 , 85 : 670 - 674 .10.1002/ajh.21788 PubMed View Article .Elliott PJ , Zollner TM , Boehncke WH : Proteasome inhibition : a new anti - inflammatory strategy .", "label": "", "metadata": {}, "score": "65.318054"}
{"text": "Alterations in apoptotic signals and p53 status contribute to drug resistance , and CD95-mediated apoptosis is also deficient in resistant cells .We analyzed the mechanism of resistance to CD95-mediated apoptosis in ovarian carcinoma cell lines differing in p53 status .", "label": "", "metadata": {}, "score": "65.329956"}
{"text": "We undertook high - resolution genomic analysis of 161 prospectively enrolled CLLs using Affymetrix 6.0 SNP arrays , and integrated analysis of this data set with gene expression profiles .", "label": "", "metadata": {}, "score": "65.33533"}
{"text": "High levels of ROS can inhibit apoptosis by inactivating caspases by oxidation of their thiol groups .Furthermore , ROS can affect mitochondrial energy ( ATP ) production causing depletion of ATP .", "label": "", "metadata": {}, "score": "65.35463"}
{"text": "Natl .Acad .Sci .USA 2006 , 103 , 15056 - 15061 .[ Google Scholar ] .Boeckler , F.M. ; Joerger , A.C. ; Jaggi , G. ; Rutherford , T.J. ; Veprintsev , D.B. ; Fersht , A.R. Targeted rescue of a destabilized mutant of p53 by an in silico screened drug .", "label": "", "metadata": {}, "score": "65.35978"}
{"text": "[ Google Scholar ] .Int .J. Cancer 1999 , 81 , 180 - 188 .[ Google Scholar ] .Joerger , A.C. ; Rajagopalan , S. ; Natan , E. ; Veprintsev , D.B. ; Robinson , C.V. ; Fersht , A.R. Structural evolution of p53 , p63 , and p73 : Implication for heterotetramer formation .", "label": "", "metadata": {}, "score": "65.38844"}
{"text": "Lu S , Yang J , Chen Z , Gong S , Zhou H , Xu X , Wang J : Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma / leukemia cells derived from the Jurkat cell line .", "label": "", "metadata": {}, "score": "65.401596"}
{"text": "Indeed , the past 20 years have laid a significant foundation , demonstrating the function of distinct TP53 mutants in cultured cells and animal models .", "label": "", "metadata": {}, "score": "65.43287"}
{"text": "Methods of Identifying and Understanding Oncomorphisms .Given the vast heterogeneity of tumors , it is reasonable to assume that each oncomorphic TP53 mutation has context - specific effects .", "label": "", "metadata": {}, "score": "65.48959"}
{"text": "S. Knop , A. Jakob , L. Kanz , H. Hebart , R. Bares , and B. Dohmen , \" 186Rhenium - labeled anti - CD20 antibody radioimmunotherapy followed by autologous peripheral blood stem cell transplantation in patients with relapsed or refractory non - Hodgkin lymphoma , \" Blood , vol .", "label": "", "metadata": {}, "score": "65.50682"}
{"text": "In this review , we discuss the most common TP53 mutations in ovarian cancers that confer oncomorphic activity .Many clinical studies have attempted to correlate the presence of a TP53 mutation with patient survival or the development of chemoresistance [ 4 - 22 ] .", "label": "", "metadata": {}, "score": "65.53493"}
{"text": "Lactate dehydrogenase ( LDH ) assay ( necrosis assessment ) .LDH release was measured using CytoTox - One Homogenous Membrane Integrity kit ( Promega ) following the manufacturer 's instructions .", "label": "", "metadata": {}, "score": "65.63315"}
{"text": "Gene activation of the target genes is mediated through p300 , the histone acetyltransferase , and the transcriptional co - factor TopBP1 [ 64 ] .", "label": "", "metadata": {}, "score": "65.7166"}
{"text": "Such a preferential cytotoxicity could be attributed to the failure of p53-deficient cells to undergo cell cycle arrest in response to SP600125 .TP53(-/- ) ( but not TP53(+/+ ) ) cells treated with SP600125 became polyploid upon mitotic abortion and progressively succumbed to mitochondrial apoptosis .", "label": "", "metadata": {}, "score": "65.80905"}
{"text": "[ Google Scholar ] .Marx , D. ; Meden , H. ; Ziemek , T. ; Lenthe , T. ; Kuhn , W. ; Schauer , A. Expression of the p53 tumour suppressor gene as a prognostic marker in platinum - treated patients with ovarian cancer .", "label": "", "metadata": {}, "score": "65.81503"}
{"text": "Unfortunately , an international randomized phase II / III trial of WT TP53 gene therapy in ovarian cancer was closed after the first interim analysis because adequate therapeutic benefit was not achieved [ 105 ] .", "label": "", "metadata": {}, "score": "65.834114"}
{"text": "23 , no .18 , pp .4079 - 4088 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . C. S. Tam , S. O'Brien , W. Wierda et al . , \" Long - term results of the fludarabine , cyclophosphamide , and rituximab regimen as initial therapy of chronic lymphocytic leukemia , \" Blood , vol .", "label": "", "metadata": {}, "score": "65.86549"}
{"text": "Accumulation of ROS inside the cell may result in apoptosis or terminal differentiation [ 36 ] .Our results demonstrate significant generation of ROS in BT treated cells as compared to untreated cells in both a concentration and time dependent fashion .", "label": "", "metadata": {}, "score": "65.88173"}
{"text": "Cancer Res 2007 , 67 : 6383 - 6391 .CAN-06 - 4086 PubMed View Article .van der Heijden JW , Dijkmans BA , Scheper RJ , Jansen G : Drug Insight : resistance to methotrexate and other disease - modifying antirheumatic drugs - from bench to bedside .", "label": "", "metadata": {}, "score": "65.905556"}
{"text": "49 - 51 , 2008 .View at Publisher \u00b7 View at Google Scholar . D. Ma , M. R. McDevitt , E. Barendswaard et al . , \" Radioimmunotherapy for model B cell malignancies using Y - labeled anti - CD19 and anti - CD20 monoclonal antibodies , \" Leukemia , vol .", "label": "", "metadata": {}, "score": "65.91208"}
{"text": "TP53 ; oncomorphic mutation ; ovarian cancer ; mutant p53 ; chemoresistance .Introduction .One of the main goals of clinical research is to establish better drug regimens for patients suffering from specific diseases .", "label": "", "metadata": {}, "score": "65.91252"}
{"text": "Progressive CLL with 13q deletion was associated with additional somatic CNAs , and a greater number of CNAs was predictive of TTFT .We identified other recurrent CNAs associated with short TTFT : 8q24 amplification focused on the cancer susceptibility locus near MYC in 3.7 % ; 3q26 amplifications focused on PIK3CA in 5.6 % ; and 8p deletions in 5 % of patients .", "label": "", "metadata": {}, "score": "65.9175"}
{"text": "In nude mice , V158411 showed minimal toxicity as a single agent and in combination with irinotecan .In tumor bearing animals , V158411 was detected at high levels in the tumor with a long elimination half - life ; no pharmacologically significant in vivo drug - drug interactions with irinotecan were identified through analysis of the pharmacokinetic profiles .", "label": "", "metadata": {}, "score": "65.94858"}
{"text": "Reagents / chemicals / antibodies .Bortezomib ( BTZ)/Velcade \u2122 was provided by Millennium Pharmaceuticals ( Cambridge , USA ) .Carfilzomib and ONX 0914 were generously provided by Onyx Pharmaceuticals , Inc. ( South San Francisco , USA ) .", "label": "", "metadata": {}, "score": "65.9545"}
{"text": "Effect of BT on lactate dehydrogenase ( LDH ) activity ( necrosis assessment ) .Our results demonstrate that LDH release is dependent on BT concentration and treatment time .", "label": "", "metadata": {}, "score": "65.97085"}
{"text": "Moore BS , Eustaquio AS , McGlinchey RP : Advances in and applications of proteasome inhibitors .Curr Opin Chem Biol 2008 , 12 : 434 - 440 .", "label": "", "metadata": {}, "score": "65.988434"}
{"text": "This work demonstrates the power of structure - based design for the rapid evolution of potent Hsp90 inhibitors and the importance of considering conserved water molecules in drug design .", "label": "", "metadata": {}, "score": "65.9904"}
{"text": "However , in order to \" repurpose \" these drugs for novel targets / diseases , it is essential to first understand the basic biological action(s ) and mechanism(s ) of action in preclinical and animal models .", "label": "", "metadata": {}, "score": "66.00536"}
{"text": "BT treatment resulted in cell cycle arrest at G1/M phase and increased ROS generation .Treatment with ascorbic acid resulted in partial restoration of cell viability .", "label": "", "metadata": {}, "score": "66.0078"}
{"text": "Nat Med 2009 , 15 : 781 - 787 .10.1038/nm.1978 PubMed View Article .Lee SW , Kim JH , Park YB , Lee SK : Bortezomib attenuates murine collagen - induced arthritis .", "label": "", "metadata": {}, "score": "66.08472"}
{"text": "Cytokine release assay .JY cells were seeded in 96-wells plates at a cell density of 5 x 10 4 /200\u03bcl and stimulated with 10 ng / ml PMA ( Sigma ) and 750 ng / ml ionomycin ( Sigma ) .", "label": "", "metadata": {}, "score": "66.09675"}
{"text": "IFN- \u03b1 has potent immunostimulatory properties and antiproliferative effects in some B - cell NHLs , but its systemic administration is frequently associated to significant toxicity .", "label": "", "metadata": {}, "score": "66.128525"}
{"text": "PubMed View Article .Cheng JQ , Jiang X , Fraser M , Li M , Dan HC , Sun M , Tsang BK : Role of X - linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer : possible involvement of the phosphoinositide-3 kinase / Akt pathway .", "label": "", "metadata": {}, "score": "66.13932"}
{"text": "[ Google Scholar ] .Chang , F.L. ; Lai , M.D. Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells .", "label": "", "metadata": {}, "score": "66.1397"}
{"text": "Experiments should be performed to compare the various oncomorphic mutants in the same parental cancer cell line in order to reduce variability .Two main strategies should be utilized for these studies : over - expression of oncomorphic mutants in p53-null cells , as well as knockdown of WT p53 concomitant with re - expression of the oncomorphic p53 variants ( Figure 3a ) .", "label": "", "metadata": {}, "score": "66.168465"}
{"text": "Ye X , Ishii I , Kingsbury MA , Chun J : Lysophosphatidic acid as a novel cell survival / apoptotic factor .Biochim Biophys Acta 2002 , 1585 : 108 - 113 .", "label": "", "metadata": {}, "score": "66.17319"}
{"text": "Chi - square test , Kaplan - Meier method , and Cox proportional hazard analyses were used to relate ALCAM cellular localization to clinical - pathologic parameters and to overall survival ( OS ) rate .", "label": "", "metadata": {}, "score": "66.18901"}
{"text": "Strikingly , only six of 64 clinical publications fulfilled the criteria .The most common reasons for exclusion were the use of IHC as the only method to identify the presence of a TP53 mutation , sequencing only partial segments of the TP53 gene , and importantly , bundling all mutations in the same group .", "label": "", "metadata": {}, "score": "66.20015"}
{"text": "\" [ Show abstract ] [ Hide abstract ] ABSTRACT : Transducer of ErbB-2.1 ( Tob1 ) , a tumor suppressor protein , is inactivated in a variety of cancers including stomach cancer .", "label": "", "metadata": {}, "score": "66.21098"}
{"text": "The expression of MRP1 and MRP4 was examined by immunohistochemistry using tissue microarrays in tumor specimens collected at the time of initial surgery expression .These results suggest that in epithelial ovarian cancer , MRP1 may be a marker for aggressiveness because its expression was associated with tumor grade and support that MRP4 may play an unfavourable role in disease outcome .", "label": "", "metadata": {}, "score": "66.29759"}
{"text": "Pharmacol 2004 , 53 , 519 - 526 .[ Google Scholar ] .Sigal , A. ; Rotter , V. Oncogenic mutations of the p53 tumor suppressor : The demons of the guardian of the genome .", "label": "", "metadata": {}, "score": "66.36735"}
{"text": "CD19 and CD20 expression in BTZ - resistant JY cells .CD19 and CD20 are prototypical B cell surface markers , and lost upon differentiation to plasma cells [ 2 , 3 , 45 ] .", "label": "", "metadata": {}, "score": "66.38291"}
{"text": "J. Oncol 2002 , 21 , 243 - 249 .[ Google Scholar ] .Wadayama , B. ; Toguchida , J. ; Yamaguchi , T. ; Sasaki , M.S. ; Yamamuro , T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas .", "label": "", "metadata": {}, "score": "66.394714"}
{"text": "After blocking , the membranes were incubated for 1 hour at room temperature with an ubiquitin - specific antibody ( 1:200 ) .After 3 washing steps with Tris - buffered saline with 0.5 % Tween , the membranes were incubated for 1 hour with goat - anti - mouse secondary antibody conjugated to IRDye \u00ae 800CW ( 1:10000 , Odyssey ; L1-CORBiosciences , Nebraska , USA ) .", "label": "", "metadata": {}, "score": "66.39752"}
{"text": "Mutations in codon R273 are the most common TP53 alterations in ovarian carcinomas , with the most frequent mutations resulting in an amino acid change to histidine or cysteine .", "label": "", "metadata": {}, "score": "66.42288"}
{"text": "Normally , FLT3 is expressed on immature myeloid - lymphocytic precursor cells and dendritic cell precursors , but rarely on mature adult cells .FLT3 is overexpressed in approximately 90 % of acute myeloid leukemia ( AML ) , a majority of acute lymphocytic leukemia ( ALL ) and the blast - crisis phase of chronic myeloid leukemia ( BC - CML ) .", "label": "", "metadata": {}, "score": "66.44585"}
{"text": "BT ) .At 48 hrs post treatment , caspase activity was still observed at lower concentrations but absent at higher concentrations .No caspase activity was observed at 400 \u03bcM BT at any time points .", "label": "", "metadata": {}, "score": "66.478546"}
{"text": "[ Google Scholar ] .Cancer Gene Ther 2002 , 9 , 567 - 572 .[ Google Scholar ] .Sepehrnia , B. ; Paz , I.B. ; Dasgupta , G. ; Momand , J. Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell .", "label": "", "metadata": {}, "score": "66.48947"}
{"text": "12 , pp .4416 - 4423 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . H. Schulz , S. K. Klein , U. Rehwald et al . , \" Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia , \" Blood , vol .", "label": "", "metadata": {}, "score": "66.52109"}
{"text": "Mutat 2007 , 28 , 622 - 629 .[ Google Scholar ] .Olive , K.P. ; Tuveson , D.A. ; Ruhe , Z.C. ; Yin , B. ; Willis , N.A. ; Bronson , R.T. ; Crowley , D. ; Jacks , T. Mutant p53 gain of function in two mouse models of Li - Fraumeni syndrome .", "label": "", "metadata": {}, "score": "66.56743"}
{"text": "Conclusions .BT exhibits cytotoxic effects on various ovarian cancer cell lines regardless of their sensitivities to cisplatin .Cell death appears to be via caspases mediated apoptosis .", "label": "", "metadata": {}, "score": "66.642334"}
{"text": "Conflicts of Interest .The authors declare no conflict of interest .References .McGuire , W.P. ; Hoskins , W.J. ; Brady , M.F. ; Kucera , P.R. ; Partridge , E.E. ; Look , K.Y. ; Clarke - Pearson , D.L. ; Davidson , M. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer .", "label": "", "metadata": {}, "score": "66.68073"}
{"text": "[ Google Scholar ] .Magnusson , K.P. ; Sandstrom , M. ; Stahlberg , M. ; Larsson , M. ; Flygare , J. ; Hellgren , D. ; Wiman , K.G. ; Ljungquist , S. p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom 's syndrome GM1492 fibroblasts .", "label": "", "metadata": {}, "score": "66.7354"}
{"text": "5 , pp .379 - 391 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .T. M. Habermann , E. A. Weller , V. A. Morrison et al . , \" Rituximab - CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B - cell lymphoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "66.75722"}
{"text": "856 - 862 , 2002 .View at Publisher \u00b7 View at Google Scholar .C. G. A. Price , J. Meerabux , S. Murtagh et al . , \" The significance of circulating cells carrying t(14;18 ) in long remission from follicular lymphoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "66.812805"}
{"text": "The use of mAbs in cancer treatment stems from the idea that these , because of their intrinsic specificity , could be used to selectively target cancer cells based on the expression of one or more antigens .", "label": "", "metadata": {}, "score": "66.81707"}
{"text": "In our studies , we also observed a significant inhibition of ATX by BT .Based on our findings , BT affects cells by causing mitochondrial dysfunction , ROS generation , cell cycle arrest and ATX inhibition , ultimately leading to cell death ( apoptosis at low concentrations and necrosis at higher concentrations ) .", "label": "", "metadata": {}, "score": "66.87369"}
{"text": "R248 p53 .The codon R248 is the second most commonly altered amino acid in ovarian carcinomas , occurring at a frequency of 6.02 % [ 33 , 34 ] .", "label": "", "metadata": {}, "score": "66.88396"}
{"text": "11 , pp .3023 - 3029 , 1995 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .J. M. Munro , A. S. Freedman , J. C. Aster et al . , \" In vivo expression of the B7 costimulatory molecule by subsets of antigen- presenting cells and the malignant cells of Hodgkin 's disease , \" Blood , vol .", "label": "", "metadata": {}, "score": "66.93225"}
{"text": "1121 - 1132 , 1993 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. J. Grillo - L\u00f3pez , E. Hedrick , M. Rashford , and M. Benyunes , \" Rituximab : ongoing and future clinical development , \" Seminars in Oncology , vol .", "label": "", "metadata": {}, "score": "67.01581"}
{"text": "On the other hand , a recent report from the French group shows benefit in both Bcl-2-positive and Bcl-2-negative lymphomas using the method of competing risks [ 27 , 60 , 61 ] .", "label": "", "metadata": {}, "score": "67.019005"}
{"text": "10.1074/jbc .M509043200 PubMed View Article .Kisselev AF , van der Linden WA , Overkleeft HS : Proteasome inhibitors : an expanding army attacking a unique target .", "label": "", "metadata": {}, "score": "67.15934"}
{"text": "4 , pp .257 - 259 , 2003 .View at Google Scholar .F. A. Vyth - Dreese , T. A. M. Dellemijn , D. Majoor , and D. De Jong , \" Localization in situ of the co - stimulatory molecules B7.1 , B7.2 , CD40 and their ligands in normal human lymphoid tissue , \" European Journal of Immunology , vol .", "label": "", "metadata": {}, "score": "67.19536"}
{"text": "Petty , R. ; Evans , A. ; Duncan , I. ; Kurbacher , C. ; Cree , I. Drug resistance in ovarian cancer - The role of p53 .", "label": "", "metadata": {}, "score": "67.21328"}
{"text": "Natl .Acad .Sci .USA 1999 , 96 , 8438 - 8442 .[ Google Scholar ] .Hanel , W. ; Marchenko , N. ; Xu , S. ; Yu , S.X. ; Weng , W. ; Moll , U. Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis .", "label": "", "metadata": {}, "score": "67.234665"}
{"text": "Short peptides have been designed to interfere with oncomorphic p53 binding to p73 [ 66 , 88 ] .Consistent with a role for R248 mutations in chemoresistance , disruption of this complex sensitizes cells to adriamycin and cisplatin and induces apoptosis .", "label": "", "metadata": {}, "score": "67.23729"}
{"text": "The epitope consists of the tetrasaccharide Fuc(alpha1 - 2)Ga1(beta1 - 3)GalNAc(beta1 - 3)Ga1alpha - O - spacer , which has recently become available as a synthetic oligosaccharide .", "label": "", "metadata": {}, "score": "67.35142"}
{"text": "In vivo , ALCAM was localized to cell membrane in normal surface ovarian epithelium , whereas in 67 % of the epithelial ovarian cancer samples , membrane localization was decreased or even lost , and the molecule was mainly expressed in cytoplasm .", "label": "", "metadata": {}, "score": "67.377144"}
{"text": "PubMed View Article .Eliopoulos AG , Kerr DJ , Herod J , Hodgkins L , Krajewski S , Reed JC , Young LS : The control of apoptosis and drug resistance in ovarian cancer : influence of p53 and Bcl-2 .", "label": "", "metadata": {}, "score": "67.38864"}
{"text": "Transcriptome analysis of bulk and single CLL cells revealed that methylation disorder was linked to low - level expression .Disordered methylation was further associated with adverse clinical outcome .", "label": "", "metadata": {}, "score": "67.3981"}
{"text": "Razzell WE , Khorana HG : Studies on polynucleotides .III .Enzymatic degradation ; substrate specificity and properties of snake venom phosphodiesterase .J Biol Chem 1959 , 234 : 2105 - 2113 .", "label": "", "metadata": {}, "score": "67.416725"}
{"text": "Autotaxin ( ATX ) assay .The phosphodiesterase activity of ATX was measured using a modification of the method of Razzell and Khorana [ 16 ] .", "label": "", "metadata": {}, "score": "67.475235"}
{"text": "Assessment of type of cell death induced by BT on various ovarian cancer cell lines .( A ) Effect of BT on casapses3/7 ( columns ) and LDH activities ( line graph ) .", "label": "", "metadata": {}, "score": "67.4964"}
{"text": "BT .Similarly , pI\u03baB\u03b1 levels were reduced at 24 hrs post - treatment .The extent of decrease varied between cell lines with a significant decrease observed in A2780 , SKOV-3 and OVACAR-3 .", "label": "", "metadata": {}, "score": "67.62533"}
{"text": "Bacq Y , Besnier JM , Duong TH , Pavie G , Metman EH , Choutet P : Successful treatment of acute fascioliasis with bithionol .", "label": "", "metadata": {}, "score": "67.67681"}
{"text": "An early process in the release of cytochrome c is its dissociation from the inner membrane .Mitochondrial ROS have been shown to promote cytochrome c release to the cytosol by dissociation from these membrane phospholipids [ 46 , 47 ] .", "label": "", "metadata": {}, "score": "67.67859"}
{"text": "Further exploration of its anti - tumor potential in ovarian cancer animal xenograft model is essential before proceeding to clinical trials .Additionally , it is interesting to focus on synergistic , additive or antagonistic effects of BT in combination with other standard chemo drugs .", "label": "", "metadata": {}, "score": "67.792175"}
{"text": "The majority of spice site mutations ( 10/32 , 31 % ) occurred at the exon 4 boundary .Interestingly , particular codons in TP53 are mutated at a higher frequency than others , termed \" hot spot \" mutations .", "label": "", "metadata": {}, "score": "67.824905"}
{"text": "Biophys .Acta 1998 , 1366 , 139 - 149 .[ Google Scholar ] .Petrosillo , G ; Ruggiero , FM ; Pistolese , M ; Paradies , G. Reactive oxygen species generated from the mitochondrial electron transport chain induce cytochrome c dissociation from beef - heart submitochondrial particles via cardiolipin peroxidation .", "label": "", "metadata": {}, "score": "67.82992"}
{"text": "Compound K inhibited HT-29 cell growth in a dose - dependent manner at 10 , 20 , 30 , and 40 \u03bcg / mL at 48 h , and the concentration effecting 50 % growth inhibition ( IC 50 ) was 20 \u03bcg / mL ( Figure 2A ) .", "label": "", "metadata": {}, "score": "67.91853"}
{"text": "Methods 1992 , 156 , 39 - 45 .[ Google Scholar ] .Zamzami , N ; Marchetti , P ; Castedo , M ; Zanin , C ; Vayssi\u00e8re , JL ; Petit , PX ; Kroemer , G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo .", "label": "", "metadata": {}, "score": "67.94379"}
{"text": "It is excited by UV light and emits blue fluorescence at 460 nm when bound to DNA .To detect apoptotic specific nuclear changes , cells ( 1 \u00d7 10 5 cells ) were seeded into 12-well plate and treated with sub - cytotoxic BT at concentrations of 25 \u03bcM , 50 \u03bcM or 100 \u03bcM for 6 or 24 hrs .", "label": "", "metadata": {}, "score": "67.95568"}
{"text": "Compound K - treated cells exhibited a loss of \u0394\u03c8 m , as substantiated by an increase of fluorescence intensity in fluorescence ( FL-1 ) using the JC-1 dye ( Figure 4B ) .", "label": "", "metadata": {}, "score": "67.97392"}
{"text": "Results .BT caused dose dependent cytotoxicity against all ovarian cancer cell lines tested with IC 50 values ranging from 19 \u03bcM - 60 \u03bcM. Cisplatin - resistant variants of A2780 and IGROV-1 have shown almost similar IC 50 values compared to their sensitive counterparts .", "label": "", "metadata": {}, "score": "67.992355"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Clonal evolution is a key feature of cancer progression and relapse .We studied intratumoral heterogeneity in 149 chronic lymphocytic leukemia ( CLL ) cases by integrating whole - exome sequence and copy number to measure the fraction of cancer cells harboring each somatic mutation .", "label": "", "metadata": {}, "score": "68.01396"}
{"text": "The additional mutations are poorly characterized and occur at lower frequencies .It is of note that many of the hot spot mutations are associated with oncomorphic activity and/or create a highly - stable p53 protein [ 35 - 37 ] , but their association with sensitivity to therapy in ovarian cancer is unknown .", "label": "", "metadata": {}, "score": "68.1362"}
{"text": "[ Google Scholar ] .Buller , R.E. ; Runnebaum , I.B. ; Karlan , B.Y. ; Horowitz , J.A. ; Shahin , M. ; Buekers , T. ; Petrauskas , S. ; Kreienberg , R. ; Slamon , D. ; Pegram , M. A phase I / II trial of rAd / p53 ( SCH 58500 ) gene replacement in recurrent ovarian cancer .", "label": "", "metadata": {}, "score": "68.20972"}
{"text": "View at Google Scholar .R. T. O'Donnell , G. L. DeNardo , D. L. Kukis et al . , \" A clinical trial of radioimmunotherapy with Cu-2IT - BAT - Lym-1 for non - Hodgkin 's lymphoma , \" Journal of Nuclear Medicine , vol .", "label": "", "metadata": {}, "score": "68.27782"}
{"text": "Although we did not focus on which apoptotic pathway was induced by BT , decreased mitochondrial transmembrane potential following BT treatment implicates the intrinsic ( mitochondrial ) pathway .", "label": "", "metadata": {}, "score": "68.31257"}
{"text": "PubMed View Article .Brindley DN , Pilquil C : Lipid phosphate phosphatases and signaling .J Lipid Res 2009 , 50 : S225-S230 .", "label": "", "metadata": {}, "score": "68.334694"}
{"text": "Compound K ; reactive oxygen species ; mitochondrial membrane potential ; c - Jun NH 2 -terminal kinase ; p38 mitogen - activated protein kinase .", "label": "", "metadata": {}, "score": "68.35042"}
{"text": "This review will analyze the most common oncomorphisms of p53 in ovarian cancer and the pathophysiological mechanisms contributing to cancer progression .Given that survival of patients who become chemoresistant and recur is very low , a better understanding of the biology of distinct p53 mutant proteins is vital to predict response to tumor therapies as well as to identify future platforms for novel treatment strategies based on individual TP53 mutations .", "label": "", "metadata": {}, "score": "68.43937"}
{"text": "Our aim was to identify a microRNA ( miRNA ) signature associated with early relapse in advanced - stage EOC patients .Thirty - two differentially expressed miRNAs in early vs. late relapsing patients were identified in the training set .", "label": "", "metadata": {}, "score": "68.46782"}
{"text": "The cellular effects include a reduction in the response to DNA damage , increased genomic instability , increased invasion , and regulation of cell cycle genes [ 73 ] .", "label": "", "metadata": {}, "score": "68.49658"}
{"text": "PubMed .Xu Y , Xiao YJ , Zhu K , Baudhuin LM , Lu J , Hong G , Kim KS , Cristina KL , Song L , Elson P , Markman M , Belinson J : Unfolding the pathophysiological role of bioactive lysophospholipids .", "label": "", "metadata": {}, "score": "68.560036"}
{"text": "Cytotoxic effect of Compound K in human colon cells .Figure 3 .Intracellular ROS generation induced by Compound K treatment .( A ) Intracellular ROS generated by Compound K were detected at indicated times by a spectrofluorometer after DCF - DA treatment .", "label": "", "metadata": {}, "score": "68.56757"}
{"text": "M. S. Kaminski , A. D. Zelenetz , O. W. Press et al . , \" Pivotal study of iodine I 131 tositumomab for chemotherapy - refractory low - grade or transformed low - grade B - cell non - Hodgkin 's lymphomas , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "68.59654"}
{"text": "Superior survival rates have also been reported for patients who become PCR negative for BCL2/JH rearrangements in peripheral blood or bone marrow compared with those who remain positive .", "label": "", "metadata": {}, "score": "68.61733"}
{"text": "Tigyi G , Parrill AL : Molecular mechanisms of lysophosphatidic acid action .Prog Lipid Res 2003 , 42 : 498 - 526 .PubMed View Article .", "label": "", "metadata": {}, "score": "68.644104"}
{"text": "However , it is clear that mutations in the tumor suppressor gene TP53 , which occur in 96 % of serous ovarian tumors , alter the core molecular pathways involved in drug response .", "label": "", "metadata": {}, "score": "68.739525"}
{"text": "We further discovered that tumor samples with mutations in SF3B1 had alterations in pre - messenger RNA ( mRNA ) splicing .Our study defines the landscape of somatic mutations in chronic lymphocytic leukemia and highlights pre - mRNA splicing as a critical cellular process contributing to chronic lymphocytic leukemia .", "label": "", "metadata": {}, "score": "68.75377"}
{"text": "Results were expressed as percentages of positive cells and the mean fluorescence index was calculated based on mean fluorescence intensities .Western blot analysis .Accumulation of ubiquitinated proteins upon treatment with BTZ was determined by Western blot analysis as described previously [ 38 ] .", "label": "", "metadata": {}, "score": "68.80539"}
{"text": "No preview \u00b7 Article \u00b7 Aug 2006 \u00b7 Current opinion in drug discovery & development Monoclonal Antibodies for Non - Hodgkin 's Lymphoma : State of the Art and Perspectives .", "label": "", "metadata": {}, "score": "68.83905"}
{"text": "( non - toxic concentration ) for 48 hrs and cell viability was determined .Lastly , to test if Akt inactivation is essential for drug sensitivity in ovarian cell lines treated with BT , a third cell viability assay was performed in order to see if additional pAkt inactivation would further enhance the effectiveness of BT .", "label": "", "metadata": {}, "score": "68.88701"}
{"text": "Oncogene 2010 , 29 , 1997 - 2004 .[ Google Scholar ] .Rowan , S. ; Ludwig , R.L. ; Haupt , Y. ; Bates , S. ; Lu , X. ; Oren , M. ; Vousden , K.H. Specific loss of apoptotic but not cell - cycle arrest function in a human tumor derived p53 mutant .", "label": "", "metadata": {}, "score": "68.91954"}
{"text": "TUNEL assay .DNA fragmentation was detected using the TiterTACS \u00ae 2 TdT In Situ Colorimetric Apoptosis Detection Kit ( Trevigen , Gaithersburg , MD ) following the manufacturer 's instructions .", "label": "", "metadata": {}, "score": "68.929245"}
{"text": "Taking all of these differing mechanisms into consideration , it is likely that the function of each oncomorph varies greatly depending on the mutation , and potentially between tumor types that harbor unique mutations in other genes in addition to an oncomorphic TP53 mutation .", "label": "", "metadata": {}, "score": "68.96057"}
{"text": "Gynecol .Oncol 2012 , 128 , 461 - 469 .[ Google Scholar ] .Dong , P. ; Xu , Z. ; Jia , N. ; Li , D. ; Feng , Y. Elevated expression of p53 gain - of - function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR / PI3K / AKT pathway .", "label": "", "metadata": {}, "score": "68.97438"}
{"text": "Liu , G. ; McDonnell , T.J. ; Montes de Oca Luna , R. ; Kapoor , M. ; Mims , B. ; El - Naggar , A.K. ; Lozano , G. High metastatic potential in mice inheriting a targeted p53 missense mutation .", "label": "", "metadata": {}, "score": "69.0041"}
{"text": "Med 1995 , 181 , 1661 - 1672 .[ Google Scholar ] .Zamzami , N ; Susin , SA ; Marchetti , P ; Hirsch , T ; G\u00f3mez - Monterrey , I ; Castedo , M ; Kroemer , G. Mitochondrial control of nuclear apoptosis .", "label": "", "metadata": {}, "score": "69.025795"}
{"text": "Lowry OH , Rosebrough NJ , Farr A , Randall RJ : Protein measurement with the folin phenol reagent .J Biol Chem 1951 , 193 ( 1):265 - 275 .", "label": "", "metadata": {}, "score": "69.195526"}
{"text": "Oncomorphic p53 Mutations .Oncomorphic p53 proteins were first identified over two decades ago , when different TP53 mutants were introduced into cells devoid of endogenous p53 [ 38 , 39 ] .", "label": "", "metadata": {}, "score": "69.227066"}
{"text": "( Cross ) resistance factor represents the ratio of drug concentration required to inhibit cell growth of BTZ - resistant JY cells by 50 % over JY / WT cells .", "label": "", "metadata": {}, "score": "69.227165"}
{"text": "To detect nuclear condensation indicative of apoptosis , NucBlue Live Cell Stain ( Hoechst 33342 ) was used ( Invitrogen , Carlsbad , CA ) .", "label": "", "metadata": {}, "score": "69.24275"}
{"text": "[ Google Scholar ] .Joerger , A.C. ; Ang , H.C. ; Fersht , A.R. Structural basis for understanding oncogenic p53 mutations and designing rescue drugs .", "label": "", "metadata": {}, "score": "69.32759"}
{"text": "We sampled leukemia cells from 18 patients at two time points .Ten of twelve CLL cases treated with chemotherapy ( but only one of six without treatment ) underwent clonal evolution , predominantly involving subclones with driver mutations ( e.g. , SF3B1 and TP53 ) that expanded over time .", "label": "", "metadata": {}, "score": "69.32821"}
{"text": "LY294002 ( non - toxic conc . 's ) for 48 hrs and cell viability determined by presto blue cell viability reagent .The results represent % viability when compared with untreated cells .", "label": "", "metadata": {}, "score": "69.4528"}
{"text": "Cells and Cell Culture .Cell Viability Assay .The effect of Compound K on the viability of the cells was determined by the MTT assay , which is based on the reduction of a tetrazolium salt by mitochondrial succinatedehydrogenase in viable cells [ 56 ] .", "label": "", "metadata": {}, "score": "69.5957"}
{"text": "The present invention is also directed to human monoclonal antagonist antibodies , and fragments thereof , that bind to the human antigen FLT3 .Another aspect of the present invention is an antibody or fragment thereof that binds FLT3 , and comprises a VL having the sequence : .", "label": "", "metadata": {}, "score": "69.728775"}
{"text": "Cell 2004 , 119 , 861 - 872 .[ Google Scholar ] .Liu , D.P. ; Song , H. ; Xu , Y. A common gain of function of p53 cancer mutants in inducing genetic instability .", "label": "", "metadata": {}, "score": "69.833565"}
{"text": "Methods .Cell lines and chemicals .In order to assess the cytotoxic effects of BT , a panel of ovarian cancer cell lines exhibiting varying degrees of sensitivities to cisplatin was selected .", "label": "", "metadata": {}, "score": "69.85518"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Complement activation and neutrophil stimulation are two major components in events leading to ischemia and reperfusion ( IR ) injury .", "label": "", "metadata": {}, "score": "69.86482"}
{"text": "( C ) Western blot analysis of polyubiquitinated cellular proteins prior to and after 24 hours treatment of BTZ ; JY / WT ( \u00b1 10nM BTZ ) , JY/35 ( \u00b1 35nM BTZ ) and JY/100 ( \u00b1 100nM BTZ ) .", "label": "", "metadata": {}, "score": "69.88523"}
{"text": "Daily dosing of NVP - AUY922 ( 50 mg / kg i.p . or i.v . ) to athymic mice generated peak tumor levels at least 100-fold above cellular GI(50 ) .", "label": "", "metadata": {}, "score": "69.91325"}
{"text": "As shown in Figure 1 , treatment with increasing concentrations of BT resulted in dose dependent reduction in cell viability in all the cell lines tested .", "label": "", "metadata": {}, "score": "69.952736"}
{"text": "It is well known that many drugs exhibit polypharmacological properties , and hence can be explored for their ability to modulate new / alternate targets . '", "label": "", "metadata": {}, "score": "69.95729"}
{"text": "We previously showed that EOC are generally resistant to CD95-dependent apoptosis .In p53 wild - type EOC tumors , CD95-mediated apoptosis is impaired at the receptor level by the long form of cellular FLICE - inhibitory protein , whereas this mechanism does not account for resistance in tumors with mutated p53 ( p53mu ) .", "label": "", "metadata": {}, "score": "70.03149"}
{"text": "ATX was shown to delay carboplatin induced apoptosis in ovarian cancer cells [ 55 ] .ATX inhibition was a proposed mechanism of action of BT in a melanoma model via inhibition of cell migration and invasion [ 13 ] .", "label": "", "metadata": {}, "score": "70.031784"}
{"text": "Nat .Med 2001 , 7 , 1111 - 1117 .[ Google Scholar ] .Alexandre , J ; Hu , Y ; Lu , W ; Pelicano , H ; Huang , P. Novel action of paclitaxel against cancer cells : Bystander effect mediated by reactive oxygen species .", "label": "", "metadata": {}, "score": "70.07635"}
{"text": "Western blot image is representative of 3 separate experiments .Increased sensitivity to anti - CD20/rituximab - mediated CDC in bortezomib - resistant JY cells .", "label": "", "metadata": {}, "score": "70.09001"}
{"text": "de Wilt LH , Jansen G , Assaraf YG , Cloos J , Schimmer AD , Chan ET , Kirk CJ , Peters GJ , Kruyt FA , van MJ : Proteasome - based mechanisms of intrinsic and acquired bortezomib resistance in non - small cell lung cancer .", "label": "", "metadata": {}, "score": "70.20805"}
{"text": "Activated B cells are able to produce cytokines and consequently contribute to inflammation [ 43 ] or protective cytokine environments [ 44 ] .To this end , we examined the secretion profile of the prototypical pro - inflammatory cytokine TNF - \u03b1 by activated JY cells and explored whether or not this profile is altered in JY / BTZ cells .", "label": "", "metadata": {}, "score": "70.28485"}
{"text": "10.1182/blood-2010 - 01 - 266668 PubMed View Article .Dorner T , Kinnman N , Tak PP : Targeting B cells in immune - mediated inflammatory disease : a comprehensive review of mechanisms of action and identification of biomarkers .", "label": "", "metadata": {}, "score": "70.29995"}
{"text": "2399 - 2404 , 2000 .View at Google Scholar .C. Haioun , E. Lepage , C. Gisselbrecht et al . , \" Survival benefit of high - dose therapy in poor - risk aggressive non - Hodgkin 's lymphoma : final analysis of the prospective LNH87 - 2 protocol - a groupe d'etude des lymphomes de l'adulte study , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "70.421486"}
{"text": "Protein content of the supernatant was determined by the Bio - Rad Protein Assay using a bovine serum albumin ( BSA ) standard .Protein aliquots ( 30 \u03bcg ) of total cell lysates were fractionated on a 4 - 20 % TGX pre - cast gel ( BioRad ) containing SDS , and transferred onto a PVDF membrane .", "label": "", "metadata": {}, "score": "70.48606"}
{"text": "J. Anaesth 1996 , 77 , 3 - 10 .[ Google Scholar ] .Ziegler , U ; Groscurth , P. Morphological features of cell death .", "label": "", "metadata": {}, "score": "70.50068"}
{"text": "An understanding of the pathological pathways altered by each mutation is necessary in order to design appropriate drug interventions for patients suffering from this deadly disease .", "label": "", "metadata": {}, "score": "70.51834"}
{"text": "NCCN clinical practice guidelines in oncology : non - Hodgkin 's lymphoma ) .Tolerability .Adverse events were reported in 84 % of patients , receiving rituximab , during therapy or within the first 30 days following treatment [ 4 , 35 ] .", "label": "", "metadata": {}, "score": "70.59294"}
{"text": "McDonald ER , El - Deiry WS : Cell cycle control as a basis for cancer drug development .Int J Oncol 2000 , 16 : 871 - 886 .", "label": "", "metadata": {}, "score": "70.62308"}
{"text": "Thus , cancer - specific antigens would be the first choice .Unfortunately , true cancer - specific antigens , such as new proteins resulting from fusion oncogenes , are not frequent in NHL .", "label": "", "metadata": {}, "score": "70.67955"}
{"text": "After treatment with BT , cell - free supernatants were collected for ATX estimation .The cells were gently scraped off for analysis of cellular protein levels , according to the method of Lowry et al . , [ 17 ] .", "label": "", "metadata": {}, "score": "70.69501"}
{"text": "These adverse events were less common during the subsequent rituximab administrations .One possible hematological adverse event is the reduction in peripheral B - lymphocyte counts , which can last for up to 6 months with a recovery period of 9 to 12 months [ 4 , 35 ] .", "label": "", "metadata": {}, "score": "70.8273"}
{"text": "Meshkini A , Yazdanparast R : Involvement of oxidative stress in taxol - induced apoptosis in chronic myelogenous leukemia K562 cells .Exp Toxicol Pathol 2012 , 64 ( 4):357 - 365 .", "label": "", "metadata": {}, "score": "70.86271"}
{"text": "Top panel , baseline p53 expression in SKOV3 cells ( LOF TP53 , nonsense mutation ) , TOV112D ( oncomorphic p53 , R175H ) , and UCI-107 cells ( WT p53 ) .", "label": "", "metadata": {}, "score": "70.96469"}
{"text": "Top panel , baseline p53 expression in SKOV3 cells ( LOF TP53 , nonsense mutation ) , TOV112D ( oncomorphic p53 , R175H ) , and UCI-107 cells ( WT p53 ) .", "label": "", "metadata": {}, "score": "70.96469"}
{"text": "10 , pp .3246 - 3256 , 1998 .View at Google Scholar .R. Schnell , M. Dietlein , K. Schom\u00e4cker et al . , \" Yttrium-90 ibritumomab tiuxetan - induced complete remission in a patient with classical lymphocyte - rich Hodgkin 's lymphoma , \" Onkologie , vol .", "label": "", "metadata": {}, "score": "71.004425"}
{"text": "It will be further necessary to complement in vitro studies with animal models of ovarian cancer to understand the function of these oncomorphs and identify drug strategies that will be most useful .", "label": "", "metadata": {}, "score": "71.05451"}
{"text": ": The objective of this study was to elucidate the cytotoxic mechanism of Compound K , with respect to the involvement of reactive oxygen species ( ROS ) and the mitochondrial involved apoptosis , in HT-29 human colon cancer cells .", "label": "", "metadata": {}, "score": "71.16695"}
{"text": "[ Google Scholar ] .Xue , W. ; Zender , L. ; Miething , C. ; Dickins , R.A. ; Hernando , E. ; Krizhanovsky , V. ; Cordon - Cardo , C. ; Lowe , S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas .", "label": "", "metadata": {}, "score": "71.18582"}
{"text": "J. Cancer 1993 , 68 , 1134 - 1139 .[ Google Scholar ] .Jolly , K.W. ; Malkin , D. ; Douglass , E.C. ; Brown , T.F. ; Sinclair , A.E. ; Look , A.T. Splice - site mutation of the p53 gene in a family with hereditary breast - ovarian cancer .", "label": "", "metadata": {}, "score": "71.22442"}
{"text": "BT treatment significantly inhibited ATX in all the cell lines tested ( Figure 8 ) .BT induced ATX inhibition was time dependent as more inhibition was observed at 48 hrs post treatment than at 24 hrs .", "label": "", "metadata": {}, "score": "71.237404"}
{"text": "Three percent DSS was used in drinking water to induce colitis in complement C3-deficient ( C3(-/- ) ) mice , bradykinin type 2 receptor deficient ( Bk(2)R(-/- ) ) mice , and C57BL/6 mice .", "label": "", "metadata": {}, "score": "71.25006"}
{"text": "Cancer Sci 2011 , 102 : 1236 - 1241 .10.1111/j.1349 - 7006.2011.01924.x PubMed View Article .Landowski TH , Megli CJ , Nullmeyer KD , Lynch RM , Dorr RT : Mitochondrial - mediated disregulation of Ca2 + is a critical determinant of Velcade ( PS-341/bortezomib ) cytotoxicity in myeloma cell lines .", "label": "", "metadata": {}, "score": "71.274574"}
{"text": "[ Google Scholar ] .Donehower , L.A. Does p53 affect organismal aging ?J. Cell .Physiol 2002 , 192 , 23 - 33 .", "label": "", "metadata": {}, "score": "71.37387"}
{"text": "BT was tested against a panel of ovarian cancer lines exhibiting varying sensitivities to cisplatin .Our results demonstrate the cytotoxic effects of BT towards all the ovarian cancer cells lines tested with IC 50 values ranging from 19 \u03bcM to 60 \u03bcM , at 72 hrs post treatment .", "label": "", "metadata": {}, "score": "71.40579"}
{"text": "Intravenous acute administration of NVP - AUY922 to athymic mice ( 30 mg / kg ) bearing subcutaneous BT-474 breast tumors resulted in drug levels in excess of 1,000 times the cellular GI50 value for about 2 days .", "label": "", "metadata": {}, "score": "71.4475"}
{"text": "Toledano MB , Leonard WJ : Modulation of transcription factor NF - kappa B binding activity by oxidation - reduction in vitro .Proc Natl Acad Sci USA 1991 , 88 ( 10):4328 - 4332 .", "label": "", "metadata": {}, "score": "71.45711"}
{"text": "67 - 71 , 1994 .View at Google Scholar .22 , no .23 , pp .4659 - 4664 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . E. Domingo - Domenech , E. Gonz\u00e1lez - Borco , C. Estany , A. Sureda , J. Besalduch , and A. F. De Sevilla , \" Combined treatment with anti CD20 ( rituximab ) and CHOP in relapsed advanced - stage follicular lymphomas , \" Haematologica , vol .", "label": "", "metadata": {}, "score": "71.46097"}
{"text": "Oncomorphic mutations are due to missense mutations that produce p53 proteins with oncogenic functions that are entirely independent of WT p53 functions .Oncomorphic p53 activity requires the absence of the second WT TP53 allele .", "label": "", "metadata": {}, "score": "71.462616"}
{"text": "PubMed .Lee S , Choi EJ , Jin C , Kim DH : Activation of PI-3 K / Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line .", "label": "", "metadata": {}, "score": "71.46597"}
{"text": "DLBCL .After the disappointing results obtained with third - generation chemotherapy regimens in the United States , the CHOP regimen was reverted to as the standard of therapy .", "label": "", "metadata": {}, "score": "71.4888"}
{"text": "Following treatment , Caspase - Glo 3/7 reagent was added and incubated for 30 min .at room temperature .The luminescence intensity was measured using luminometer ( luminoskan , Thermo Scientifics ) .", "label": "", "metadata": {}, "score": "71.488914"}
{"text": "Rev. Mol .Med 2004 , 6 , 1 - 20 .[ Google Scholar ] .Hall , P.A. ; Lane , D.P. p53 in tumour pathology : Can we trust immunohistochemistry ?", "label": "", "metadata": {}, "score": "71.560265"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .M. Ghielmini , S. F. H. Schmitz , S. B. Cogliatti et al . , \" Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event - free survival and response duration compared with the standard weekly \u00d7 4 schedule , \" Blood , vol .", "label": "", "metadata": {}, "score": "71.58259"}
{"text": "54 - 58 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .P. L. Zinzani , M. Tani , S. Fanti et al . , \" A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan ( Zevalin ) for previously untreated elderly diffuse large B - cell lymphoma patients , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "71.7264"}
{"text": "PubMed .Vidot S , Witham J , Agarwal R , Greenhough S , Bamrah HS , Tigyi GJ , Kaye SB , Richardson A : Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells .", "label": "", "metadata": {}, "score": "71.8483"}
{"text": "Effect of BT on cell cycle in ovarian cancer cell lines .At 24 hrs post treatment , cell - cycle analysis of BT treated ovarian cancer cell lines revealed a significant increase in the G1-phase cell population with a concomitant decrease in S and G2 phases as compared to untreated control ( Figure 5 A and B ) .", "label": "", "metadata": {}, "score": "71.86653"}
{"text": "PubMed .Bharti AC , Aggarwal BB : Chemopreventive agents induce suppression of nuclear factor - kappaB leading to chemo sensitization .Ann N Y Acad Sci 2002 , 973 : 392 - 395 .", "label": "", "metadata": {}, "score": "71.86999"}
{"text": "91 , no .5 , pp .715 - 716 , 2006 .View at Google Scholar .T. Kewalramani , A. D. Zelenetz , E. E. Hedrick et al . , \" High - dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non - Hodgkin lymphoma : an intention - to - treat analysis , \" Blood , vol .", "label": "", "metadata": {}, "score": "71.91751"}
{"text": "12 , pp .2014 - 2020 , 1999 .View at Google Scholar . E. Aurlien , R. H. Larsen , G. Kvalheim , and \u00d8. S. Bruland , \" Demonstration of highly specific toxicity of the \u03b1 -emitting radioimmunoconjugate .", "label": "", "metadata": {}, "score": "71.93032"}
{"text": "Biol .[ Google Scholar ] [ CrossRef ] .Donehower , L.A. ; Lozano , G. 20 years studying p53 functions in genetically engineered mice .", "label": "", "metadata": {}, "score": "72.025475"}
{"text": "Quantitative measurements of TNF - \u03b1 were performed using a FACSCalibur flow cytometer ( Becton and Dickinson , San Jose , CA ) with the CellQuest program .", "label": "", "metadata": {}, "score": "72.04113"}
{"text": "The most common method used to date is gene therapy , namely introducing a copy of the WT TP53 gene into tumors using an adenovirus .", "label": "", "metadata": {}, "score": "72.05839"}
{"text": "Figure 2 .Hotspots for TP53 mutations .Mutations that occur at a frequency greater than 3 % are highlighted .Codons in the \" other \" category include those that produce non - functional p53 or have not been characterized to date .", "label": "", "metadata": {}, "score": "72.08061"}
{"text": "PubMed Central PubMed View Article .Kasibhatla S , Amarante - Mendes GP , et al .:Staining of suspension cells with Hoechst 33258 to detect apoptosis .", "label": "", "metadata": {}, "score": "72.09709"}
{"text": "Methods 1991 , 139 , 271 - 279 .[ Google Scholar ] .Troiano , L ; Ferraresi , R ; Lugli , E ; Nemes , E ; Roat , E ; Nasi , M ; Pinti , M ; Cossarizza , A. Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry .", "label": "", "metadata": {}, "score": "72.10768"}
{"text": "Additionally , reactive oxygen species ( ROS ) are known to cause apoptosis or necrosis , depending on the amount and type of ROS generated [ 24 ] .", "label": "", "metadata": {}, "score": "72.16379"}
{"text": "Surface molecules involved in antigen - presentation .JY cells are efficient antigen - presenting cells [ 42 ] and we therefore examined whether or not BTZ selection would induce alterations in markers involved in antigen presentation .", "label": "", "metadata": {}, "score": "72.210846"}
{"text": "Our results also indicate that ovarian cancer cells undergo apoptosis upon BT treatment initially at lower concentrations .Hallmarks of apoptosis , such as nuclear condensation , DNA fragmentation , and loss of mitochondrial potential , were observed further demonstrating that BT triggers apoptosis in ovarian cancer cells .", "label": "", "metadata": {}, "score": "72.27311"}
{"text": "Clinical observations on the treatment with bithionol .Jap J Parasitol 1961 , 10 : 317 .Arts HJ , Van Der Zee AG , De Jong S , De Vries EG : Options for modulation of drug resistance in ovarian cancer .", "label": "", "metadata": {}, "score": "72.28611"}
{"text": "J. Biol .Chem 2000 , 275 , 29503 - 29512 .[ Google Scholar ] .Li , B. ; Murphy , K.L. ; Laucirica , R. ; Kittrell , F. ; Medina , D. ; Rosen , J.M. A transgenic mouse model for mammary carcinogenesis .", "label": "", "metadata": {}, "score": "72.44101"}
{"text": "We found that approximately 15 % of all TP53 mutations are null mutations resulting in a true LOF ( i.e. , nonsense or frame shift mutations ) .", "label": "", "metadata": {}, "score": "72.46156"}
{"text": "( SEQ ID NO : 19 ) EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGI INPSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARGV GAHDAFDIWGQGTTVTVSS .Another aspect of the present invention is an antibody or fragment thereof that binds FLT3 , and comprises a VL having the sequence : .", "label": "", "metadata": {}, "score": "72.47733"}
{"text": "Incubation of EOC cells with neutralizing mAbs to CD46 and CD59 led to a significant increase in the CDC from 10%-20 % to 45%-50 % .", "label": "", "metadata": {}, "score": "72.49673"}
{"text": "Oncol 1998 , 15 , 119 - 123 .[ Google Scholar ] .Frank , T.S. ; Bartos , R.E. ; Haefner , H.K. ; Roberts , J.A. ; Wilson , M.D. ; Hubbell , G.P. Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma .", "label": "", "metadata": {}, "score": "72.69267"}
{"text": "Niwa , K. ; Itoh , M. ; Murase , T. ; Morishita , S. ; Itoh , N. ; Mori , H. ; Tamaya , T. Alteration of p53 gene in ovarian carcinoma : Clinicopathological correlation and prognostic significance .", "label": "", "metadata": {}, "score": "72.80969"}
{"text": "Failure of DNA repair mechanisms leads to p53-mediated induction of cell death programs .p53 also induces permanent cell cycle arrest known as cellular senescence .", "label": "", "metadata": {}, "score": "72.83351"}
{"text": "Yokogawa M , Yoshimura H , Okura T , Sano M , Tsuji M , Iwasaki M , Hirose H : Chemotherapy of paragonimiasis with bithionol .", "label": "", "metadata": {}, "score": "72.8399"}
{"text": "Kaufmann SH , Earnshaw WC : Induction of apoptosis by cancer chemotherapy .Exp Cell Res 2000 , 256 : 42 - 49 .PubMed View Article .", "label": "", "metadata": {}, "score": "72.87907"}
{"text": "J. Pathol 1994 , 172 , 1 - 4 . [ Google Scholar ] .Kern , A. ; Taubert , H. ; Scheele , J. ; Rudroff , C. ; Mothes , H. ; Kappler , M. ; Bartel , F. ; Richter , K.K. Association of p53 mutations , microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases .", "label": "", "metadata": {}, "score": "72.97771"}
{"text": "The present study provides preclinical data suggesting a potential therapeutic role for BT against recurrent ovarian cancer .Keywords .Bithionol Ovarian cancer cell lines Apoptosis Reactive oxygen species Autotaxin .", "label": "", "metadata": {}, "score": "73.20515"}
{"text": "For these LOF mutants , typically p53 can not be detected at the protein level , though some exceptions exist [ 26 ] .For example , an analysis of TP53 mutations in bone and soft tissue sarcomas found positive p53 staining in 1/10 tumors analyzed with LOF TP53 mutations [ 27 ] .", "label": "", "metadata": {}, "score": "73.26092"}
{"text": "PubMed View Article .Deigner HP , Kinscherf R : Modulating apoptosis : current applications and prospects for future drug development .Curr Med Chem 1999 , 6 : 399 - 414 .", "label": "", "metadata": {}, "score": "73.26349"}
{"text": "View Article .Watson AS , Mortensen M , Simon AK : Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia .Cell Cycle 2011 , 10 ( 11):1719 - 1725 .", "label": "", "metadata": {}, "score": "73.28876"}
{"text": "Here , we will summarize some of the most recent and promising observations , and the related suggestions for therapeutic interventions .( i )Interfering with CD20 Downregulation / Shaving .", "label": "", "metadata": {}, "score": "73.524635"}
{"text": "Alessio Nencioni is supported by the Associazione Italiana per la Ricerca sul Cancro ( AIRC ) and by the University of Genoa .References .G. Kohler and C. Milstein , \" Continuous cultures of fused cells secreting antibody of predefined specificity , \" Nature , vol .", "label": "", "metadata": {}, "score": "73.60999"}
{"text": "[ Google Scholar ] .Biomed .Res 2010 , 31 , 401 - 411 .[ Google Scholar ] .Chan , K.T. ; Lung , M.L. Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line .", "label": "", "metadata": {}, "score": "73.64928"}
{"text": "Hydrogen peroxide induces apoptosis in human hepatoma cells and alters cell redox status .Cell Biol .Int 2000 , 24 , 9 - 23 .", "label": "", "metadata": {}, "score": "73.6909"}
{"text": "Biol .Med 1997 , 22 , 269 - 285 .[ Google Scholar ] .Kannan , K ; Jain , SK .Oxidative stress and apoptosis .", "label": "", "metadata": {}, "score": "73.708084"}
{"text": "Biol .Rep 1994 , 19 , 23 - 29 .[ Google Scholar ] .Hall , J. ; Paul , J. ; Brown , R. Critical evaluation of p53 as a prognostic marker in ovarian cancer .", "label": "", "metadata": {}, "score": "73.7567"}
{"text": "Nat Rev Cancer 2003 , 3 ( 7):502 - 516 .PubMed View Article .McGuire WP , Hoskins WJ , Brady MF , Kucera PR , Partridge EE , Look KY , Clarke - Pearson DL , Davidson M : Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer .", "label": "", "metadata": {}, "score": "73.76872"}
{"text": "Conclusions .We demonstrated the ability of BT to exert cytotoxic effects on a panel of ovarian cancer cell lines regardless of their cisplatin sensitivities .", "label": "", "metadata": {}, "score": "73.773605"}
{"text": "The present study aimed to investigate whether Tob1 could inhibit gastric cancer progression in vitro , and to elucidate its underlying molecular mechanisms .We found differential expression of Tob1 in human gastric cancer ( MKN28 , AGS and MKN1 ) cells .", "label": "", "metadata": {}, "score": "73.7752"}
{"text": "Analysis of the expression of proteins in the lysates of treated and untreated cells ( control ) was carried out by PAGE and western blot analysis as described ( Materials and Methods ) .", "label": "", "metadata": {}, "score": "74.032196"}
{"text": "Chem .Biol .Interact 2010 , 183 , 357 - 362 .[ Google Scholar ] .Rosenkranz , AR ; Schmaldienst , S ; Stuhlmeier , KM ; Chen , W ; Knapp , W ; Zlabinger , GJ .", "label": "", "metadata": {}, "score": "74.09028"}
{"text": "Weinberg , R.A. Tumor suppressor genes .Science 1991 , 254 , 1138 - 1146 .[ Google Scholar ] .Anticancer Res 2006 , 26 , 687 - 693 .", "label": "", "metadata": {}, "score": "74.09671"}
{"text": "J. Cancer 1994 , 70 , 1191 - 1197 .[ Google Scholar ] .Herod , J.J. ; Eliopoulos , A.G. ; Warwick , J. ; Niedobitek , G. ; Young , L.S. ; Kerr , D.J. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma .", "label": "", "metadata": {}, "score": "74.13988"}
{"text": "Cells were transfected with 10 - 50 nM siRNA using lipofectamineTM 2000 ( Invitrogen , Carlsbad , CA , USA ) based on the manufacturer 's instruction .", "label": "", "metadata": {}, "score": "74.1794"}
{"text": "NK cell - mediated ADCC can be exhausted .Studies showed that NK cells can engage and kill 3 - 4 target cells in 16 hours .", "label": "", "metadata": {}, "score": "74.18057"}
{"text": "1804 - 1810 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . F. Morschhauser , T. Illidge , D. Huglo et al . , \" Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B - cell lymphoma not appropriate for autologous stem - cell transplantation , \" Blood , vol .", "label": "", "metadata": {}, "score": "74.22095"}
{"text": "113 , no .24 , pp .6161 - 6171 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . E. A. Rossi , D. M. Goldenberg , T. M. Cardillo , R. Stein , Y. Wang , and C. H. Chang , \" Novel designs of multivalent anti - CD20 humanized antibodies as improved lymphoma therapeutics , \" Cancer Research , vol .", "label": "", "metadata": {}, "score": "74.24603"}
{"text": "The CaMBr1 hexasaccharide antigen , originally defined on the human breast carcinoma cell line MCF7 , is expressed on some normal tissues but overexpressed in a high percentage of human breast , ovary , prostate and lung carcinomas .", "label": "", "metadata": {}, "score": "74.290695"}
{"text": "J. Cell .Biochem 2004 , 91 , 384 - 397 .[ Google Scholar ] .Thompson , CB .Apoptosis in the pathogenesis and treatment of disease .", "label": "", "metadata": {}, "score": "74.38881"}
{"text": "It is dependent on availability of ATP , which in turn depends on the correct function of mitochondria .As mentioned in our manuscript , BT causes mitochondrial transmembrane depolarization , thus affecting mitochondrial function .", "label": "", "metadata": {}, "score": "74.41162"}
{"text": "Jacks T , Weinberg RA : Cell - cycle control and its watchman .Nature ( London ) 1996 , 381 : 643 - 644 .", "label": "", "metadata": {}, "score": "74.47748"}
{"text": "Cell .Biol 1996 , 16 , 6009 - 6019 .[ Google Scholar ] .Strano , S. ; Munarriz , E. ; Rossi , M. ; Cristofanelli , B. ; Shaul , Y. ; Castagnoli , L. ; Levine , A.J. ; Sacchi , A. ; Cesareni , G. ; Oren , M. ; et al .", "label": "", "metadata": {}, "score": "74.58276"}
{"text": "Mutant p53 can be classified as a loss - of - function or gain - of - function protein depending on the type of mutation .", "label": "", "metadata": {}, "score": "74.62286"}
{"text": "The cascade of downstream events in response to BT treatment may lead to blockage of the cell cycle at the G1-to - S phase transition , and thus halting ovarian cancer cell growth .", "label": "", "metadata": {}, "score": "74.72358"}
{"text": "Carcinog 2010 , 49 , 141 - 151 .[ Google Scholar ] .Choi , SL ; Kim , SJ ; Lee , KT ; Kim , J ; Mu , J ; Birnbaum , MJ ; Kim , SS ; Ha , J. The regulation of AMP - activated protein kinase by H 2 O 2 . Biochem .", "label": "", "metadata": {}, "score": "74.75069"}
{"text": "[ Google Scholar ] .Lang , G.A. ; Iwakuma , T. ; Suh , Y.A. ; Liu , G. ; Rao , V.A. ; Parant , J.M. ; Valentin - Vega , Y.A. ; Terzian , T. ; Caldwell , L.C. ; Strong , L.C. ; et al .", "label": "", "metadata": {}, "score": "74.78107"}
{"text": "Bithionol dose response curves .Cytotoxic effects of BT on a panel of ovarian cancer cell lines with varying cisplatin sensitivities .Cells were treated with different concentrations of BT for 48 or 72 hrs .", "label": "", "metadata": {}, "score": "74.81233"}
{"text": "Cancer Res 1987 , 47 , 936 - 942 .[ Google Scholar ] .Nicoletti , I ; Migliorati , G ; Pagliacci , MC ; Grignani , F ; Riccardi , C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry .", "label": "", "metadata": {}, "score": "74.816696"}
{"text": "Biochem .Biophys 2011 , 512 , 52 - 60 .[ Google Scholar ] .Freed - Pastor , W.A. ; Mizuno , H. ; Zhao , X. ; Langerod , A. ; Moon , S.H. ; Rodriguez - Barrueco , R. ; Barsotti , A. ; Chicas , A. ; Li , W. ; Polotskaia , A. ; et al .", "label": "", "metadata": {}, "score": "74.85498"}
{"text": "Colmegna I , Sainz B Jr , Garry RF , Espinoza LR : The proteasome and its implications in rheumatology .J Rheumatol 2005 , 32 : 1192 - 1198 .", "label": "", "metadata": {}, "score": "74.98956"}
{"text": "PubMed .Herod JO , Eliopoulos AG , Warwick J , Niedobitek G , Young LS , Kerr DJ : The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma .", "label": "", "metadata": {}, "score": "75.11295"}
{"text": "Oncol 1999 , 17 , 2061 .[ Google Scholar ] .Righetti , S.C. ; Della Torre , G. ; Pilotti , S. ; Menard , S. ; Ottone , F. ; Colnaghi , M.I. ; Pierotti , M.A. ; Lavarino , C. ; Cornarotti , M. ; Oriana , S. ; et al .", "label": "", "metadata": {}, "score": "75.11656"}
{"text": "Oncol .Res 1998 , 4 , 97 - 102 .[ Google Scholar ] .Laframboise , S. ; Chapman , W. ; McLaughlin , J. ; Andrulis , I.L. p53 mutations in epithelial ovarian cancers : Possible role in predicting chemoresistance .", "label": "", "metadata": {}, "score": "75.11916"}
{"text": "10 , pp .2453 - 2463 , 2002 .View at Publisher \u00b7 View at Google Scholar .T. E. Witzig , A. Molina , L. I. Gordon et al . , \" Long - term responses in patients with recurring or refractory B - cell non - Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan , \" Cancer , vol .", "label": "", "metadata": {}, "score": "75.12584"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The impairment of apoptotic pathways represents an efficient mechanism to promote chemoresistance in cancer cells .", "label": "", "metadata": {}, "score": "75.127495"}
{"text": "[ 20- O -(\u03b2- d -glucopyranosyl)-20 ( S ) -protopanaxadiol ] ( Compound K , Figure 1 ) is the main metabolite of protopanaxadiol - type ginsenoside formed in the intestine after oral administration [ 15 - 18 ] .", "label": "", "metadata": {}, "score": "75.132355"}
{"text": "Cell .Biol 1999 , 19 , 1438 - 1449 .[ Google Scholar ] .Marin , M.C. ; Jost , C.A. ; Brooks , L.A. ; Irwin , M.S. ; O'Nions , J. ; Tidy , J.A. ; James , N. ; McGregor , J.M. ; Harwood , C.A. ; Yulug , I.G. ; et al .", "label": "", "metadata": {}, "score": "75.14074"}
{"text": "All cell lines exhibited similar results .Morphological hallmarks of apoptosis .As shown in Figure 3 , normal control cells stained very faintly with the Hoechst stain but treated cells had a stronger blue fluorescence indicative of apoptosis .", "label": "", "metadata": {}, "score": "75.33476"}
{"text": "[ Google Scholar ] .Cobb , JP ; Hotchkiss , RS ; Karl , IE ; Buchman , TG .Mechanisms of cell injury and death .", "label": "", "metadata": {}, "score": "75.527664"}
{"text": "Mutat 2003 , 21 , 101 - 102 .[ Google Scholar ] .Hofstetter , G. ; Berger , A. ; Fiegl , H. ; Slade , N. ; Zoric , A. ; Holzer , B. ; Schuster , E. ; Mobus , V.J. ; Reimer , D. ; Daxenbichler , G. ; et al .", "label": "", "metadata": {}, "score": "75.54715"}
{"text": "Graph : Quantification of percent of apoptosis in terms of DNA fragmentation using Trevigen 's TACS \u00ae 2 TdT in Situ Apoptosis Detection Kit ( TUNEL assay ) .", "label": "", "metadata": {}, "score": "75.555145"}
{"text": "2920 - 2924 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . A. Gallamini , F. Zaja , C. Patti et al . , \" Alemtuzumab ( Campath-1H ) and CHOP chemotherapy as first - line treatment of peripheral T - cell lymphoma : results of a GITIL ( Gruppo Italiano Terapie Innovative nei Linfomi ) prospective multicenter trial , \" Blood , vol .", "label": "", "metadata": {}, "score": "75.58458"}
{"text": "For comparisons between groups , ANOVA and Student 's t - test were used .Abbreviations .BTZ : .Bortezomib .TNF - \u03b1 : .", "label": "", "metadata": {}, "score": "75.61028"}
{"text": "Cell .Biol 2001 , 21 , 1874 - 1887 .[ Google Scholar ] .Strano , S. ; Fontemaggi , G. ; Costanzo , A. ; Rizzo , M.G. ; Monti , O. ; Baccarini , A. ; del Sal , G. ; Levrero , M. ; Sacchi , A. ; Oren , M. ; et al .", "label": "", "metadata": {}, "score": "75.69452"}
{"text": "View Article .Ott I , Gust R : Non platinum metal complexes as anti - cancer drugs .Arch Pharm 2007 , 340 : 117 - 126 .", "label": "", "metadata": {}, "score": "75.80766"}
{"text": "However , the term GOF is arguably a misnomer because the WT function of p53 is lost while oncogenic function is gained , thereby contributing to confusion about the biology of these mutations .", "label": "", "metadata": {}, "score": "75.86922"}
{"text": "In 1975 , Kohler and Milstein heralded a new era in antibody research with their discovery of hybridoma technology [ 1 ] .Mouse hybridomas were the first reliable source of monoclonal antibodies .", "label": "", "metadata": {}, "score": "75.96103"}
{"text": "J. Gynecol .Cancer 2002 , 12 , 720 - 727 .[ Google Scholar ] .Lane , D.P. On the expression of the p53 protein in human cancer .", "label": "", "metadata": {}, "score": "75.98515"}
{"text": "( F ) Representative figure of CD20 expression in JY / WT cells and BTZ - resistant variants .Percentages and mean fluorescence intensity are indicated in the upper left quadrant .", "label": "", "metadata": {}, "score": "76.10118"}
{"text": "Cell viability after BT treatment was determined by PrestoBlue cell viability reagent ( Invitrogen ) following the manufacturer 's instructions .A 20 mM stock of BT was prepared in DMSO and all the working dilutions were prepared in DMEM media .", "label": "", "metadata": {}, "score": "76.20256"}
{"text": "Y220C p53 .The Y220C mutation occurs in 3.74 % of ovarian carcinomas , though it has not been as extensively studied as the other TP53 mutations .", "label": "", "metadata": {}, "score": "76.23685"}
{"text": "177 - 186 , 1997 .View at Google Scholar \u00b7 View at Scopus .L. M. Nadler , J. Ritz , and R. Hardy , \" A unique cell surface antigen identifying lymphoid malignancies of B cell origin , \" Journal of Clinical Investigation , vol .", "label": "", "metadata": {}, "score": "76.35182"}
{"text": "( v )Radioimmunotherapy : this type of treatment involves the administration of an antibody linked to a radioisotope .This approach permits the targeting of the radioactive isotopes to cancer tissues and is especially interesting as it allows for killing neighboring cancer cells that either are inaccessible to the antibody or express insufficient antigen for the antibody to bind in adequate quantities .", "label": "", "metadata": {}, "score": "76.43925"}
{"text": "Natl .Acad .Sci .USA 2008 , 105 , 10360 -10365 .[ Google Scholar ] .Suzuki , M. ; Saito , S. ; Saga , Y. ; Ohwada , M. ; Sato , I. Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer .", "label": "", "metadata": {}, "score": "76.51548"}
{"text": "Pathol 1994 , 7 , 3 - 8 .[ Google Scholar ] .Martins , C.P. ; Brown - Swigart , L. ; Evan , G.I. Modeling the therapeutic efficacy of p53 restoration in tumors .", "label": "", "metadata": {}, "score": "76.63158"}
{"text": "JY cells ( 5 x 10 4 cells ) were plated in triplicate in 96-well plates in IMDM medium with or without rituximab ( concentrations ranging from 0.1 \u03bcg-50 \u03bcg / ml ) and 5 % baby rabbit complement serum ( Cedarlane , Ontario , Canada ) .", "label": "", "metadata": {}, "score": "76.668076"}
{"text": "JC , MV , GLS , CJK contributed new reagents or analytic tools .SEV , DN , ETC , JLA , and GJ performed data analysis .", "label": "", "metadata": {}, "score": "76.74191"}
{"text": "Sci 2008 , 121 , 1899 - 1906 .[ Google Scholar ] .Lozano , G. Mouse models of p53 functions .Cold Spring Harb .", "label": "", "metadata": {}, "score": "76.87311"}
{"text": "J. Gynaecol .Oncol 2002 , 23 , 505 - 510 .[ Google Scholar ] .Berker , B. ; Dunder , I. ; Ensari , A. ; Cengiz , S.D. Prognostic value of p53 accumulation in epithelial ovarian carcinomas .", "label": "", "metadata": {}, "score": "77.07064"}
{"text": "The formazan crystals in each well were then dissolved in 150 \u03bcL dimethylsulfoxide , and the absorbance at 540 nm was read on a scanning multi - well spectrophotometer .", "label": "", "metadata": {}, "score": "77.20441"}
{"text": "Leitao MM Jr , Hummer A , Dizon DS , Aghajanian C , Hensley M , Sabbatini P , Venkatraman E , Spriggs DR : Platinum retreatment of platinum - resistant ovarian cancer after nonplatinum therapy .", "label": "", "metadata": {}, "score": "77.25223"}
{"text": "We recently reported up - regulation of PC - specific phospholipases in epithelial ovarian cancer cells ( EOC ) compared with nontumoral ( normal or immortalized ) counterparts ( EONT ) .", "label": "", "metadata": {}, "score": "77.2851"}
{"text": "The percent of ATX inhibition of treated cells was calculated against untreated cells .Experiments were performed in triplicate .Data was expressed as mean \u00b1 SD of triplicate experiments .", "label": "", "metadata": {}, "score": "77.34273"}
{"text": "PubMed View Article .Kikuchi Y : The mechanism of cisplatin - resistance in ovarian cancer .Hum Cell 2001 , 14 ( 2):115 - 133 .", "label": "", "metadata": {}, "score": "77.34791"}
{"text": "Green , DR ; Reed , JC .Mitochondria and apoptosis .Science 1998 , 281 , 1309 - 1312 .[ Google Scholar ] .", "label": "", "metadata": {}, "score": "77.439384"}
{"text": "The SuperSignal ELISA Pico chemiluminescent substrate kit ( Pierce ) was utilized to generate luminescent signal associated with HRP binding .Luminescence after 5 minutes of signal development was monitored on a plate reader ( Tecan Safire ) .", "label": "", "metadata": {}, "score": "77.492966"}
{"text": "\u0394\u03c8 m was analyzed by flow cytometry and ( C ) confocal microscopy after staining cells with JC-1 dye .( D ) Cell lysates were electrophoresed and Bax , Bcl-2 , cytochrome c , active caspase-9 , active caspase-3 , and cleaved PARP proteins were detected using their corresponding antibodies .", "label": "", "metadata": {}, "score": "77.55558"}
{"text": "\u0394\u03c8 m was analyzed by flow cytometry and ( C ) confocal microscopy after staining cells with JC-1 dye .( D ) Cell lysates were electrophoresed and Bax , Bcl-2 , cytochrome c , active caspase-9 , active caspase-3 , and cleaved PARP proteins were detected using their corresponding antibodies .", "label": "", "metadata": {}, "score": "77.55558"}
{"text": "Loss of transmembrane potential was shown by shift in peaks in treated cells as compared to control ( C- vehicle treated ) .All experiments were performed in triplicate .", "label": "", "metadata": {}, "score": "77.63225"}
{"text": "Updat 2004 , 7 , 97 - 110 .[ Google Scholar ] .Hwang , PM ; Bunz , F ; Yu , J ; Rago , C ; Chan , TA ; Murphy , MP ; Kelso , GF ; Smith , RA ; Kinzler , KW .", "label": "", "metadata": {}, "score": "77.67323"}
{"text": "J. Pharm .Pharmacol 1998 , 50 , 1155 - 1160 .[ Google Scholar ] .Hasegawa , H ; Sung , JH ; Huh , JH .", "label": "", "metadata": {}, "score": "77.68605"}
{"text": "BT at 48 hrs post treatment in all cell lines tested .The extent of ATX inhibition was nearly similar in all cell lines .Effect of BT on ATX secretion in ovarian cancer cell lines .", "label": "", "metadata": {}, "score": "77.762665"}
{"text": "Cell 2012 , 148 , 244 - 258 .[ Google Scholar ] .Girardini , J.E. ; Napoli , M. ; Piazza , S. ; Rustighi , A. ; Marotta , C. ; Radaelli , E. ; Capaci , V. ; Jordan , L. ; Quinlan , P. ; Thompson , A. ; et al .", "label": "", "metadata": {}, "score": "77.77014"}
{"text": "Cells stably growing in the presence of 35 nM ( JY/35 ) and 100 nM BTZ ( JY/100 ) were isolated after 3 months and 6 months of stepwise selection , respectively .", "label": "", "metadata": {}, "score": "77.788635"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . A. Rambaldi , M. Lazzari , C. Manzoni et al . , \" Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma , \" Blood , vol .", "label": "", "metadata": {}, "score": "77.96693"}
{"text": "J. Cancer 1998 , 78 , 375 - 381 .[ Google Scholar ] .Bosari , S. ; Viale , G. ; Radaelli , U. ; Bossi , P. ; Bonoldi , E. ; Coggi , G. p53 accumulation in ovarian carcinomas and its prognostic implications .", "label": "", "metadata": {}, "score": "78.125305"}
{"text": "The control cells exhibited strong red fluorescence in the mitochondria ; however , Compound K - treated cells resulted in a decreased red fluorescence in the mitochondria and increased green fluorescence , suggesting that Compound K treatment disrupted the mitochondrial \u0394\u03c8 ( Figure 4C ) .", "label": "", "metadata": {}, "score": "78.367744"}
{"text": "In the present study , we analyzed the concentrations of phosphatidylcholine metabolites , activities of phosphocholine - producing enzymes , and uptake of [ methyl-14C]choline in human epithelial ovarian carcinoma cell lines ( EOC ) compared with normal or immortalized ovary epithelial cells ( EONT ) .", "label": "", "metadata": {}, "score": "78.47025"}
{"text": "Cancer Cell 2011 , 20 , 79 - 91 .[ Google Scholar ] .Fontemaggi , G. ; Dell'Orso , S. ; Trisciuoglio , D. ; Shay , T. ; Melucci , E. ; Fazi , F. ; Terrenato , I. ; Mottolese , M. ; Muti , P. ; Domany , E. ; et al .", "label": "", "metadata": {}, "score": "78.57098"}
{"text": "40164_2013_40_MOESM1_ESM.pdfAdditional file 1 : Table S1 .Overview of primer and probe sequences for PSMB6 , PSMB7 , PSMB8 , PSMB9 , PSMB10 and GUS .", "label": "", "metadata": {}, "score": "78.57614"}
{"text": "[ Google Scholar ] .Dr\u00f6ge , W. Free radicals in the physiological control of cell function .Physiol .Rev 2002 , 82 , 47 - 95 .", "label": "", "metadata": {}, "score": "78.8093"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed Tumor suppressor p53 is a transcription factor that regulates a large number of genes and guards against genomic instability .", "label": "", "metadata": {}, "score": "78.90788"}
{"text": "[ Google Scholar ] .Liu , H. ; Xiao , F. ; Serebriiskii , I.G. ; O'Brien , S.W. ; Maglaty , M.A. ; Astsaturov , I.A. ; Martin , L. ; Litwin , S. ; Proia , D.A. ; Golemis , E.A. ; et al .", "label": "", "metadata": {}, "score": "79.05395"}
{"text": "Analysis of Mitochondrial Membrane Potential ( \u0394\u03c8 m ) .Cells were stained with JC-1 ( 10 \u03bcg / mL ) , and were then analyzed using flow cytometry [ 58 ] .", "label": "", "metadata": {}, "score": "79.06717"}
{"text": "Conclusions and Consequences for the Future .The process of carcinogenesis involves gaining oncogenic activities as well as losing tumor suppressive activities .Tumors that acquire an oncomorphic TP53 mutation get a double hit - as a consequence of a single mutation , tumors lose WT p53 tumor suppressive activity and gain a new oncogenic tumor promoter .", "label": "", "metadata": {}, "score": "79.12679"}
{"text": "Transient Transfection of Small RNA Interference ( siRNA ) .Cells were seeded at 1.5 \u00d7 10 5 cells / well in 24 well plate and allowed to reach approximately 50 % confluence on the day of transfection .", "label": "", "metadata": {}, "score": "79.14267"}
{"text": "Similar results are obtained with Bexxar .In particular in patients with NHL refractory to standard chemotherapy , treatment with Bexxar resulted in CR in 20 % of patients [ 124 ] .", "label": "", "metadata": {}, "score": "79.14561"}
{"text": "Isogenic ovarian cancer cell lines pairs , e.g. , A2780/A2780-CDDP and IGROV-1/ , IGROV-1CDDP were received as a generous gift from Dr. Brodsky ( Brown University , Providence , RI ) .", "label": "", "metadata": {}, "score": "79.237495"}
{"text": "1527 - 1532 , 1991 .View at Google Scholar .J. Limpens , R. Stad , C. Vos et al . , \" Lymphoma - associated translocation t(14;18 ) in blood B cells of normal individuals , \" Blood , vol . 85 , no . 9 , pp .", "label": "", "metadata": {}, "score": "79.25018"}
{"text": "[ Google Scholar ] .Qanungo , S ; Das , M ; Haldar , S ; Basu , A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase - dependent apoptosis in pancreatic cancer cells .", "label": "", "metadata": {}, "score": "79.368744"}
{"text": "Cells were activated for 24 hours with 10 ng / ml PMA and 750 ng / ml Ionomycin , in the absence or presence of the indicated concentration bortezomib .", "label": "", "metadata": {}, "score": "79.66806"}
{"text": "Irani K : Oxidant signaling in vascular cell growth , death , and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling .", "label": "", "metadata": {}, "score": "79.679565"}
{"text": "PubMed Central PubMed View Article .Asselin E , Mills GB , Tsang BK : XIA P regulates Akt activity and caspase-3-dependent cleavage during cisplatin - induced apoptosis in human ovarian epithelial cancer cells .", "label": "", "metadata": {}, "score": "79.71029"}
{"text": "All experiments were performed in triplicate .( B ) Effect of antioxidant ascorbic acid on BT treated cells .Cells were pre - treated with 1 mM ascorbic acid for 2 hrs before addition of drug and further incubated for 48 hrs with both BT and ascorbic acid .", "label": "", "metadata": {}, "score": "79.920815"}
{"text": "J. Biol .Chem 2005 , 280 , 9963 - 9972 .[ Google Scholar ] .Carmichael , J ; DeGraff , WG ; Gazdar , AF ; Minna , JD ; Mitchell , JB .", "label": "", "metadata": {}, "score": "80.02171"}
{"text": "Cell .Biochem 1999 , 194 , 185 - 191 .[ Google Scholar ] .Rainis , T ; Keren , D ; Goldstein , O ; Stermer , E ; Lavy , A. Diagnostic yield and safety of colonoscopy in Israeli patients in an open access referral system .", "label": "", "metadata": {}, "score": "80.08211"}
{"text": "Cancer 2009 , 8 , 103 .[ Google Scholar ] .Yan , W. ; Chen , X. Characterization of functional domains necessary for mutant p53 gain of function .", "label": "", "metadata": {}, "score": "80.21497"}
{"text": "10.1093/intimm / dxl098 PubMed View Article .Browning JL : B cells move to centre stage : novel opportunities for autoimmune disease treatment .", "label": "", "metadata": {}, "score": "80.227135"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Cellular senescence is a barrier to tumorigenesis in normal cells , and tumor cells undergo senescence responses to genotoxic stimuli , which is a potential target phenotype for cancer therapy .", "label": "", "metadata": {}, "score": "80.30399"}
{"text": "Perez - Galan P , Dreyling M , Wiestner A : Mantle cell lymphoma : biology , pathogenesis , and the molecular basis of treatment in the genomic era .", "label": "", "metadata": {}, "score": "80.36232"}
{"text": "10.1182/blood-2010 - 04 - 189977 PubMed Central PubMed View Article .Kastritis E , Terpos E , Dimopoulos MA : Emerging drugs for Waldenstrom 's macroglobulinemia .", "label": "", "metadata": {}, "score": "80.366714"}
{"text": "Experiments were performed in duplicate .Data was expressed as mean \u00b1 SD of duplicate experiments .Analysis of mitochondrial transmembrane potential .BT treatment resulted in slight decrease in mitochondrial potential as early as 6 hrs post treatment .", "label": "", "metadata": {}, "score": "80.37044"}
{"text": "Treat 2009 , 41 , 36 - 44 .[ Google Scholar ] .Pelicano , H ; Carney , D ; Huang , P. ROS stress in cancer cells and therapeutic implications .", "label": "", "metadata": {}, "score": "80.54915"}
{"text": "Bottom panel , stabilization of p53 expression was demonstrated 10 h after irradiation .all Addendum Article Book Review Case Report Comment Commentary Communication Concept Paper Conference Report Correction Creative Data Descriptor Discussion Editorial Erratum Essay Interesting Images Letter New Book Received Obituary Opinion Project Report Reply Retraction Review Short Note Technical Note .", "label": "", "metadata": {}, "score": "80.87445"}
{"text": "Natl .Acad .Sci .USA 1998 , 95 , 5166 - 5171 .[ Google Scholar ] .Adorno , M. ; Cordenonsi , M. ; Montagner , M. ; Dupont , S. ; Wong , C. ; Hann , B. ; Solari , A. ; Bobisse , S. ; Rondina , M.B. ; Guzzardo , V. ; et al .", "label": "", "metadata": {}, "score": "81.03371"}
{"text": "[ Google Scholar ] .Cancer Cell 2006 , 10 , 191 - 202 .[ Google Scholar ] .Stambolsky , P. ; Tabach , Y. ; Fontemaggi , G. ; Weisz , L. ; Maor - Aloni , R. ; Siegfried , Z. ; Shiff , I. ; Kogan , I. ; Shay , M. ; Kalo , E. ; et al .", "label": "", "metadata": {}, "score": "81.23584"}
{"text": "The second trial , known as REACH , enrolled 552 patients with relapsed or refractory B - CLL following prior systemic therapy [ 40 ] .", "label": "", "metadata": {}, "score": "81.28201"}
{"text": "Environ .Toxicol .Pharmacol 2010 , 30 , 134 - 140 .[ Google Scholar ] .Blau , S ; Rubinstein , A ; Bass , P ; Singaram , C ; Kohen , R. Differences in the reducing power along the rat GI tract : Lower antioxidant capacity of the colon .", "label": "", "metadata": {}, "score": "81.29254"}
{"text": "Copyright \u00a9 2014 Elsevier Inc.All rights reserved .[ Show abstract ] [ Hide abstract ] ABSTRACT :This study assessed the safety and preliminary efficacy of escalated dose subcutaneous alemtuzumab in combination with rituximab in chronic lymphocytic leukemia .", "label": "", "metadata": {}, "score": "81.37577"}
{"text": "Cell 2009 , 137 , 87 - 98 .[ Google Scholar ] .Muller , P.A. ; Caswell , P.T. ; Doyle , B. ; Iwanicki , M.P. ; Tan , E.H. ; Karim , S. ; Lukashchuk , N. ; Gillespie , D.A. ; Ludwig , R.L. ; Gosselin , P. ; et al .", "label": "", "metadata": {}, "score": "81.38156"}
{"text": "After 24 hours of incubation , cells were harvested and washed 3 times with ice - cold PBS at pH 7.4 .Total cell lysates were prepared by resuspending in 0.1 ml lysis buffer ( Cell Signaling Technology ) containing : 20 % PIC ( Protease Inhibitor Cocktail ) and 10 % NaVO 4 .", "label": "", "metadata": {}, "score": "81.38199"}
{"text": "Shahin , M.S. ; Hughes , J.H. ; Sood , A.K. ; Buller , R.E. The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma .", "label": "", "metadata": {}, "score": "81.48482"}
{"text": "BT treated cells ( Figure 4 ) .As compared to OVACAR-3 and IGROV-1 and IGROV1-CDDP , loss of mitochondrial potential was greater in SKOV-3 , A2780 and A2780-CDDP at 24 hrs post treatment .", "label": "", "metadata": {}, "score": "81.51868"}
{"text": "Hence there is a need for more effective therapies and/or treatment approaches to overcome drug resistance .New drug discovery demands enormous cost and time .", "label": "", "metadata": {}, "score": "81.59951"}
{"text": "Pathol 1993 , 24 , 1175 - 1179 .[ Google Scholar ] .Berker , B. ; Dunder , I. ; Ensari , A. ; Cengiz , S.D. ; Simsek , E. Prognostic significance of apoptotic index and bcl-2 and p53 expression in epithelial ovarian carcinoma .", "label": "", "metadata": {}, "score": "81.70615"}
{"text": "10.3324/haematol.2008.001677 PubMed Central PubMed View Article .McInnes IB , Schett G : The pathogenesis of rheumatoid arthritis .N Engl J Med 2011 , 365 : 2205 - 2219 .", "label": "", "metadata": {}, "score": "81.76739"}
{"text": "We believe that these mutants can not be binned into two simplistic categories ( mutant vs. WT ) since clearly all TP53 mutants are not equal .", "label": "", "metadata": {}, "score": "81.931046"}
{"text": "( A ) Cells were treated with 50 \u03bcM or 100 \u03bcMBT for 24 hrs , proteins extracted , subjected to electrophoresis and detected by western blotting using primary antibodies specifically recognizing the phosphorylated active forms of these proteins .", "label": "", "metadata": {}, "score": "81.97771"}
{"text": "In spite of the efficacy of platinum - paclitaxel treatment in patients with primary epithelial ovarian carcinoma , platinum - based chemotherapy is not curative and resistance remains one of the most important causes of treatment failure .", "label": "", "metadata": {}, "score": "81.99389"}
{"text": "HLA class II antigens are expressed at the surface of professional antigen presenting cells , including B cells .They are involved in antigen presentation and in promoting cell proliferation .", "label": "", "metadata": {}, "score": "82.00609"}
{"text": "Based on our calculations , oncomorphic mutations may comprise up to 20 % of all mutations in ovarian tumors .However , a single therapy may not be adequate for all tumors with oncomorphic TP53 mutations .", "label": "", "metadata": {}, "score": "82.030045"}
{"text": "65(4 ) : 1514 - 22 ( 2005 ) , Williams B. , et al . , Leukemia 19(8):1432 - 8 ( 2005 ) , Piloto O. , et al . , Cancer Res .", "label": "", "metadata": {}, "score": "82.06741"}
{"text": "Drug resistance is the key reason for ovarian cancer recurrence and poor overall survival [ 2 - 4 ] .Although most ovarian cancer patients ( 70 - 80 % ) initially respond to cytoreductive surgery and adjuvant paclitaxel and platinum - based chemotherapy , the majority will experience disease recurrence [ 5 , 6 ] .", "label": "", "metadata": {}, "score": "82.12444"}
{"text": "This study is supported by Cancer Center Amsterdam ( CCA)/VU- Institute of Cancer and Immunology ( V - ICI ) [ Grant 07/36].Y.G. Assaraf is recipient of an Award Visiting Professor Fellowships from the Royal Netherlands Academy of Arts and Sciences ( KNAW ) , the Netherlands Organization for Scientific Research ( NWO ) , and the Dutch Arthritis Foundation .", "label": "", "metadata": {}, "score": "82.14154"}
{"text": "IC 50 values for Cisplatin in isogenic ovarian cancer cell line pairs consisting of Cisplatin - sensitive parental lines and stable Cisplatin - resistant sub - lines derived by in vitro selection with Cisplatin .", "label": "", "metadata": {}, "score": "82.15681"}
{"text": "At the end of the treatment , ATX was measured from culture media by a colorimetric assay using p -nitrophenylphosphonate ( pNppp ) as substrate .", "label": "", "metadata": {}, "score": "82.183716"}
{"text": "Hotspots for TP53 mutations .Mutations that occur at a frequency greater than 3 % are highlighted .Codons in the \" other \" category include those that produce non - functional p53 or have not been characterized to date .", "label": "", "metadata": {}, "score": "82.191414"}
{"text": "When designing a therapeutic approach for NHL , cancer immunologists face the issue of selecting the best target antigen .Tumor antigens are traditionally divided in tumor - specific antigens ( proteins that are uniquely expressed by cancer cells ) and tumor - associated antigens ( molecules that are expressed by cancer cells , although their expression is also found on normal cells ) [ 3 ] .", "label": "", "metadata": {}, "score": "82.255936"}
{"text": "The UPS is the master regulator of cellular homeostasis by mediating ubiquitination and degradation of proteins that control apoptosis induction , and also mediate pro - inflammatory cytokine production via NF\u03baB activation [ 24 - 26 ] .", "label": "", "metadata": {}, "score": "82.31095"}
{"text": "Arch .Pharm .Res 1997 , 20 , 539 - 544 .[ Google Scholar ] .Hasegawa , H ; Sung , JH ; Benno , Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins .", "label": "", "metadata": {}, "score": "82.353806"}
{"text": "PubMed View Article .Lamberth E , Gregory WM , Nelstrop AE , Rustin GJ : Long - term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary : life expectancy compared to women of an age - matched normal population .", "label": "", "metadata": {}, "score": "82.41334"}
{"text": "These results are significant when considering that clinically , all recurrent ovarian cancers will eventually be platinum - resistant .Interestingly , BT IC 50 values observed for various ovarian cancer cell lines are significantly below the clinically tolerable doses of BT for humans .", "label": "", "metadata": {}, "score": "82.67551"}
{"text": "Flow cytometric analyses revealed a significant decrease in CD19 + cells ( 55 \u00b1 16 % ) in JY / WT cells to 14 \u00b1 11 % in JY/100 cells ( Figure 4A ) along with a concomitant 3-fold decrease in CD19 cell surface expression ( Figure 4B ) .", "label": "", "metadata": {}, "score": "82.73359"}
{"text": "The most resounding finding from this study was the identification of mutations in a single gene , TP53 , in 96 % of all serous ovarian tumors .", "label": "", "metadata": {}, "score": "82.8033"}
{"text": "Cells treated with BT showed ROS generation as early as 6 hrs post treatment .This was more remarkable when treatment was extended up to 24 hrs .", "label": "", "metadata": {}, "score": "82.88774"}
{"text": "Bioorg .Med .Chem 2009 , 17 , 7239 - 7247 .[ Google Scholar ] .Sahu , RP ; Zhang , R ; Batra , S ; Shi , Y ; Srivastava , SK .", "label": "", "metadata": {}, "score": "83.19635"}
{"text": "Department of Medical Oncology , VU University Medical Center .Department of Pathology , VU University Medical Center .Onyx Pharmaceuticals .References .Maloney DG : Anti - CD20 antibody therapy for B - cell lymphomas .", "label": "", "metadata": {}, "score": "83.30966"}
{"text": "Of note , short term ( 24 hr ) incubations with maximal non - toxic concentrations of BTZ also did not affect their ability to induce proliferation of allo - T - cells ( Additional file 1 : Figure S3 ) .", "label": "", "metadata": {}, "score": "83.35893"}
{"text": "The DCF - DA method was used to detect the levels of intracellular ROS [ 42 ] .Cells were seeded onto a 96 well plate at 2 \u00d7 10 4 cells / well .", "label": "", "metadata": {}, "score": "83.67868"}
{"text": "Cells were incubated with increasing concentrations anti - CD20/rituximab ( range ; 0.1 \u03bcg-50 \u03bcg / ml ) and 5 % baby rabbit complement serum .", "label": "", "metadata": {}, "score": "83.881424"}
{"text": "Twenty thousand events were analyzed for each sample .Appropriate gating was used to select standardized cell population .Estimation of reactive oxygen species ( ROS ) production .", "label": "", "metadata": {}, "score": "83.91853"}
{"text": "After centrifugation ( 250 g , 5 min . ) , cells were fixed by adding ice - cold 70 % ethanol gradually .Following fixation , cells were stained with propidium iodide ( 50 \u03bcg / mL ) in presence of 100 \u03bcg / mL of RNase for 30 min at 37 \u00b0 C in the dark .", "label": "", "metadata": {}, "score": "84.14999"}
{"text": "10 , pp .1756 - 1765 , 2010 .View at Google Scholar .CLL8- German CLL Study Group . E. Kimby , M. Bjorkholm , G. Gahrton et al . , \" Chlorambucil / prednisone vs. CHOP in symptomatic low - grade non - Hodgkin 's lymphomas : a randomized trial from the Lymphoma Group of Central Sweden , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "84.28398"}
{"text": "Indeed , since their initial discovery , more than 20 mAbs have been approved by the US Food and Drug Administration ( FDA ) for the treatment of several conditions , including several types of cancers .", "label": "", "metadata": {}, "score": "84.501175"}
{"text": "In Ghielmini et al . , at a median followup of 35 months , the median EFS was 12 months in the no - maintenance group versus 23 months in the prolonged treatment arm ( . )", "label": "", "metadata": {}, "score": "84.5327"}
{"text": "The addition of CT scan evaluation per International Workshop on Chronic Lymphocytic Leukemia 2008 criteria reduced the overall response rate to 14 % .Median overall survival was 35 months , with twelve patients able to proceed to stem cell transplantation .", "label": "", "metadata": {}, "score": "84.544304"}
{"text": "( A ) Cell cycle analysis was carried out by flow cytometry .Cells were treated with 50 \u03bcMBT for 24 hrs .At the end of the incubation period , cells were collected , fixed and stained with 50 \u03bcg / mL of propidium iodide and 100 \u03bcg / mL of RNase for 30 min at 37 \u00b0 C in the dark .", "label": "", "metadata": {}, "score": "84.62112"}
{"text": "Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "84.96666"}
{"text": "Abstract .Background .Drug resistance is a cause of ovarian cancer recurrence and low overall survival rates .There is a need for more effective treatment approaches because the development of new drug is expensive and time consuming .", "label": "", "metadata": {}, "score": "85.02046"}
{"text": "BT treated cells .Detection of intracellular ROS following BT treatment in ovarian cancer cell lines .( A ) Detection of ROS by flow cytometry .", "label": "", "metadata": {}, "score": "85.18787"}
{"text": "[ Google Scholar ] .Muller , P.A. ; Vousden , K.H. p53 mutations in cancer .Nat .Cell Biol 2013 , 15 , 2 - 8 .", "label": "", "metadata": {}, "score": "85.230545"}
{"text": "Follicular and Low Grade Lymphoma .Until the early 90 's , the first - line therapy in symptomatic low - grade NHL was chlorambucil and prednisone [ 42 ] .", "label": "", "metadata": {}, "score": "85.4617"}
{"text": "[ Google Scholar ] .Cao , XH ; Wang , AH ; Wang , CL ; Mao , DZ ; Lu , MF ; Cui , YQ ; Jiao , RZ .", "label": "", "metadata": {}, "score": "85.61141"}
{"text": "Shih , CM ; Ko , WC ; Wu , JS ; Wei , YH ; Wang , LF ; Chang , EE ; Lo , TY ; Cheng , HH ; Chen , CT .", "label": "", "metadata": {}, "score": "85.75871"}
{"text": "Biotechnol .Bioprocess Eng 2005 , 11 , 7 - 12 .[ Google Scholar ] .Chae , S ; Kang , KA ; Chang , WY ; Kim , MJ ; Lee , SJ ; Lee , YS ; Kim , HS ; Kim , DH ; Hyun , JW .", "label": "", "metadata": {}, "score": "86.39429"}
{"text": "Carcinogenesis 2005 , 26 , 359 - 367 .[ Google Scholar ] .Yim , HW ; Jong , HS ; Kim , TY ; Choi , HH ; Kim , SG ; Song , SH ; Kim , J ; Ko , SG ; Lee , JW ; Kim , TY ; Bang , YJ .", "label": "", "metadata": {}, "score": "86.59427"}
{"text": "PubMed Central PubMed View Article .Conklin KA : Chemotherapy - associated oxidative stress : Impact on chemotherapeutic effectiveness .Integr Cancer Ther 2004 , 3 : 294 - 300 .", "label": "", "metadata": {}, "score": "86.970894"}
{"text": "10.3816/CLML.2010 .n.015 PubMed View Article .Laubach J , Richardson P , Anderson K : Multiple myeloma .Annu Rev Med 2011 , 62 : 249 - 264 .", "label": "", "metadata": {}, "score": "87.002304"}
{"text": "Jemal A , Siegel R , Xu J , Ward E : Cancer statistics , 2010 .CA Cancer J Clin 2010 , 60 ( 5):277 - 300 .", "label": "", "metadata": {}, "score": "87.04756"}
{"text": "Data was acquired on a BD Accuri C6 flow cytometer and analyzed using Accuri C6 software ( BD Immunocytometry - Systems , San Jose , CA ) .", "label": "", "metadata": {}, "score": "87.11334"}
{"text": "Drug resistance is a major cause for ovarian cancer recurrence .New drug discovery requires significant resources and time .Alternatively , the concept of ' drug repurposing ' appears promising .", "label": "", "metadata": {}, "score": "87.25685"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Finding novel compounds as starting points for optimization is a major challenge in drug discovery research .", "label": "", "metadata": {}, "score": "87.510284"}
{"text": "Percent of LDH released from vehicle treated ( 1 % DMSO media ) control set is considered as 100 % intact or 0 % LDH release .", "label": "", "metadata": {}, "score": "87.61713"}
{"text": "J. Hematol .82(2):108 - 14 ( 2005 ) , Li Y. , Drug Development Research 67(6 ) : 495 - 500 ( 2006 ) .", "label": "", "metadata": {}, "score": "87.66165"}
{"text": "Authors ' contributions .GJ was the principle investigator and takes primary responsibility for the paper .SEV , TDG and GJ participated in research design .", "label": "", "metadata": {}, "score": "87.69014"}
{"text": "Following treatment , cells were harvested by trypsinization , washed with PBS ( 1\u00d7 ) , and resuspended in fresh DMEM medium ( 1 \u00d7 10 6 cells / mL ) containing rhodamine 123 at a concentration of 0.5 mg / mL , and incubated for 30 min .", "label": "", "metadata": {}, "score": "87.88322"}
{"text": "Res .Commun 2001 , 287 , 92 - 97 .[ Google Scholar ] .Yun , H ; Lee , M ; Kim , SS .", "label": "", "metadata": {}, "score": "88.01818"}
{"text": "Even though forced overexpression represents an artificial biological system , ovarian cancer tumors have high levels of stable p53 mutants , thus justifying this method .", "label": "", "metadata": {}, "score": "88.16918"}
{"text": "Tuning CIR expression and affinity might help in discriminating different biologic contexts .[ Show abstract ] [ Hide abstract ] ABSTRACT : Epithelial ovarian carcinoma ( EOC ) remains a highly lethal malignancy .", "label": "", "metadata": {}, "score": "88.209015"}
{"text": "Real - time PCR was performed in a total reaction volume of 25 \u03bcl containing TaqMan buffer A ( Applied Biosystems ) , 4 mM MgCl 2 , 0.25 mM of each dNTP ( Amersham Pharmacia Biotech ) , and 1.25 U AmpliTaq Gold DNA polymerase ( Applied Biosystems ) .", "label": "", "metadata": {}, "score": "88.41771"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The disease course of chronic lymphocytic leukemia ( CLL ) varies significantly within cytogenetic groups .", "label": "", "metadata": {}, "score": "88.42817"}
{"text": "Cells were treated with BT as described previously .Following treatment , cells were washed and fixed followed by addition of labeled nucleotides and subsequent detection with HRP - HRP substrate ( TACS - Sapphire ) system .", "label": "", "metadata": {}, "score": "88.55786"}
{"text": "The membranes were further incubated with secondary immunoglobulin G - horseradish peroxidase conjugates , and then underwent enhanced chemiluminescence using a Western blotting detection kit ( Amersham , Buckinghamshire , UK ) .", "label": "", "metadata": {}, "score": "88.676865"}
{"text": "J. Food Biochem 2005 , 29 , 27 - 40 .[ Google Scholar ] .Kang , KA ; Lim , HK ; Chae , S ; Kim , JK ; Seo , JY ; Ham , YH ; Lee , KH ; Kim , BJ ; Kim , HS ; Kim , DH ; Hyun , JW .", "label": "", "metadata": {}, "score": "88.69382"}
{"text": "The cells were washed twice with DPBS , re - suspended in DPBS and analyzed by flow cytometry ( 488 nm excitation/520 nm emission ) .", "label": "", "metadata": {}, "score": "88.76969"}
{"text": "[ Google Scholar ] .Mol .Carcinog 1998 , 23 , 185 - 192 .[ Google Scholar ] .Meng , X. ; Laidler , L.L. ; Kosmacek , E.A. ; Yang , S. ; Xiong , Z. ; Zhu , D. ; Wang , X. ; Dai , D. ; Zhang , Y. ; Wang , X. ; et al .", "label": "", "metadata": {}, "score": "88.935524"}
{"text": "PI : .Proteasome inhibitor .CDC : .Complement - dependent cytotoxicity .Declarations .Acknowledgements .The authors would like to thank Dr. Saskia A. Cillessen ( Department of Pathology ) , VU University Medical Center , Amsterdam , The Netherlands , for critical reading of the manuscript .", "label": "", "metadata": {}, "score": "89.20125"}
{"text": "Fifty mg / kg in three divided alternate daily doses for 5 days will maintain serum levels of BT in the range of 140 to 550 \u03bcM in rabbits , dogs and humans [ 13 , 18 ] .", "label": "", "metadata": {}, "score": "89.35782"}
{"text": "Lee , BH ; Lee , SJ ; Hur , JH ; Lee , S ; Sung , JH ; Huh , JD ; Moon , CK .", "label": "", "metadata": {}, "score": "89.43727"}
{"text": "Protoc 2007 , 2 , 2719 - 2727 .[ Google Scholar ] .Figure 2 .Cytotoxic effect of Compound K in human colon cells .", "label": "", "metadata": {}, "score": "89.456696"}
{"text": "Rev. Cell Dev .Biol 1999 , 15 , 269 - 290 .[ Google Scholar ] .Earnshaw , WC ; Martins , LM ; Kaufmann , SH .", "label": "", "metadata": {}, "score": "89.773186"}
{"text": "Arch .Pharm .Res 2005 , 28 , 685 - 690 .[ Google Scholar ] .Kang , KA ; Lim , HK ; Kim , SU ; Kim , YW ; Kim , WT ; Chung , HS ; Choo , MK ; Kim , DH ; Kim , HS ; Shim , MJ ; Chung , MH ; Hyun , JW .", "label": "", "metadata": {}, "score": "89.79848"}
{"text": "Sci 2004 , 19 , 124 - 128 .[ Google Scholar ] .Thornberry , NA ; Lazebnik , Y. Caspases : Enemies within .", "label": "", "metadata": {}, "score": "89.8342"}
{"text": "Results : Myocardial infarct size relative to the area at risk or relative to left ventricular area was significantly reduced in C1INH - treated wild - type , C1INH(-/- ) , and C3(-/- ) mice compared with vehicle - treated mice .", "label": "", "metadata": {}, "score": "89.895096"}
{"text": "Arthritis Rheum 2011 , 63 : 3038 - 3047 .10.1002/art.30466 PubMed View Article .Clin Cancer Res 2008 , 14 : 1561 - 1570 .", "label": "", "metadata": {}, "score": "89.914635"}
{"text": "J. Agric .Food Chem 2009 , 57 , 5777 - 5782 .[ Google Scholar ] .Kim , AD ; Kang , KA ; Zhang , R ; Lim , CM ; Kim , HS ; Kim , DH ; Jeon , YJ ; Lee , CH ; Park , J ; Chang , WY ; Hyun , JW .", "label": "", "metadata": {}, "score": "89.92262"}
{"text": "The most common adverse effects were infusion - related reactions and lymphopenia .Ten percent of the patients reported severe fever , chills , infections , or other adverse effects .", "label": "", "metadata": {}, "score": "90.16054"}
{"text": "Browse recent Imclone Llc patents USPTO Applicaton # : # 20110008355 Inventors : Yiwen Li , Dan Lu , James Robert Tonra , David Surguladze .", "label": "", "metadata": {}, "score": "90.43457"}
{"text": "The percentage of lysed ( PI+ ) cells was calculated based on a total of 1.2 x 10 4 measured events .Cell lysis in control conditions ( without baby rabbit serum ) was subtracted to obtain specific complement - dependent lysis .", "label": "", "metadata": {}, "score": "90.57255"}
{"text": "Cancer Res 2005 , 65 , 1952 - 1960 .[ Google Scholar ] .Kim , YS ; Kim , JJ ; Cho , KH ; Jung , WS ; Moon , SK ; Park , EK ; Kim , DH .", "label": "", "metadata": {}, "score": "90.57464"}
{"text": "( PDF 532 KB ) .Authors ' original submitted files for images .Below are the links to the authors ' original submitted files for images .", "label": "", "metadata": {}, "score": "90.57778"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The identification of high - quality hits during the early phases of drug discovery is essential if projects are to have a realistic chance of progressing into clinical development and delivering marketed drugs .", "label": "", "metadata": {}, "score": "90.737274"}
{"text": "Declarations .Acknowledgements .This work was supported by a NIH / NCI LRP grant NIH2674 - 4/OHGB1623 LRP to LB .We would also like to thank Krishna Rao , MD , PhD for his critical review of this manuscript .", "label": "", "metadata": {}, "score": "90.884926"}
{"text": "The amount of apoptotic sub - G 1 hypodiploid cells was determined by flow cytometry [ 57 ] .A flow cytometric analysis was performed using a FACS Calibur flow cytometer ( Becton Dickinson , Mountain View , CA , USA ) .", "label": "", "metadata": {}, "score": "90.95114"}
{"text": "J. Agric .Food Chem 2009 , 57 , 1532 - 1537 .[ Google Scholar ] .Kim , do Y ; Park , MW ; Yuan , HD ; Lee , HJ ; Kim , SH ; Chung , SH .", "label": "", "metadata": {}, "score": "90.98672"}
{"text": "19 , pp .3918 - 3928 , 2001 .View at Google Scholar .5 , no .10 , pp .3292s-3303s , 1999 .", "label": "", "metadata": {}, "score": "91.24399"}
{"text": "[ Google Scholar ] .Chen , HL ; Chang , CY ; Lee , HT ; Lin , HH ; Lu , PJ ; Yang , CN ; Shiau , CW ; Shaw , AY .", "label": "", "metadata": {}, "score": "91.7784"}
{"text": "J. Cancer 1998 , 34 , 845 - 850 .[ Google Scholar ] .Clin .Cancer Res 2000 , 6 , 3260 - 3270 .", "label": "", "metadata": {}, "score": "92.01611"}
{"text": "Control cells ( vehicle treated ) were considered as 100 % viable against which treated cells were compared .Experiments were performed in triplicate .Data was expressed as mean \u00b1 SD of triplicate experiments .", "label": "", "metadata": {}, "score": "92.15425"}
{"text": "BT for 24 hrs .After treatment , cells were collected , washed and incubated with 5 \u03bcM C400 and analyzed by flow cytometry .Data was presented as relative - fluorescence intensity in a 2-dimensional FACS profile ( standardized gating , 20,000 events ) .", "label": "", "metadata": {}, "score": "92.32883"}
{"text": "Twenty thousand events were analyzed for each sample .Appropriate gating was used to select standardized cell population .( B ) Graphical representation of cell cycles analysis by FACS .", "label": "", "metadata": {}, "score": "92.4592"}
{"text": "To estimate ATX , cell free culture media ( 100 \u03bcL ) was incubated with 100 \u03bcL substrate containing p -nitrophenylphosphonate ( pNppp ) at a final concentration of 5 mM prepared in 50 mM Tris - HCl buffer , pH 9.0 .", "label": "", "metadata": {}, "score": "92.658554"}
{"text": "Rep 2008 , 19 , 595 - 600 .[ Google Scholar ] .Kim , do Y ; Yuan , HD ; Chung , IK ; Chung , SH .", "label": "", "metadata": {}, "score": "92.7325"}
{"text": "Lysed pellets were micro - centrifuged ( 15 min , 14,000 rpm , 4 \u00b0 C ) , the supernatant collected , and protein content determined by BCA assay ( Pierce ) , utilizing a BSA standard .", "label": "", "metadata": {}, "score": "92.902466"}
{"text": "Vehicle treated control cells ( media with 1 % DMSO ) were considered as 100 % viable against which treated cells were compared .Experiments were performed in triplicate .", "label": "", "metadata": {}, "score": "93.170105"}
{"text": "Aliquots of the lysates ( 50 \u03bcg of protein ) were boiled at 95 \u00b0 C for 5 min and electrophoresed on SDS - polyacrylamide gels .", "label": "", "metadata": {}, "score": "93.46483"}
{"text": "Mitochondrial transmembrane depolarization potential assay .Mitochondrial transmembrane depolarization potential was determined by flow cytometry using Rhodamine-123 .Ovarian cancer cells ( 1 \u00d7 10 6 ) were seeded in a 100 mm 2 culture dishes and treated with 50 \u03bcM or 100 \u03bcM", "label": "", "metadata": {}, "score": "93.71242"}
{"text": "Annu .Rev. Biochem 1999 , 68 , 383 - 424 .[ Google Scholar ] .Am .J. Pathol 1999 , 154 , 1439 - 1447 .", "label": "", "metadata": {}, "score": "94.43013"}
{"text": "Following treatment , 100 \u03bcL of CytoTox - One reagent was added to each well .After incubation for 10 min at room temperature , the fluorescence intensity ( 560 nm excitation/590 nm emission ) was measured using a fluorescence microplate reader , Fluoroskan ( Thermo Scientifics ) .", "label": "", "metadata": {}, "score": "94.78156"}
{"text": "Cell 2009 , 139 , 1327 - 1341 .[ Google Scholar ] .Mol .Cell .Biol 2005 , 25 , 3737 - 3751 .", "label": "", "metadata": {}, "score": "94.92499"}
{"text": "Twenty thousand cells were analyzed for each sample .Appropriate gating was used to select standardized cell population .Cell - cycle analysis .Cell cycle analysis was carried out by flow cytometry .", "label": "", "metadata": {}, "score": "95.0975"}
{"text": "J. Med 1996 , 334 , 1 - 6 .[ Google Scholar ] .Cancer Genome Atlas Research Network .Integrated genomic analyses of ovarian carcinoma .", "label": "", "metadata": {}, "score": "95.20301"}
{"text": "Cancer Res 1996 , 56 , 689 - 693 .[ Google Scholar ] .Int .J. Gynecol .Pathol 1999 , 18 , 29 - 41 .", "label": "", "metadata": {}, "score": "95.3582"}
{"text": "Blood 2009 , 114 : 3439 - 3447 . 10.1182/blood-2009 - 05 - 223677 PubMed View Article .Clin Cancer Res 2011 , 17 : 1753 - 1764 .", "label": "", "metadata": {}, "score": "95.60848"}
{"text": "Herzog TJ : The current treatment of recurrent ovarian cancer .Curr Oncol Rep 2006 , 8 ( 6):448 - 454 .PubMed View Article .", "label": "", "metadata": {}, "score": "95.90859"}
{"text": "10.1002/art.22400 PubMed View Article .Ann Rheum Dis 2011 , 70 : 909 - 920 .10.1136/ard.2010.144998 PubMed Central PubMed View Article .", "label": "", "metadata": {}, "score": "96.199524"}
{"text": "In lung cancer cells , although there are no differences in the proliferation rate of clones stably expressing this mutant , cells with this mutation do display significantly higher migration [ 36 ] .", "label": "", "metadata": {}, "score": "96.62165"}
{"text": "20 , pp .4261 - 4267 , 2002 .View at Publisher \u00b7 View at Google Scholar .23 , no .6 , pp .", "label": "", "metadata": {}, "score": "96.63034"}
{"text": "27 , no .6 , pp .53 - 61 , 2000 .View at Google Scholar .114 , no .26 , pp .", "label": "", "metadata": {}, "score": "96.88884"}
{"text": "All data were expressed as mean \u00b1 SD .Comparisons between untreated and each treated group were performed by Student 's t - test .Results .", "label": "", "metadata": {}, "score": "97.33157"}
{"text": "B - cell Chronic Lymphocytic Leukemia ( B - CLL ) .B - CLL is a heterogeneous disorder with a variable course ( i.e. , following diagnosis , survival ranges from months to decades ) and risk factors such as age and performance status should be considered when selecting the most appropriate treatment option [ 70 ] .", "label": "", "metadata": {}, "score": "97.39629"}
{"text": "Cells were treated with different concentrations of BT ranging from 0.178 \u03bcM to 400 \u03bcM and further incubated for 48 hrs or 72 hrs .At least 4 - 6 hrs before the end of treatment time , presto blue reagent was added and incubated for total of 48 or 72 hrs and fluorescence measured ( 540 nm excitation/590 nm emissions ) .", "label": "", "metadata": {}, "score": "97.400246"}
{"text": "J. Agric .Food Chem 2009 , 57 , 10573 - 10578 .[ Google Scholar ] .Planta Med 1994 , 60 , 240 - 243 .", "label": "", "metadata": {}, "score": "97.70777"}
{"text": "Control ( untreated ) cells were considered as 100 % viable against which treated cells were compared .The results represent % viability recovery when compared with 100 \u03bcM", "label": "", "metadata": {}, "score": "97.831436"}
{"text": "Gynecol .Obstet 2002 , 266 , 205 - 209 .[ Google Scholar ] .Gynecol .Oncol 2002 , 87 , 17 - 23 .", "label": "", "metadata": {}, "score": "97.91884"}
{"text": "Clin .Oncol 1997 , 123 , 496 - 501 .[ Google Scholar ] .J. Clin .Oncol 1995 , 13 , 70 - 78 .", "label": "", "metadata": {}, "score": "97.95125"}
{"text": "10.1182/blood-2010 - 04 - 276626 PubMed Central PubMed View Article .Clin Cancer Res 2012 , 18 : 4830 - 4840 . CCR-11- 3007 PubMed View Article .", "label": "", "metadata": {}, "score": "97.966515"}
{"text": "Pharm .Bull 1998 , 21 , 245 - 249 .[ Google Scholar ] .Kang , KA ; Kim , YW ; Kim , SU ; Chae , S ; Koh , YS ; Kim , HS ; Choo , MK ; Kim , DH ; Hyun , JW .", "label": "", "metadata": {}, "score": "98.24246"}
{"text": "Cell lines were treated with 100 \u03bcMBT for 24 hrs .Mitochondrial potential was determined by flow cytometry using Rhodamne-123 .Data was acquired by BD 's Accuri C6 flow cytometer system and analyzed .", "label": "", "metadata": {}, "score": "98.3656"}
{"text": "Free Radic Biol Med 2012 , 52 ( 2):516 - 526 .PubMed View Article .Pre - publication history .Copyright .\u00a9 Ayyagari and Brard ; licensee BioMed Central Ltd. 2014 .", "label": "", "metadata": {}, "score": "98.36587"}
{"text": "Department of Neuroscience , College of Medicine , Ewha Womans University , Seoul 110 - 783 , Korea .Department of Microbial Chemistry , College of Pharmacy , Kyung Hee University , Seoul 130 - 701 , Korea .", "label": "", "metadata": {}, "score": "98.82207"}
{"text": "Planta Med 1998 , 64 , 500 - 503 .[ Google Scholar ] .Lee , JY ; Shin , JW ; Chun , KS ; Park , KK ; Chung , WY ; Bang , YJ ; Sung , JH ; Surh , YJ .", "label": "", "metadata": {}, "score": "99.23695"}
{"text": "PubMed View Article .Leukemia 2012 , 26 : 149 - 157 .10.1038/leu.2011.196 PubMed Central PubMed View Article .Blood 2008 , 112 : 2489 - 2499 .", "label": "", "metadata": {}, "score": "99.33623"}
{"text": "Apoptosis is followed by cell shrinkage , nuclear fragmentation , membrane blebbing , DNA fragmentation , and finally the breakdown of the cell into apoptotic bodies [ 7 - 9 ] .", "label": "", "metadata": {}, "score": "99.50878"}
{"text": "4 , pp .712 - 719 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .24 , no .", "label": "", "metadata": {}, "score": "100.63162"}
{"text": "19 , pp .3121 - 3127 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .23 , no . 9 , pp .", "label": "", "metadata": {}, "score": "101.10423"}
{"text": "3725 - 3732 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .108 , no .10 , pp .", "label": "", "metadata": {}, "score": "101.296196"}
{"text": "The authors declare that they have no competing interests .Authors ' contributions .VA performed experimental procedures ; LB and VA are responsible for study design , interpretation of results and writing of manuscript .", "label": "", "metadata": {}, "score": "101.304855"}
{"text": "Piloto O. , et al . , Blood 109(4 ) : 1643 - 1652 ( 2007 ) and Brent R. , et al . , AACR Annual Meeting 2007 , Los Angeles ( 2007 ) .", "label": "", "metadata": {}, "score": "101.44417"}
{"text": "Med 1996 , 183 , 1533 - 1544 .[ Google Scholar ] .Cai , J ; Yang , J ; Jones , DP .", "label": "", "metadata": {}, "score": "101.52352"}
{"text": "5 , pp .3280 - 3288 , 2004 .View at Google Scholar .289 , no . 1 - 2 , pp .97 - 109 , 2004 .", "label": "", "metadata": {}, "score": "102.18085"}
{"text": "5 , pp .944 - 956 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .103 , no .", "label": "", "metadata": {}, "score": "102.2153"}
{"text": "10.1016/j.exphem.2009.04.001 PubMed View Article .Leukemia 2010 , 24 : 1506 - 1512 .10.1038/leu.2010.137 PubMed View Article .Leukemia 2012 , 26 : 757 - 768 .", "label": "", "metadata": {}, "score": "102.24707"}
{"text": "2316 - 2323 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .108 , no . 8 , pp .", "label": "", "metadata": {}, "score": "102.50681"}
{"text": "115 , no .14 , pp .2864 - 2871 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . 10 , no . 8 , pp .", "label": "", "metadata": {}, "score": "102.54795"}
{"text": "4143 - 4149 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .22 , p. 597 , 2003 .", "label": "", "metadata": {}, "score": "103.06145"}
{"text": "BT for 24 hrs .At the end of the incubation period , detached cells were collected in 15 mL polypropylene centrifuge tubes along with the medium ; culture dishes were washed once with PBS .", "label": "", "metadata": {}, "score": "103.719574"}
{"text": "28 , pp .4579 - 4586 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .106 , no .", "label": "", "metadata": {}, "score": "104.370766"}
{"text": "Authors ' Affiliations .Division of Gynecologic Oncology ; Department of Obstetrics and Gynecology , Southern Illinois University School of Medicine .References .American Cancer Society : Cancer facts and figures 2013 .", "label": "", "metadata": {}, "score": "104.54509"}
{"text": "+1 - 319 - 356 - 1976 ; Fax :+1 - 319 - 335 - 8448 .Received : 18 July 2013 ; in revised form : 13 August 2013 / Accepted : 15 August 2013 / Published : 23 September 2013 .", "label": "", "metadata": {}, "score": "104.963684"}
{"text": "Cells were treated with BT for 6 , 24 and 48 hrs .Vehicle treated ( media with 1 % DMSO ) were considered as control against which treated cells were compared .", "label": "", "metadata": {}, "score": "104.980415"}
{"text": "Ovarian cancer cell lines were treated with 100 \u03bcMBT for 24 hrs .Treated / untreated cells were stained with Hoechst 33258 and visualized by fluorescence microscopy .", "label": "", "metadata": {}, "score": "104.989334"}
{"text": "Microscopic images were collected using the Laser Scanning Microscope 5 PASCAL program ( Carl Zeiss , Jena , Germany ) on a confocal microscope .Western Blot Analysis .", "label": "", "metadata": {}, "score": "104.99775"}
{"text": "- 3684 PubMed View Article .Copyright .\u00a9 Verbrugge et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "105.28659"}
{"text": "No preview \u00b7 Article \u00b7 Feb 2012 \u00b7 Leukemia : official journal of the Leukemia Society of America , Leukemia Research Fund , U.K .[ Show abstract ] [ Hide abstract ] ABSTRACT : The somatic genetic basis of chronic lymphocytic leukemia , a common and clinically heterogeneous leukemia occurring in adults , remains poorly understood .", "label": "", "metadata": {}, "score": "105.56146"}
{"text": "Colorectal cancer is the fourth most prevalent carcinoma in western society and the second cause of cancer death [ 25 ] .And genetic alterations by ROS are the ultimate underlying mechanisms of colorectal carcinogenesis [ 26 , 27 ] .", "label": "", "metadata": {}, "score": "105.905624"}
{"text": "Cells were incubated 15 min .at 25 \u00b0 C and observed under fluorescent microscope .Representative images were taken with an inverted microscope ( Olympus H4 - 100 , CCD camera ) and 20\u00d7 objective .", "label": "", "metadata": {}, "score": "106.18611"}
{"text": "Reactive oxygen species ( ROS ) are the by - products of normal cellular oxidative processes , and are mainly generated in the mitochondria .They attack lipid membranes , proteins , and DNA , leading to serious cell damage , and regulate apoptotic signal transduction [ 1 - 3 ] .", "label": "", "metadata": {}, "score": "106.21047"}
{"text": "Short term incubations of 24 hours and 48 hours were performed with 5nM BTZ for JY / WT , 35nM for JY/35BTZ cells and 100nM BTZ for JY/100BTZ cells .", "label": "", "metadata": {}, "score": "106.41366"}
{"text": "6 , pp .1851 - 1857 , 1999 .View at Google Scholar .27 , no .4 , pp .491 - 497 , 2009 .", "label": "", "metadata": {}, "score": "106.49329"}
{"text": "101 , no .11 , pp .4279 - 4284 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .", "label": "", "metadata": {}, "score": "107.442566"}
{"text": "No .12/473,295 filed 28 May 2009 , which claims the benefit of U.S. Provisional Application Nos .61/130,395 , 61/130,539 , and 61/103,394 all of which were filed May 30 , 2008 .", "label": "", "metadata": {}, "score": "107.446304"}
{"text": ": Ovarian cancer is the most lethal gynecological malignancy , with an alarmingly poor prognosis attributed to late detection and chemoresistance .Initially , most tumors respond to chemotherapy but eventually relapse due to the development of drug resistance .", "label": "", "metadata": {}, "score": "107.994415"}
{"text": "Patent applications , documents and images may contain trademarks of the respective companies / authors .FreshPatents is not responsible for the accuracy , validity or otherwise contents of these public document patent application filings .", "label": "", "metadata": {}, "score": "108.44976"}
{"text": "4 , pp .259 - 263 , 1992 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .121 , no .", "label": "", "metadata": {}, "score": "108.53371"}
{"text": "24 , no .10 , pp .1760 - 1768 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .", "label": "", "metadata": {}, "score": "108.67302"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Plasmodium falciparum - induced severe malaria remains a continuing problem in endemic areas , with elevated morbidity and mortality .", "label": "", "metadata": {}, "score": "108.766174"}
{"text": "5137 - 5144 , 2001 .View at Google Scholar \u00b7 View at Scopus .175 , no .4 , pp .2174- 2183 , 2005 .", "label": "", "metadata": {}, "score": "108.945694"}
{"text": "2121 - 2143 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus . 64 , no .", "label": "", "metadata": {}, "score": "109.187874"}
{"text": "27 , no .4 , pp .479 - 480 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .", "label": "", "metadata": {}, "score": "109.80295"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Leukemia is one of the leading journals in hematology and oncology .It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases .", "label": "", "metadata": {}, "score": "110.359314"}
{"text": "Sign up ( takes 30 seconds ) .Fill in the keywords to be monitored .Each week you receive an email with patent applications related to your keywords .", "label": "", "metadata": {}, "score": "111.25249"}
{"text": "Cells ( 1 \u00d7 10 6 ) were seeded in a 100 mm 2 culture dishes and treated with 50 \u03bcM or 100 \u03bcMBT for 6 and 24 hrs .", "label": "", "metadata": {}, "score": "111.91269"}
{"text": "Chem 2009 , 284 , 12178 - 12187 .[ Google Scholar ] .Cell Cycle 2008 , 7 , 1870 - 1879 .[ Google Scholar ] .", "label": "", "metadata": {}, "score": "113.07202"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable .all Addendum Article Book Review Case Report Comment Commentary Communication Concept Paper Conference Report Correction Creative Data Descriptor Discussion Editorial Erratum Essay Interesting Images Letter New Book Received Obituary Opinion Project Report Reply Retraction Review Short Note Technical Note .", "label": "", "metadata": {}, "score": "113.20167"}
{"text": "All authors read and approved the final manuscript .Authors ' Affiliations .Department of Rheumatology , VU University Medical Center .The Fred Wyszkowski Cancer Research Laboratory , Faculty of Biology , The Technion - Israel Institute of Technology .", "label": "", "metadata": {}, "score": "115.19339"}
{"text": "We would like to thank Shawn Roach for the assistance with figure preparation .This work was partially supported by NIH Grant R01CA99908 - 7 to K.K.L. and the Department of Obstetrics and Gynecology Research Development Fund at the University of Iowa .", "label": "", "metadata": {}, "score": "115.68018"}
{"text": "Gastroenterol 2007 , 41 , 394 - 399 .[ Google Scholar ] .J. Pathol 2009 , 219 , 77 - 86 .[ Google Scholar ] .", "label": "", "metadata": {}, "score": "117.801605"}
{"text": "Statistical Analysis .All the measurements were performed in triplicate and all values were represented as the mean standard error ( SE ) .Results were subjected to an analysis of the variance ( ANOVA ) using the Tukey test for analysis of the differences .", "label": "", "metadata": {}, "score": "119.81955"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .108 , no . 13 , pp .4003 - 4008 , 2006 .", "label": "", "metadata": {}, "score": "121.6262"}
{"text": "Department of Obstetrics and Gynecology , Carver College of Medicine , University of Iowa , Iowa City , IA 52242 , USA .Holden Comprehensive Cancer Center , Carver College of Medicine , University of Iowa , Iowa City , IA 52242 , USA .", "label": "", "metadata": {}, "score": "121.99462"}
{"text": "Ovarian cancer accounts for 5 % of cancer deaths among women in the United States and has the highest mortality rate of all gynecologic cancers [ 1 ] .", "label": "", "metadata": {}, "score": "124.72098"}
{"text": "Received : 30 October 2010 ; in revised form : 19 November 2010 / Accepted : 19 November 2010 / Published : 1 December 2010 .", "label": "", "metadata": {}, "score": "128.60944"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .M. Hallek , G. Fingerle - Rowson , and A.-M. View at Google Scholar .", "label": "", "metadata": {}, "score": "131.46785"}
{"text": "View at Google Scholar .28 , no . 13 , pp .2246 - 2252 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .", "label": "", "metadata": {}, "score": "135.91255"}
{"text": "Received 1 July 2010 ; Revised 5 November 2010 ; Accepted 22 December 2010 .Academic Editor : Scott Antonia .Copyright \u00a9 2010 Giulia Motta et al .", "label": "", "metadata": {}, "score": "136.16231"}
{"text": "Data source : patent applications published in the public domain by the United States Patent and Trademark Office ( USPTO ) .Information published here is for research / educational purposes only .", "label": "", "metadata": {}, "score": "137.40149"}
